0001213900-17-005341.txt : 20170516 0001213900-17-005341.hdr.sgml : 20170516 20170516104413 ACCESSION NUMBER: 0001213900-17-005341 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 42 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170516 DATE AS OF CHANGE: 20170516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: My Size, Inc. CENTRAL INDEX KEY: 0001211805 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37370 FILM NUMBER: 17847506 BUSINESS ADDRESS: STREET 1: 3 ARAVA ST. CITY: AIRPORT CITY STATE: L3 ZIP: 7010000 BUSINESS PHONE: 972-36009030 MAIL ADDRESS: STREET 1: 3 ARAVA ST. CITY: AIRPORT CITY STATE: L3 ZIP: 7010000 FORMER COMPANY: FORMER CONFORMED NAME: Mysize Inc. DATE OF NAME CHANGE: 20150317 FORMER COMPANY: FORMER CONFORMED NAME: TOPSPIN MEDICAL INC DATE OF NAME CHANGE: 20021226 10-Q 1 f10q0317_mysizeinc.htm QUARTERLY REPORT

U. S. Securities and Exchange Commission

Washington, D. C. 20549

FORM 10-Q

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2017

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission File No. 001-37370

MY SIZE, INC.

(Exact name of registrant as specified in its charter)

Delaware		51-0394637
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer I.D. No.)

3 Arava St., pob 1026, Airport City, Israel, 7010000

(Address of principal executive offices)

+972-3-600-9030

Registrant’s telephone number, including area code:

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.) Yes ☒ No ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐ (Do not check if a smaller reporting company)	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 17,605,359 shares of common stock, par value $0.001 as of May 16, 2017.

MY SIZE, INC.

INDEX TO FORM 10-Q FILING

FOR THE THREE MONTHS ENDED MARCH 31, 2017

TABLE OF CONTENTS

		PAGE
PART I - FINANCIAL INFORMATION

Item 1.	Condensed Consolidated Financial Statements (Unaudited)	1
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Comprehensive Income (Loss)	4
	Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficiency)	5
	Condensed Consolidated Statements of Cash Flows	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management Discussion & Analysis of Financial Condition and Results of Operations	19
Item 3.	Quantitative and Qualitative Disclosure About Market Risk	22
Item 4.	Controls and Procedures	22

PART II - OTHER INFORMATION

Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	26
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	26
Item 3.	Defaults Upon Senior Securities	26
Item 4.	Mining Safety Disclosures	26
Item 5	Other information	26
Item 6.	Exhibits	26

PART I

FINANCIAL INFORMATION

Item 1. Financial Statements.

My Size Inc. and Subsidiaries

Condensed Interim

Consolidated

Financial Statements

As of March 31, 2017

U.S. Dollars in Thousands

My Size Inc.

Condensed Interim Consolidated Financial Statements as of March 31, 2017 (Unaudited)

Contents

	Page

Condensed Consolidated Balance Sheets	3

Condensed consolidated Statements of Comprehensive Income (Loss)	4

Condensed Consolidated Statements of Stockholders’ Equity (Deficiency)	5-6

Condensed Consolidated Statements of Cash flows	7

Notes to Condensed Consolidated Financial Statements	8-18

My Size Inc.

Condensed Consolidated Balance Sheets

U.S. dollars in thousands (except share data and per share data)

	March 31			December 31
	2017			2016
	(Unaudited)			(Audited)
	$ thousands			$ thousands
Assets
Curent Assets:
Cash and cash equivalents		359			34
Other receivables and prepaid expenses		1,619			1,401
Restricted cash		66			62
Total current assets		2,044			1,497

Investment in marketable securities		362			579
Property and equipment, net		75			74
		437			653

Total assets		2,481			2,150

Liabilities and stockholders’ equity
Current liabilities
Trade payable		188			229
Accounts payable		431			316
Derivative liabilities		78			80
Warrants to purchase common stock		168			-

Total current liabilities		865			625

COMMITMENTS AND CONTINGENCIES
Stockholders’ equity (Deficiency):
Capital stock -
Common stock of $ 0.001 par value - Authorized: 50,000,000 shares; Issued and outstanding: 17,605,359 and 17,405,359 respectively		17			17
Additional paid-in capital		14,744			13,347
Available for sale reserve		-			(93	)
Accumulated other comprehensive loss		(107	)		(102	)
Accumulated deficit		(13,038	)		(11,644	)

Total stockholders’ equity		1,616			1,525
Total liabilities and stockholders’ equity		2,481			2,150

The accompanying notes are an integral part of the consolidated financial statements.

My Size Inc.

Condensed Consolidated Statements of Comprehensive Loss

U.S. dollars in thousands (except share data and per share data)

	Three months ended March 31						Year ended
	2017			2016			December 31
	(Unaudited)			(Unaudited)			2016
	$ thousands			$ thousands			$ thousands
Operating expenses
Research and development		207			177			727
Marketing, General and administrative		879			326			1,859

Total operating expenses		1,086			503			2,586
Operating loss		(1,086	)		(503	)		(2,586	)
Financial (expense) income, net		(308	)		614			(1,748	)

Net (loss) income from continuing operations		(1,394	)		111			(4,334	)

Other comprehensive (loss) income:

Gain (loss) on available for sale securities		93			67			(24	)
Foreign currency translation differences		(5	)		(90	)		2

Total comprehensive (loss) income		(1,306	)		88			(4,356	)

Basic (loss) earnings per share		(0.08	)		0.01			(0.27	)
Diluted (loss) earnings per share		(0.08	)		0.05			(0.27	)
Basic weighted average number shares outstanding		17,525,359			15,313,793			16,345,499

Diluted weighted average number of shares outstanding		17,525,359			15,492,659			16,345,499

The accompanying notes are an integral part of the interim financial statements

My Size Inc.

Condensed Consolidated Statements Shareholders’ Equity (Unaudited)

U.S. dollars in thousands (except share data and per share data)

	Common stock					Additional paid-in		Available for sale			Foreign currency			Accumulated			Total Stockholders’
	Number		Amount			capital		reserve			transaction			Deficit			equity

Balance as of January 1, 2017		17,405,359		17			13,347		(93	)		(102	)		(11,644	)		1,525

Total comprehensive loss		-		-			-		93			(5	)		(1,394	)		(1,306	)
Stock-based compensation related to
options granted to consultants		-		-			997		-			-			-			997
Receipts on account of shares and New investments		200,000		(*	)		400		-			-			-			400
Balance as of March 31, 2017		17,605,359		17			14,744		-			(107	)		(13,038	)		1,616

(*) Represent an amount less than $1.

The accompanying notes are an integral part of the interim financial statements

My Size Inc.

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficiency)

U.S. dollars in thousands (except share data and per share data)

	Common stock				Additional paid-in			Available for sale			Accumulated other comprehensive income			Accumulated			Total stockholders' equity
	Number		Amount		capital			reserve			(loss)			Deficit			(deficiency)

Balance as of January 1, 2016		15,313,793	$	15	$	4,853		$	(67	)	$	(104	)	$	(7,310	)	$	(2,613	)

Total comprehensive gain		-		-		-			-			(90	)		111			21
Stock-based compensation related to options granted to consultants		-		-		(50	)		-			-			-			(50	)
Gain on marketable securities		-		-		-			67			-			-			67
Warrants reclassified to equity as a result of amended exercise price currency		-		-		1,041			-			-			-			1,041
Balance as of March 31, 2016		15,313,793	$	15	$	5,844		$	-		$	(194	)	$	(7,199	)	$	(1,534	)

	Common stock				Additional paid-in			Available for			Foreign currency			Accumulated			Total Stockholders’ equity
	Number		Amount		capital			sale			transaction			Deficit			(deficiency)

Balance as of December 31, 2015	15,313,793		15		4,855			(69)			(104)			(7,310)			(2,613)

Stock-based compensation related to options granted - to consultants		-		-		(23	)		-			-			-			(23	)
Total comprehensive loss		-		-		-			(24	)		2			(4,334	)		(4,356	)
Convertible loans converted to equity		2,091,566		2		7,528			-			-			-			7,530
Warrants reclassified to equity as a result of amended exercise price currency		-		-		987			-			-			-			987

Balance as of December 31, 2016		17,405,359		17		13,347			(93	)		(102	)		(11,644	)		1,525

The accompanying notes are an integral part of the interim financial statements

My Size Inc.

Condensed Interim Consolidated Statements of Cash Flows

	Three-Months Ended March 31,						Year ended December
	2017			2016			2016
	$ thousands (Unaudited)			$ thousands (Unaudited)			$ thousands (Audited)

Cash flows from operating activities:

Net income (loss)		(1,394	)		111			(4,334	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation		7			5			24
Amortization of warrant, convertible loans and Derivative		(29	)		(614	)		(182	)
Revaluation PUT Option		-			-			776
Revaluation investment in marketable securities		340			-			1,233
Stock based compensation		39			(50	)		(23	)
Decrease (increase) in receivables and prepaid expenses		(8	)		(15	)		(27	)
Increase (decrease) in embedded derivative		(6	)		-			80
Increase (decrease) in trade payable		(54	)		56			86
Increase in other accounts payable		93			28			208

Net cash used in operating activities		(1,012	)		(479	)		(2,159	)

Cash flows from investing activities:

Purchase of property and equipment		(3	)		(13	)		(36	)

Net cash used in investing activities		(3	)		(13	)		(36	)

Cash flows from financing activities:
Payment for a loan		-			-			(25	)
Payment from guarantees		1,149			-			-
Proceeds from Issuing shares, warrants and convertible loans		200			-			1,339

Net cash provided by financing activities		1,349			-			1,314

Effect of exchange rate changes on cash and cash equivalents		(9	)		(2	)		(4	)

(Decrease) Increase in cash and cash equivalents		325			(494	)		(885	)
Cash and cash equivalents at the beginning of the period		34			919			919

Cash and cash equivalents at the end of the period		359			425			34

Non cash transactions
Warrants reclassified to equity as a result of amended exercise price currency		-			1,041			-
Warrants reclassified to equity as a result of amended exercise price currency		-			-			987
Conversion of loan to equity		-			-			4,846
Non cash share base payments		958			-			-

The accompanying notes are an integral part of the interim financial statements.

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 1 – General

	a.	My Size Inc. (the “Company”) developed a unique measurement technology based on sophisticated algorithms with broad applications in a variety of areas, from the apparel e-commerce market to Do It Yourself (DIY) smartphone & tablet apps. The technology is driven by several patent-pending algorithms which are able to calculate and record measurements in a variety of novel ways.

	b.	Since inception, the Company has incurred losses and negative cash flows from operations and the accumulated loss has reached $13 million. The Company has financed its operations mainly through fundraising from private investors. As of March 31, 2017, the Company entered into fund raising agreements in a total sum of $8,015 out of which the sum of $4,596 and $1,410 was received in cash and marketable securities, respectively. The marketable securities are shares of common stock of Diamante minerals Inc (“DIMN”), which are presented in the Company’s balance sheet as a financial asset available for sale.

As of the date of the report, the Company has $1,514 and $495 in guaranteed notes and checks, respectively. The guarantee has been provided by an ungraded financial institution. Subsequent to March 31, 2017, the sum of $550 and $40 of the guarantee notes and the checks respectively have been redeemed in cash.

For the purpose of financing its operating activities in the foreseeable future, the Company relies on the collection of existing cash commitments from investors, the sale of marketable securities and raising additional funds. However, there is no certainty regarding the Company’s ability to collect committed funds, obtain additional funding or sell the DIMN shares that it holds. The Company estimates that the committed investments will be adequate to fund its operations through the 12 months following the approval date of the financial statements. Failure to obtain the additional funds as mentioned above will require the Company to curtail operations.

However, If all the committed funds are not collected or not replaced by additional funding, there is a significant doubt regarding the Company's ability to continue its operation as a going concern. The financial statements include no adjustments for measurement or presentation of assets and liabilities, which may be required should the Company fail to operate as a going concern.

Note 2 - Significant Accounting Policies

Unaudited condensed consolidated financial statements:

The accompanying unaudited condensed consolidated financial statements included herein have been prepared by the Company in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements are comprised of the financial statements of the Company and its subsidiaries collectively referred to as the Company. In management’s opinion, the interim financial data presented includes all adjustments necessary for a fair presentation. All intercompany accounts and transactions have been eliminated. Certain information required by U.S. generally accepted accounting principles has been condensed or omitted in accordance with rules and regulations of the SEC. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for any future period or for the year ending December 31, 2017.

These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2016.

Use of estimates:

The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates.

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 2 - Significant Accounting Policies (cont’d)

Impact of recently issued accounting standard not yet adopted:

In January 2016, the FASB issued Accounting Standards Update No. 2016-01 (ASU 2016-01) “Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 amends various aspects of the recognition, measurement, presentation, and disclosure for financial instruments. With respect to our consolidated financial statements, the most significant impact relates to the recognition and measurement for equity investments. Additionally, ASU 2016-01 will impact the disclosure and presentation of financial assets and liabilities. ASU 2016-01 is effective for annual reporting periods, and interim periods within those years beginning after December 15, 2017. Early adoption by public entities is permitted only for certain provisions. The Company is examining the effects of the update on the financial statements with no plans for early adoption.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02) which amends the FASB Accounting Standards Codification and created Topic 842, “Leases.” Under Topic 842, lessees are required to recognize assets and liabilities on the balance sheet for most leases and provides for enhanced disclosures. Leases will continue to be classified as either finance or operating. ASU 2016-02 is effective for annual reporting periods, and interim periods within those years beginning after December 15, 2018. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Full retrospective application is prohibited and early adoption by public entities is permitted. The Company is examining the possibility of early adoption of the update and the anticipated effects of its adoption on the financial statements.

In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, which significantly changes the way entities recognize impairment of many financial assets by requiring immediate recognition of estimated credit losses expected to occur over their remaining life. This ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2019. Early adoption is permitted for annual and interim periods in fiscal years beginning after December 15, 2018. The impact of adopting the new standard on the net income is not expected to be material.

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 3 - Financial Instruments

Fair value of financial instruments:

ASC 820, “Fair Value Measurements and Disclosures”, defines fair value as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

In determining fair value, the Company uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

	Level 1 -		Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

	Level 2 -		Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

	Level 3 -		Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The expected volatility of the share prices reflects the assumption that the historical volatility of the share prices is reasonably indicative of expected future trends.

The carrying amounts of cash and cash equivalents, other accounts receivable, short-term loan, accounts payable and other accounts payable approximate their fair value due to the short-term maturities of such instruments.

The Company holds shares in a publicly-traded company - Diamante minerals Inc which are classified as available-for-sale equity securities. The marketable securities have readily determinable fair market values that are calculated based on the share price in the measurement date and ranked as Level 1 assets.

March 31, 2017

Fair value hierarchy

Level 1

Level 2

Level 3

Financial assets

Investment in marketable securities (*)

362

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 3 - Financial Instruments (cont’d)

	March 31, 2017
	Fair value hierarchy
	Level 1		Level 2		Level 3
Financial liabilities

Warrants to purchase common stock (*)		-		168		-
Derivative liabilities (**)		-		78		-

(*) see note 6.

(**) see note 4a.

	March 31, 2016
	Fair value hierarchy
	Level 1		Level 2		Level 3
Financial assets

Investment in marketable securities (***)		1,012		-		-

Put Options – DIMN shares		-		989		-

	March 31, 2016
	Fair value hierarchy
	Level 1		Level 2		Level 3
Financial liabilities

Warrants		-		9		-

Derivative liabilities embedded conversion options		-		14		-

December 31, 2016

Fair value hierarchy

Level 1

Level 2

Level 3

Financial assets

Investment in marketable securities (***)

579

December 31, 2016

Fair value hierarchy

Level 1

Level 2

Level 3

Financial liabilities

Derivative liabilities

(***) At March 31, 2017, gross unrecognized loss, recognized loss and fair value (based on quoted market prices) of these securities were $(93), $340 and $362, respectively (At December 31, 2016, $24, $1,233 and $579, respectively)

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 4 - Stock Based Compensation

The stock based expense (income) recognized in the financial statements for services received from employees and non-employees is shown in the following table:

	Three months ended March 31					Year ended December 31,
	2017		2016			2016

Marketing, General and Administrative		39		(50	)		(23	)

		39		(50	)		(23	)

In December 2016, the Company entered into a consulting agreement with a consultant (the “Consultant”) for the rendering of providing services in connection with marketing strategies, micro and macro-economic issues and for the promotion of the Company's marketing, business, products and operations through smartphone applications. The agreement is for a period of 18 months commencing from October 2016.

In consideration for the services the Company will issue to the Consultant 25,000 shares of common stock of the Company which will be transferred in five installments of 4,150 each and a sixth installment of 4,250 shares each quarter. In addition, the company will issue to the Consultant stock options for the acquisition of the Company shares, exercisable not later than March 31, 2018 at an exercise price of NIS18 per share.

In addition, the Company undertook to pay the balance of the consideration for the sale of the shares by the Consultant up to the sum of NIS500,000. If the consideration for the sale of the shares falls below 90% of the shares' price on the stock exchange on the date of their sale, the Company shall pay the Consultant the difference. The company may decide at its own discretion whether to make such payment in cash or shares.

On March 21, 2017, the general meeting adopted a resolution for the approval of a capital remuneration plan for consultants. The approval was required for the issue of the shares of common stock of the Company and the stock options.

During 2017, costs in the sum of $12 ($90 during 2016) were recorded by the Company and an undertaking to pay the balance of the consideration was recognized in the sum of $78 ($80 during 2016) according to the fair value of the undertaking. The issue of the shares of common stock of the Company and stock options was subject to the receipt of all required regulatory approvals. As of the date of the financial report, the shares and options have not yet been issued.

In December 2016, the Company engaged with an external consultant (the “Consultant”) to provide services in marketing strategy and public relations, including potential investors relations. For such consulting services, the Company shall issue to the Consultant options to purchase 2,000,000 shares of common stock at variable exercise prices ranging from $3.50 to $9.00 per share and exercisable for periods ranging from 12 month (or 6 months from filing date of registration statement) to 36 months. The issuance of the options under the agreement is subject to the receipt of all the approvals required by the laws applicable to the Company, including stock exchange approvals and the approval of a meeting of its shareholders to adopt an equity incentive plan for consultants. The equity incentive plan for consultants was approved by the shareholders on March 21, 2017, and such options have not yet been issued. The expenses were recognized for the proportion of the time in the sum of $26 according to the fair value of the undertaking. The balance of the consideration for the rest of the expenses in accordance with the fair value was recognized in trade receivables for the sum of $958.

On May 16, 2017, subsequent to the reporting period, the Company and the Consultant signed an amendment to the agreement for making the adjustment to the strike prices so prices ranging from $1.50 to $5.00 per share.

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 5 - Contingencies and Commitments

On December 27, 2015, the Company received a legal complaint. The defendants are the Company, all the members of the Board of Directors, Mrs. Shoshana Zigdon, a shareholder and related party of the Company, as well as two additional defendants who are not shareholders, officers or directors of the Company. The plaintiff alleges that the Company violated its obligation to register his shares for trade with the Tel Aviv Stock Exchange causing a total of 2,622,500 NIS damage. The plaintiff seeks relief against the defendants through financial compensation at the rate of the aforementioned alleged damage; additional compensation of 400,000 NIS due to mental anguish; and if and to the extent that until the time the plaintiff can sell its shares on the Tel Aviv Stock Exchange ("the exercise date "), if the rate of a Company shares rises above the amount of 20.98 NIS ("the base rate"), an additional amount at the rate of the difference between the base rate and the highest rate of the Company's shares between the time the claim was submitted and the exercise date; and also court costs and attorney's fees of the plaintiff.

All pre-trial preliminary proceedings as well as submission of all evidentiary affidavits and expert opinions by both parties have been completed.

Pursuant to the Court's recommendation, the case was referred to mediation by the honorable Judge (Rtd.) Hilla Gerstel, former president of the Central District Court. The mediation is going on and the next mediation session is scheduled for June 5, 2017.

The Company estimates, based on the opinion of its legal counsel that the risk of acceptance of the remedy requested by the plaintiff in his claim, namely, that the Company was obligated to remove the restriction which was imposed on the shares and register plaintiff's shares for trade on the stock exchange, exceeds the chance of its dismissal. This remedy, as such, does not constitute any financial exposure to the Company. However, the company believes, based on the opinion of its legal counsel, that assuming the plaintiff's claim for the main relief, i.e. the removal of the restriction from and the registration of his shares on the stock exchange, will be accepted by the court, it appears that prima face the risk that the court will also rule that the plaintiff is entitled to financial compensation for the alleged delay in registering his shares, exceeds the chance that such financial compensation will not be awarded.

According to the expert opinion submitted to the court by the plaintiff, the plaintiff's expert calculates the approximate damage allegedly caused to the plaintiff between 3-3.6 million NIS assuming the shares will be registered by December 31, 2016, and additional compensation for each additional month subsequently. According to the Company's expert opinion submitted to the court, the Company's expert asserts that the plaintiff's expert opinion is erroneous and in his opinion and assuming the plaintiff's claim will be accepted by the court, than the estimated damage caused to the plaintiff as a result of a 4-5 years delay in registering his shares is estimated at approximately NIS 234,000 (plus interest and CPI differences) if it will be ruled that the restriction from plaintiff's shares should have been removed within six months as of the purchase date thereof and at approximately NIS 130,000 if it will be ruled that the restriction from plaintiff's shares should have been removed within twelve months as of the purchase day thereof. It should be noted that all experts' calculations are based on the share market price, and consequently any changes in the share price at the time a judgement will be rendered by the court, could increase or decrease the Company's exposure, respectively.

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 5 - Contingencies and Commitments (cont’d)

At this stage, the time for the submission of an expert opinion on behalf of the Company for the calculation of the damage has not arrived and the appropriate method of calculating the loss based on the circumstances in this case has not been determined.

On May 17, 2012, the Company signed an agreement for a convertible loan with a third party (hereinafter the “Investor”). In accordance with the loan agreement, the Company received a total of NIS 200,000 with the signing of the loan agreement and was to receive an additional amount of NIS 100,000 at the end of a period not exceeding 21 days, during which the investor would perform due diligence on the Company. In addition, the agreement was for additional investments up to a total of NIS 2,000,000.

Under the agreement, the investor was entitled to convert the loan amounts granted to the Company into common shares of the Company with US $ 0.001 par value each, at a price per share equal to the amount of NIS 0.97. If the loans were not converted into the Company shares, the loan was to be repaid one year after the date of the loan agreement plus annual interest of 10%.

On February 18, 2015, the Company received a claim in a summary judgement for the investor’s demand of payment of the loan amount of NIS 200,000, which was granted to the Company on May 17, 2012, plus interest of 10% annually as from May 20, 2012 until payment of the debt, which as of the date of filing of the claim was NIS 258,000.

On June 13, 2016, a settlement agreement was entered into between the parties according to which in consideration for the final and conclusive annulment of all claims and/or demands raised by the plaintiff against the Company in the framework of the law suit, the Company would pay the plaintiff the sum of NIS 250,000 forthwith by wire transfer of about NIS 95,000 and by the forfeiture of the sum of about NIS 155,000 which had been deposited with the court. An additional amount of NIS 50,000 would be paid within twelve months from the approval of the settlement agreement by the court or on the closing date of a public offering of Company shares, pursuant to its terms, on a stock exchange in the United States, the earlier of. As of the date on which the financial statements were signed the payment has not yet occurred.

On September 9, 2015, fourteen shareholders filed a complaint against the Company and its CEO Mr. Ronen Luzon, alleging that in accordance with agreements signed between plaintiffs and the Company, the plaintiffs are entitled to register their shares for sale with the stock market, while the Company allegedly breached its obligation and refrained from doing its duty to register the plaintiffs' shares. The plaintiffs seek declaratory remedy that they are entitled to register their shares and also request the right to split their remedies so they will also be able subsequently to claim from the defendants compensation for any financial damage causes by the Company's failure to register their shares, including damage due to any decrease in the shares' price during the period the shares should have been registered. On November 5, 2015, the Company filed its defense and a counter claim against the plaintiffs and against two additional defendants (who are not plaintiffs) Mr. Asher Shmuelevitch and Mr. Eitan Nahum. In its counter claim, the Company allege that the agreements by force of which the counter defendants hold their shares are defunct, based on fraud, as the counter defendants never paid and never intended to pay the agreed consideration for their shares. The Company further alleges the Mr. Shmuelevitch used his position as a director and controlling shareholder of the Company to knowingly cause the Company to enter such defunct agreements. The Company moved the court to dismiss the complaint against it, declare that all agreements with the counter defendants are null and void and that the shares should be returned to the Company. Additionally, the Company seeks financial compensation from the counter defendants for financial damage caused as a result of their actions. For the purpose of the trial charge only, the Company capped the requested compensation against counter defendants at NIS 10 million. All preliminary proceedings and hearing of all evidence by the court have been completed and the case awaits the court's judgement.

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 5 - Contingencies and Commitments (cont’d)

On January 16, 2014, the Company received a demand letter from one of its shareholders for the payment of about $1.4 million as compensation for alleged breaches by several parties including the Company and its previous controlling shareholder (who is not the current controlling shareholder of the Company) of an allotment agreement between the Company and its previous controlling shareholder and the shareholders of Metamorefix. The execution of the allotment agreement was completed in December 2011 and thereafter, in January 2013, the entire share capital of Metamorefix was sold by the Company.

On November 14, 2014, the Company entered into a cooperation agreement for a period of six months with IN SITU S.A. (hereinafter respectively: the “Agreement” and “IN SITU”) the owner of the rights in the fashion brand-name TRUCCO, which includes women’s fashion, belts and footwear and which is marketed and sold all over the world by IN SITU through a chain of stores and sale points as well as through TRUCCO’s website (hereinafter: the “Website”). According to the Agreement, IN SITU and the Company will cooperate in a bid to integrate the Company’s measurement technology (hereinafter: the “Platform”) in IN SITU’s computerized data system and any other system which would enable to use the Platform on the Website as well as in the store and sale points for the examination of the Platform’s efficiency in relation to IN SITU’s sales and customers’ satisfaction. The Company undertook that not later than within six months from the date of execution of the Agreement, the Platform would be completed and operable, namely, that the integration between the data systems of the parties would be completed and the end-customer would be able to take his measurements and purchase a befitting product using the Platform. Should the Company fail to fulfill its undertakings under the Agreement to grant the license and/or fully integrate the Platform within six months from the date of execution of the Agreement, the Company shall compensate IN SITU in the sum of 60 thousand Euros. As a result of the extended timetable there is an understanding between the parties to continue cooperation.

On January 9, 2014, the Company’s general meeting approved an engagement with one of the investors (as specified in paragraph 1b above) for the acquisition of rights in a Venture for the accumulation of physical data of human beings by portable electronic devices for the purpose of locating, based on the accumulated data, articles of clothing in internet apparel stores, which will fit the person whose measurements were accumulated.

In consideration for the acquisition of the Venture, the Company will undertake to pay the seller 18% the Company’s operational profit arising directly or indirectly from the Venture during a period of seven years from the termination of the development period of the Venture. In addition the Seller received an option for a buy-back of the Venture upon the occurrence of any one or more of the following: (a) if an application was filed for the liquidation of the Company or for the appointment of a receiver for the Company’s assets or any material part thereof or for the imposition of a lien on a material part of the Company’s assets, which were not revoked within 60 days from the date they were so filed; (b) if by the end of seven years from the execution date of the agreement the entire aggregate income of the Company arising directly or indirectly from the Venture or from the commercialization of the patent was lower than NIS 3.6 million. According to the Company’s evaluation, the current value is negligible. The buy-back option is valid for 90 days from the occurrence of either one of the above events. The agreed consideration was determined based on a valuation which was prepared by an independent assessor.

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 5 - Contingencies and Commitments (cont’d)

In November, 2015, the Company entered a collaboration agreement with one of the Israel’s largest private couriers (“Katz”) under which the parties will collaborate to develop an application based on the Company’s technology, which will allow the end customer to measure the size of packages intended for shipment and to receive details about the cost of sending the package, based on its size. The collaboration agreement is for a period of up to six months, which may be extended by agreement of both parties or terminated by either party with prior notice of 14 days.

On July 4, 2016, the Company announced that it completed integration of the first app (beta) that it developed in the said affiliation in the Katz’ systems.

The application uses the Company’s exclusive measuring algorithm and enables measuring the package’s volume by moving the smart phone over the package. This information, and the package’s barcode scan, picture and location,are sent to the information servers of the Katz company and help in its pricing.

On November 7, 2016, the Company announced the launch of KatzID app, which is an application that enables customers to quickly and easily measure the size of a package and calculate the exact shipping cost. KatzID also provides shipping companies accurate logistic data to better manage the process of shipping packages before the packages reach their distribution centers. The Company is currently carrying out a pilot to implement KatzID with Katz. According to the last agreement with Katz , by the end of 2017 the commercial terms will be discussed , depends on the activity during the pilot.

On March 4, 2016, the Company entered a collaboration and license agreement with LSY International, Inc., a private company incorporated in the United States and which, among other things, sells luxury clothes made of fur, cashmere, alpaca, and shearling under the brand name
“Yudovsky”.

Under the agreement, the parties will cooperate for the purpose of integrating the Company’s measurement technology and computerized information systems of LSY. The agreement stipulates that the integration of these technologies, will be completed within four months from the date the agreement was signed. The complexity in achieving the correct matching between the fur coat and the Human body is still in an experiment stage.

The Parties are in a continues contact and decided to delay the completion of the integration.

Upon completion of the integration, a 60-day technology testing period will begin, after which, subject to the fulfillment of the technological conditions, the agreement will take effect.

According to the agreement, the Company shall be entitled to a total of 7.5% of every sale by LSY, and LSY company will pay a monthly sum of $ 2.5 for maintenance fees and services that the Company will provide.

As the Company successfully completes integration of the technology into LSY’s systems and subject to the limitations set forth in the agreement, the Company will grant to LSY exclusive license to use the technology in the field of luxury clothing made of: fur, cashmere, alpaca and shearling. The exclusive license will be awarded to LSY as long as the Company will have a minimal income from the agreement as follows:

1) Minimum income of $ 1,000 at the end of the first period of 24 months from the effective date, and

2) Minimum income of $ 5,000 at the end of each subsequent year.

Under the agreement, LSY will pay the Company $100 in fees for establishment and implementation of technology systems as follows:

1)		$ 10 upon signing the agreement.
2)		$30 upon start of implementation.
3)		$20 upon completion of implementation.
4)		$40 balance upon completion of testing and monitoring implementation and the agreement taking effect.

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 5 - Contingencies and Commitments (cont’d)

As of the reporting date, the Company received a total of $10 in accordance with the said terms of the agreement, which was recorded as deferred revenue in the framework of the payables section and credit balances until the fulfillment of conditions for revenue recognition.

On April 20, 2017, the Company received a communication from the Israeli Postal Service (the “Israeli Post”) terminating its relationship and ceasing further discussions.

Previously, on April 18, 2017, the Company announced it had entered into a cooperation agreement with Israel Post which was mischaracterized by the Company as a definitive agreement. The Company and the Israeli Post had exchanged letters under which it was agreed to enter into a non-exclusive pilot program, pursuant to which the Israeli Post would decide whether it would enter negotiations with the company regarding the purchase of the product and under which commercial terms.

On April 20, 2017, the Company issued a corrective press release explaining that while the Company had submitted a proposal to the Israel Post, which was initially received favorably, the parties had not entered into or signed any formal or definitive agreement, and did not expect to enter into a formal or definitive agreement with respect to the pilot program or new services until the completion of the development and trial periods.

The Israel Post expressed its discontent with the release of inaccurate information, and has elected to cease communication with the Company.

On May 3, 2017, Lightcom (Israel) Ltd., an Israeli company, alleging that it is a shareholder of the Company, filed a motion with the Tel Aviv District Court (Financial Division) to approve an action against the Company as a shareholders’ class action. The subject matter of the action appears to be an immediate report filed by the Company on April 19, 2017. The Court ordered the Company to respond to the motion by August 2, 2017 (“the Application”).

On May 7 2017, the Company was served with the application.

The Application alleges, inter alia, that the Company's report of April 19, 2017 regarding its engagement with the Israeli Post was false and misleading, and that as a result thereof financial damages have been incurred by two purported classes of shareholders: (i) any shareholder who sold Company's shares as of April 20, 2017 and until April 27, 2017, with respect to damage directly caused by such sale and (ii) any shareholder which held shares on April 20, 2017 and subsequent to April 27, 2017 with respect to damage caused by permanent adverse effect to the shares' value. The alleged financial damage caused to members of both classes is estimated at NIS 18.8 million.

The Company reviewed the Application initially with its legal counsel. At this preliminary stage, the Company believes that there is no direct causal connection between the Company's report which is the subject matter of the Application and the alleged damages caused to either class of purported plaintiffs and that in any case there appears to be no correlation between the alleged scope of damages and the merits of the alleged case.

The Company's is reviewing its rights to file a third party claim (notice) against third parties the unlawful acts or omissions of which may have had an adverse effect on the Company's share price and may have contributed to any alleged damage which may have been caused to any of the classes of alleged plaintiffs. The Company will respond to the Application in the time frame ordered by the Court.

Note 6 - Significant Events During the Reporting Period

In February 2017, the Board of Directors approved agreements with investors that provided an investment for a total amount of $200 in exchange for 200,000 shares of common stock of the Company and non-negotiable warrants exercisable into 250,000 shares of common stock of the Company until November 22, 2017 at an exercise price of $3.50 per share.

On the date of its receipt of the investment, the amount was attributed to options to Company shares – measured according to the fair value on the measurement date. There was no attribute to the share issuance due to the fair value of the options. The options were recorded as a liability and was recognized for the reporting date in the sum of $168 according to the fair value of the undertaking.

My Size Inc.

Notes to Condensed Consolidated Financial Statements

U.S. dollars in thousands (except share data and per share data)

Note 7 - Subsequent Events

Pro-forma equity

As described in Note 1b, as of March 31, 2017 the Company entered into fund raising agreements in a total sum of $8,015 out of which the sum of $4,596 and $1,410 was received in cash and marketable securities, respectively.

As the date of this report the Company has $1,514 and $495 in guaranteed notes and checks. Subsequent to March 31, 2017, the sum of $550 and $40 of the guarantee notes and the checks, respectively, have been redeemed in cash.

The following proforma consolidated balance sheet is based on the March 31, 2017 balance sheet with adjustments for receipt of $1,419 from the remaining guarantee notes and checks from investors for stock subscribed for but not yet issued.

Assets	$	3,900

Liabilities		865
Stockholders’ equity		3,035
Total liabilities and stockholders’ equity	$	3,900

The effect on equity and on the assets of collecting the money from the bank guarantees and the checks is an increase of $1,419. As a result of the foregoing, the Company’s stockholder’s equity, on a pro forma basis, is $3,035 as of March 31, 2017.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

You should read the following discussion along with our financial statements and the related notes included in this report. The following discussion contains forward-looking statements that are subject to risks, uncertainties and assumptions, including those discussed under “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2016. Our actual results, performance and achievements may differ materially from those expressed in, or implied by, these forward-looking statements.

Results of Operations

From inception through March 31, 2017, we have sustained an accumulated deficit of approximately $13 million. From inception through March 31, 2017, we have not generated any revenue from operations and expect to incur additional losses to perform further research and development activities and do not currently have any commercial products. Our product development efforts are thus in their early stages and we cannot make estimates of the costs or the time they will take to complete.

Three months Ended March 31, 2017 Compared to Three months Ended March 31, 2016

Research and Development Expenses

Our research and development expenses for the three months ended March 31, 2017 amounted to $207,000 compared to $177,000 for the three months ended March 31, 2016. The increase between the corresponding period primarily results from increased subcontractors expenses and the increased expenses associated with the hiring of new employees.

Marketing, General and Administrative Expenses

Our marketing, general and administrative expenses for the three months ended March 31, 2017 amounted to $879,000 compared to $326,000 for the three months ended March 31, 2016. The increase between the corresponding period in expenses derives mainly from share based payments, increases in public relations and investor relations expenses which were not significant in the corresponding period and from increased salaries expenses associated with the hiring of new employees.

Financial income and expense, net

Our financial expenses for the three months ended March 31, 2017 amounted to $308,000 compared to financial income of $614,000 for the three months ended March 31, 2016. The expenses in the reporting period are mainly from revaluation of investment in marketable securities, compared to income from revaluation of the components of the financial package in the corresponding period.

Net Loss from continuing operations

As a result of the foregoing research and development, marketing general and administrative expenses, and financial expenses, our net loss from continuing operations for the three months ended March 31, 2017 was $1,394,000, compared to our net income from continuing operations for the three months ended March 31, 2016 of $111,000. The main reasons for the change between the corresponding periods is the expenses derives mainly from share based payments, increases in public relations and investor relations expenses, which were not significant in the corresponding period, and from increased salaries expenses associated with the hiring of new employees. The financial expenses mainly from expense revaluation of investment in marketable securities, compared to income from revaluation of the components of the financial package in the corresponding period.

Liquidity and Capital Resources

Since our inception, we have funded our operations primarily through private offerings of our equity securities in Israel.

As of March 31, 2017, we had cash and cash equivalents of $359,000 as compared to $34,000 as of December 31, 2016. The increase in cash balances is due to collecting cash from the guarantees offset by cash used for operating activities during the period.

We had negative cash flow from operating activities of $1,012,000 for the three months ended March 31, 2017, compared with negative cash flow from operating activities of $479,000 for the three months ended March 31, 2016.

The increase in cash used in operating activities derives from increased payments to service providers and Company employees. The Company has expenses not in the ordinary course of business mainly from the registration of patents, the listing of our common stock on Nasdaq, Investor relations and Public relations services and legal expenses associated with lawsuits involving the Company.

As of March 31, 2017, the Company entered into fund raising agreements in a total sum of $8,015 out of which the sum of $4,596 and $1,410 was received in cash and marketable securities, respectively. The marketable securities are shares of common stock of Diamante minerals Inc (“DIMN”), which are presented in the Company’s balance sheet as a financial asset available for sale.

As of the date of the report, the Company has $1,514 and $495 in guarantee notes and checks, respectively. The guarantee has been provided by an ungraded financial institution. Subsequent to March 31, 2017, the sum of $550 and $40 of the guaranteed notes and the checks, respectively, have been redeemed in cash.

A downturn in the United States stock and debt markets could make it more difficult to obtain financing through the issuance of equity or debt securities. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our shares of common stock or the debt securities may cause us to be subject to restrictive covenants. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek additional financing. If additional financing is not available or is not available on acceptable terms, we will have to curtail our operations.

Off-Balance Sheet Arrangements

We have not entered into any transactions with unconsolidated entities in which we have financial guarantees, subordinated retained interests, derivative instruments or other contingent arrangements that expose us to material continuing risks, contingent liabilities or any other obligations under a variable interest in an unconsolidated entity that provides us with financing, liquidity, market risk or credit risk support.

Application of Critical Accounting Policies and Estimates

Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which we have prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses during the reporting periods. Actual results may differ from these estimates under different assumptions or conditions.

While our significant accounting policies are more fully described in the notes to our financial statements appearing elsewhere in this report, we believe that the accounting policies discussed below are critical to our financial results and to the understanding of our past and future performance, as these policies relate to the more significant areas involving management’s estimates and assumptions. We consider an accounting estimate to be critical if: (1) it requires us to make assumptions because information was not available at the time or it included matters that were highly uncertain at the time we were making our estimate; and (2) changes in the estimate could have a material impact on our financial condition or results of operations.

Research and development expenses

Research expenses are recognized as expenses when incurred. Costs incurred on development projects are recognized as intangible assets as of the date as of which it can be established that it is probable that future economic benefits attributable to the asset will flow to us considering its commercial feasibility. This is generally the case when regulatory approval for commercialization is achieved and costs can be measured reliably. Given the current stage of the development of our products, no development expenditures have yet been capitalized. Intellectual property-related costs for patents are part of the expenditure for the research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.

Equity-based compensation

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation” (“ASC 718”) which requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s consolidated statements of operations.

The Company recognizes compensation expenses for the value of its awards granted based on the accelerated method over the requisite service period of each of the awards, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

The Company selected the Binomial option pricing model (“the Binomial model”) as the most appropriate fair value method for its stock-options awards. The Binomial model requires a number of assumptions, of which the most significant are the suboptimal exercise factor and expected stock price volatility. The suboptimal exercise factor is estimated based on employees’ historical option exercise behavior.

The suboptimal exercise factor is the ratio by which the stock price must increase over the exercise price before employees are expected to exercise their stock options.

The expected volatility of the share prices reflects the assumption that the historical volatility of the share prices is reasonably indicative of expected future trends.

The expected option term represents the period that the Company’s stock options are expected to be outstanding. The Company currently uses simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest rate is based on the yield from Israel treasury zero-coupon bonds with an equivalent term.

The Company has historically not paid dividends and has no foreseeable plans to pay dividends.

The Company applies ASC 505-50, “Equity-Based Payments to Non-Employees” with respect to options and warrants issued to non-employees.

If any of the assumptions used in the binomial model change significantly, equity-based compensation for future awards may differ materially compared with the awards granted previously.

Convertible promissory notes

The Company applies ASC 470-20, “Debt with Conversion and Other Options” (“ASC 470-20”). Under the guidelines of ASC 470-20, the Company measures and recognizes the beneficial conversion feature on the commitment date. The beneficial conversion feature is measured by allocating a portion of the proceeds equal to the intrinsic value of the feature to additional paid-in-capital. The intrinsic value of the feature is calculated on the commitment date using the conversion price. This intrinsic value is limited to the portion of the proceeds allocated to the convertible debt.

The Company applied ASC 470-20 and ASC 815 to the Convertible promissory notes.

Item 3. Quantitative and Qualitative Disclosure About Market Risk.

Not required for a smaller reporting company.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We carried out an evaluation required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act, as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives as specified above. Management does not expect, however, that our disclosure controls and procedures will prevent or detect all error and fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.

Changes in Internal Controls

During the most recent fiscal quarter, there has not occurred any change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Part II – Other Information

Item 1. Legal Proceedings.

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

We are not currently a party to any material legal proceedings except as described below.

●

On December 27, 2015, the Company received a legal complaint. The defendants are the Company itself, all the members of the Board of Directors, Mrs. Shoshana Zigdon, a shareholder and related party of the Company, as well as two additional defendants who are nor shareholders neither officers or directors of the Company, and are not shareholders. The plaintiff alleges that the Company violated its obligation to register his shares for trade with the Tel Aviv Stock Exchange causing a total of 2,622,500 NIS damage. The plaintiff seeks relief against the defendants through financial compensation at the rate of the aforementioned alleged damage; additional compensation of 400,000 NIS due to mental anguish; and if and to the extent that until the time the plaintiff can sell its shares on the Stock Exchange (hereinafter: "the exercise date "), the rate of a Company share will rise above the amount of 20.98 NIS (hereinafter: "the base rate"), an additional amount at the rate of the difference between the base rate and the highest rate of the Company’s shares between the time the claim was submitted and the exercise date; and also court costs and attorney's fees of the plaintiff.

All pre-trial preliminary proceedings as well as submission of all evidentiary affidavits and expert opinions by both parties have been completed.

However, the company believes, based on the opinion of its legal counsel, that assuming the plaintiff's claim for the main relief, i.e. the removal of the restriction from and the registration of his shares on the stock exchange, will be accepted by the court, it appears that prima face the risk that the court will also rule that the plaintiff is entitled to financial compensation for the alleged delay in registering his shares, exceeds the chance that such financial compensation will not be awarded.

According to the expert opinion submitted to the court by the plaintiff, the plaintiff's expert calculates the approximate damage allegedly caused to the plaintiff between 3-3.6 million NIS assuming the shares will be registered by December 31, 2016, and additional compensation for each additional month subsequently. According to the Company's expert opinion submitted to the court, the Company's expert asserts that the plaintiff's expert opinion is erroneous and in his opinion and assuming the plaintiff's claim will be accepted by the court, than the estimated damage caused to the plaintiff as a result of a 4-5 years delay in registering his shares is estimated at approximately NIS 234, 000 (plus interest and CPI differences) if it will be ruled that the restriction from plaintiff's shares should have been removed within six months as of the purchase date thereof and at approximately NIS 130,000 if it will be ruled that the restriction from plaintiff's shares should have been removed within twelve months as of the purchase day thereof. It should be noted that all experts' calculations are based on the share market price, and consequently any changes in the share price at the time a judgement will be rendered by the court, could increase or decrease the Company's exposure respectively.

●

On May 17, 2012, the Company signed an agreement for a convertible loan with a third party (hereinafter the "Investor"). In accordance with the loan agreement, the Company received a total of NIS 200 thousand with the signing of the loan agreement and was to receive an additional amount of NIS 100 thousand at the end of a period not exceeding 21 days, during which the investor would perform due diligence on the Company. In addition, the agreement was for additional investments up to a total of NIS 2 million. Under the agreement, the investor were entitled to convert the loan amounts granted to the Company into common shares of the Company with US $ 0.001 par value each, at a price per share equal to the amount of NIS 0.97. If the loans were not converted into the Company shares, the loan was to be repaid one year after the date of the loan agreement plus annual interest of 10%. On February 18, 2015, the Company received a claim in a summary judgement for the investor’s demand of payment of the loan amount of NIS 200 thousand, which was granted to the Company on May 17, 2012, plus interest of 10% annually as from 20 May 2012 until payment of the debt, which as of the date of filing of the claim was NIS 258 thousand. The company denies the allegations stated in the request and is reviewing the possibilities, including the filing of reply to the court in accordance with law. On June 13, 2016, a settlement agreement was entered into between the parties according to which in consideration for the final and conclusive annulment of all claims and/or demands raised by the plaintiff against the Company in the framework of the law suit, the Company would pay the plaintiff the sum of 250 thousand NIS forthwith by wire transfer of about 95 thousand NIS and by the forfeiture of the sum of about 155 thousand NIS which had been deposited with the court. An additional amount of 50 thousand NIS would be paid within twelve months from the approval of the settlement agreement by the court or on the closing date of a public offering of Mysize shares, pursuant to its terms, on a stock exchange in the United States, the earlier of. As of the date on which the financial reports were signed the terms have not yet occurred.

●

On September 9, 2015 14 shareholders filed a complaint against the Company and its CEO Mr. Ronen Luzon, alleging that in accordance with agreements signed between plaintiffs and the Company, the plaintiffs are entitled to register their shares on the stock market while the Company allegedly breached its obligation and refrains from doing its duty to register the plaintiffs' shares. The plaintiffs seek declaratory remedy that they are entitled to register their shares and also request the right to split their remedies so they will also be able subsequently to claim from the defendants compensation for any financial damage causes by the Company's failure to register their shares, including damage due to any decrease in the shares' price during the period the shares should have been registered. On November 5, 2015, the Company filed its defense and a counter claim against the plaintiffs and against two additional defendants (who are not plaintiffs) Mr. Asher Shmuelevitch and Mr. Eitan Nahum. In its counter claim, the Company alleges that the agreements by force of which the plaintiffs (the counter defendants) hold their shares are defunct, based on fraud, as the plaintiffs (the counter defendants) never paid and never intended to pay the agreed consideration for their shares. The Company further alleges the Mr. Shmuelevitch used his position as a director and controlling shareholder of the Company to knowingly cause the Company to enter such defunct agreements. The Company moves that court will dismiss the complaint against it, declare that all agreements with the plaintiffs (the counter defendants) are null and void and that the shares should be returned to the Company. Additionally, the Company seeks financial compensation from the counter defendants for financial damage caused as a result of their actions. For the purpose of the trial charge only, the Company capped the requested compensation against counter defendants at NIS 10 million. All preliminary proceedings and hearing of all evidence by the court have been completed and the case awaits the court's judgement.

●

On January 16, 2014, the Company received a demand letter from one of its shareholders for the payment of about $1.4 million as compensation for alleged breaches by several parties including the Company and its previous controlling shareholder (who is not the current controlling shareholder of the Company) of an allotment agreement between the Company and its previous controlling shareholder and shareholders of Metamorefix. The execution of the allotment agreement was completed in December 2011 and thereafter, in January 2013, the entire share capital of Metamorefix was sold by the Company.

●

On April 20, 2017, the Company received a communication from the Israeli Postal Service (the “Israeli Post”) terminating its relationship and ceasing further discussions.

The Israel Post expressed its discontent with the release of inaccurate information, and has elected to cease communication with the Company.

●

On May 7 2017, the Company was served with the application.

Item 1A. Risk Factors.

Not required for a smaller reporting company.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On February 13, 2017, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with an accredited investor (the “Purchaser”). On February 22, 2017, the Company and the Purchaser consummated the transactions contemplated by the Securities Purchase Agreement, pursuant to which, subject to the terms and conditions set forth therein, the Purchaser acquired from the Company, for an aggregate purchase price of $200,000: (i) 200,000 shares (the “Common Shares”) of Company common stock (“Common Stock”), and (ii) warrants (the “Warrants”) to acquire 250,000 shares of Common Stock. The Common Shares and Warrants were issued pursuant to exemptions from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and Rule 506 of Regulation D promulgated thereunder.

The Warrants have an exercise price of $3.50 and are exercisable for a period of ten months.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

In November of 2015, My Size, Inc. engaged the services of ZAI Corporate Finance LTD as its London based nominated advisor to assist the Company with its listing on the AIM. In light of the Company’s Nasdaq listing in November of 2016, the Company has elected to discontinue its listing application with the London Stock Exchange.

Item 6. Exhibits.

Exhibit Number		Description of Exhibits
3.1		Amended and Restated Certificate of Incorporation (incorporated by reference to the Current Report on Form 8-K filed by the Company on March 23, 2017 as Exhibit 3.1).
31.1		Certification of Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification of Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2		Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Schema
101.CAL		XBRL Taxonomy Calculation Linkbase
101.DEF		XBRL Taxonomy Definition Linkbase
101.LAB		XBRL Taxonomy Label Linkbase
101.PRE		XBRL Taxonomy Presentation Linkbase

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	My Size, Inc.

Date: May 16, 2017	By:	/s/ Ronen Luzon
		Ronen Luzon
		Chief Executive Officer (Principal Executive Officer)

Date: May 16, 2017

By:

/s/ Or Kles

Or Kles

Chief Financial Officer

(Principal Financial and Accounting Officer)

EX-31.1 2 f10q0317ex31i_mysizeinc.htm CERTIFICATION

Exhibit 31.1

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley

Act of 2002 and pursuant to Rule 13a-14(a) and Rule 15d-14 under the Securities Exchange Act of 1934

I, Ronen Luzon certify that:

1.	I have reviewed this Quarterly report on Form 10-Q of My Size, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations; and

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 16, 2017

By:

/s/ Ronen Luzon

Ronen Luzon

Chief Executive Officer

(Principal Executive Officer)

EX-31.2 3 f10q0317ex31ii_mysizeinc.htm CERTIFICATION

Exhibit 31.2

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley

Act of 2002 and pursuant to Rule 13a-14(a) and Rule 15d-14 under the Securities Exchange Act of 1934

I, Or Kles, certify that:

1	I have reviewed this Quarterly report on Form 10-Q of My Size, Inc.;

2	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 16, 2017

By:

/s/ Or Kles

Or Kles

Chief Financial Officer

(Principal Financial Officer)

EX-32.1 4 f10q0317ex32i_mysizeinc.htm CERTIFICATION

Exhibit 32.1

CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection with the Quarterly Report of My Size, Inc. (the "Company") on Form 10-Q for the period ending March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ronen Luzon, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 16, 2017

By:

/s/ Ronen Luzon

Ronen Luzon

Chief Executive Officer

(Principal Executive Officer)

EX-32.2 5 f10q0317ex32ii_mysizeinc.htm CERTIFICATION

Exhibit 32.2

CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection with the Quarterly Report of My Size, Inc. (the "Company") on Form 10-Q for the period ending March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Or Kles, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 16, 2017

By:

/s/ Or Kles

Or Kles

Chief Financial Officer

(Principal Financial Officer)

EX-101.INS 6 mysz-20170331.xml XBRL INSTANCE FILE 0001211805 us-gaap:ConvertibleDebtMember 2012-05-17 0001211805 us-gaap:ConvertibleDebtMember 2012-05-15 2012-05-17 0001211805 2014-01-09 0001211805 2014-01-01 2014-01-09 0001211805 2014-01-01 2014-01-16 0001211805 2014-11-13 2014-11-14 0001211805 2015-02-18 0001211805 2015-02-15 2015-02-18 0001211805 2015-11-01 2015-11-15 0001211805 mysz:DefendantsMember 2015-12-25 2015-12-27 0001211805 2015-12-31 0001211805 us-gaap:CommonStockMember 2015-12-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001211805 us-gaap:RetainedEarningsMember 2015-12-31 0001211805 mysz:AvailableForSaleReserveMember 2015-12-31 0001211805 us-gaap:ForeignCurrencyGainLossMember 2015-12-31 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0001211805 2016-03-01 2016-03-04 0001211805 2016-01-01 2016-03-31 0001211805 us-gaap:CommonStockMember 2016-01-01 2016-03-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-03-31 0001211805 us-gaap:RetainedEarningsMember 2016-01-01 2016-03-31 0001211805 mysz:AvailableForSaleReserveMember 2016-01-01 2016-03-31 0001211805 us-gaap:ForeignCurrencyGainLossMember 2016-01-01 2016-03-31 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-03-31 0001211805 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-03-31 0001211805 2016-03-31 0001211805 us-gaap:CommonStockMember 2016-03-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2016-03-31 0001211805 us-gaap:RetainedEarningsMember 2016-03-31 0001211805 mysz:AvailableForSaleReserveMember 2016-03-31 0001211805 us-gaap:ForeignCurrencyGainLossMember 2016-03-31 0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-03-31 0001211805 us-gaap:FairValueInputsLevel1Member 2016-03-31 0001211805 us-gaap:FairValueInputsLevel2Member 2016-03-31 0001211805 us-gaap:FairValueInputsLevel3Member 2016-03-31 0001211805 2016-06-01 2016-06-13 0001211805 2016-01-01 2016-12-31 0001211805 us-gaap:CommonStockMember 2016-01-01 2016-12-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0001211805 us-gaap:RetainedEarningsMember 2016-01-01 2016-12-31 0001211805 mysz:AvailableForSaleReserveMember 2016-01-01 2016-12-31 0001211805 us-gaap:ForeignCurrencyGainLossMember 2016-01-01 2016-12-31 0001211805 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-12-31 0001211805 mysz:ConsultantMember 2016-01-01 2016-12-31 0001211805 us-gaap:MinimumMember 2016-01-01 2016-12-31 0001211805 us-gaap:MaximumMember 2016-01-01 2016-12-31 0001211805 2016-12-31 0001211805 us-gaap:CommonStockMember 2016-12-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001211805 us-gaap:RetainedEarningsMember 2016-12-31 0001211805 mysz:AvailableForSaleReserveMember 2016-12-31 0001211805 us-gaap:ForeignCurrencyGainLossMember 2016-12-31 0001211805 us-gaap:FairValueInputsLevel1Member 2016-12-31 0001211805 us-gaap:FairValueInputsLevel2Member 2016-12-31 0001211805 us-gaap:FairValueInputsLevel3Member 2016-12-31 0001211805 mysz:ConsultantMember us-gaap:MinimumMember 2016-12-31 0001211805 mysz:ConsultantMember us-gaap:MaximumMember 2016-12-31 0001211805 2017-02-28 0001211805 2017-02-01 2017-02-28 0001211805 2017-01-01 2017-03-31 0001211805 us-gaap:CommonStockMember 2017-01-01 2017-03-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-03-31 0001211805 us-gaap:RetainedEarningsMember 2017-01-01 2017-03-31 0001211805 mysz:AvailableForSaleReserveMember 2017-01-01 2017-03-31 0001211805 us-gaap:ForeignCurrencyGainLossMember 2017-01-01 2017-03-31 0001211805 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-03-31 0001211805 mysz:ConsultantMember 2017-01-01 2017-03-31 0001211805 mysz:FiveInstallmentMember 2017-01-01 2017-03-31 0001211805 mysz:SixthInstallmentMember 2017-01-01 2017-03-31 0001211805 2017-03-31 0001211805 us-gaap:ConvertibleDebtMember 2017-03-31 0001211805 us-gaap:CommonStockMember 2017-03-31 0001211805 us-gaap:AdditionalPaidInCapitalMember 2017-03-31 0001211805 us-gaap:RetainedEarningsMember 2017-03-31 0001211805 mysz:AvailableForSaleReserveMember 2017-03-31 0001211805 us-gaap:ForeignCurrencyGainLossMember 2017-03-31 0001211805 us-gaap:FairValueInputsLevel1Member 2017-03-31 0001211805 us-gaap:FairValueInputsLevel2Member 2017-03-31 0001211805 us-gaap:FairValueInputsLevel3Member 2017-03-31 0001211805 mysz:ConsultantMember 2017-03-31 0001211805 us-gaap:PaymentGuaranteeMember 2017-03-31 0001211805 us-gaap:ProFormaMember 2017-03-31 0001211805 mysz:FundRaisingAgreementMember 2017-03-31 0001211805 mysz:SubsequentToMarchThirtyOneTwoZeroOneSevenMember 2017-03-31 0001211805 us-gaap:SubsequentEventMember 2017-04-01 2017-04-19 0001211805 2017-05-16 0001211805 us-gaap:SubsequentEventMember us-gaap:MinimumMember 2017-05-16 0001211805 us-gaap:SubsequentEventMember us-gaap:MaximumMember 2017-05-16 xbrli:shares iso4217:USD iso4217:USDxbrli:shares iso4217:ILSxbrli:shares iso4217:ILS xbrli:pure iso4217:EUR My Size, Inc. 0001211805 MYSZ false --12-31 10-Q 2017-03-31 2017 Q1 Smaller Reporting Company 17605359

919000

425000

34000

359000

1401000

1619000

62000

66000

1497000

2044000

579000

362000

74000

75000

653000

437000

2150000

2481000

3900000

229000

188000

316000

431000

80000

78000

168000

625000

865000

17000

13347000

14744000

-93000

-102000

-107000

-11644000

-13038000

-2613000

15000

4855000

-7310000

-69000

-104000

-1534000

15000

5844000

-7199000

-194000

1525000

17000

13347000

-11644000

-93000

-102000

1616000

17000

14744000

-13038000

-107000

3035000

2150000

2481000

3900000

0.001

50000000

17405359

17605359

17405359

17605359

177000

727000

207000

326000

1859000

879000

503000

2586000

1086000

-503000

-2586000

-1086000

614000

-1748000

-308000

111000

-4334000

-1394000

-67000

24000

-93000

-90000

2000

-5000

88000

111000

-90000

-4356000

-4334000

-24000

2000

-1306000

-1394000

93000

-5000

0.01

-0.27

-0.08

0.05

-0.27

-0.08

15313793

16345499

17525359

15492659

16345499

17525359

15313793

17405359

17605359

-50000

-23000

997000

400000

200000

67000

1041000

987000

7530000

2000

7528000

2091566

5000

24000

7000

-614000

-182000

-29000

-776000 1233000 340000

-50000

-23000

39000

15000

27000

8000

-80000

6000

56000

86000

-54000

28000

208000

93000

-479000

-2159000

-1012000

13000

36000

3000

-13000

-36000

-3000

25000

1149000

1339000 200000

1314000

1349000

-2000

-4000

-9000

-494000

-885000

325000

1041000 987000

4846000

958000

<div><p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 56.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: -56.7pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Note 3 - Financial Instruments</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 85.05pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Fair value of financial instruments:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">ASC 820, “Fair Value Measurements and Disclosures”, defines fair value as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In determining fair value, the Company uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-weight: normal;">As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 56.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-right: 0px; margin-bottom: 0px; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="text-align: justify; vertical-align: top;"><td style="width: 0.75in;"> </td><td style="width: 0.75in; text-align: left; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;">Level 1 -</td><td style="width: 47px; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;"></td><td style="text-align: justify; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;">Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.</td></tr><tr style="text-align: justify; vertical-align: top;"><td> </td><td style="text-align: left; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;"> </td><td style="text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;"> </td><td style="text-align: justify; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;"> </td></tr><tr style="text-align: justify; vertical-align: top;"><td> </td><td style="text-align: left; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;">Level 2 -</td><td style="text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;"></td><td style="text-align: justify; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;">Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.</td></tr><tr style="text-align: justify; vertical-align: top;"><td> </td><td style="text-align: left; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;"> </td><td style="text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;"> </td><td style="text-align: justify; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;"> </td></tr><tr style="text-align: justify; vertical-align: top;"><td> </td><td style="text-align: left; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;">Level 3 -</td><td style="text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;"></td><td style="text-align: justify; text-indent: 0px; padding-top: 0px; padding-right: 0px; padding-left: 0px;">Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 141.75pt; text-align: justify; color: #000000; text-transform: none; text-indent: -56.7pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The expected volatility of the share prices reflects the assumption that the historical volatility of the share prices is reasonably indicative of expected future trends.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">  </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The carrying amounts of cash and cash equivalents, other accounts receivable, short-term loan, accounts payable and other accounts payable approximate their fair value due to the short-term maturities of such instruments.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company holds shares in a publicly-traded company - Diamante minerals Inc which are classified as available-for-sale equity securities. The marketable securities have readily determinable fair market values that are calculated based on the share price in the measurement date and ranked as Level 1 assets.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 85.05pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">March 31, 2017</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Financial assets</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Investment in marketable securities (*)</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">362</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: right; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">March 31, 2017</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td> </td><td style="text-align: left; font-size: 10pt;">Financial liabilities</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Warrants to purchase common stock (*)</td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">168</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td> </td><td style="text-align: left; font-size: 10pt;">Derivative liabilities (**)</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">78</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">  </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.5in; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">(*) see note 6.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 1in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">(**) see note 4a.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">March 31, 2016</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Financial assets</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Investment in marketable securities (***)</td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">1,012</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Put Options – DIMN shares</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">989</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 113.4pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">March 31, 2016</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Financial liabilities</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Warrants</td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">9</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Derivative liabilities embedded conversion options</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">14</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 85.05pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">December 31, 2016</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Financial assets</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Investment in marketable securities (***)</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">579</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 113.4pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">December 31, 2016</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Financial liabilities</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Derivative liabilities</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">80</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 85.05pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">(***) At March 31, 2017, gross unrecognized loss, recognized loss and fair value (based on quoted market prices) of these securities were $(93), $340 and $362, respectively (At December 31, 2016, $24, $1,233 and $579, respectively)</p></div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Note 5 -<font style="font-family: 'times new roman', times, serif;"></font>Contingencies and Commitments </b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 110.7pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 110.7pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; line-height: 14.26px; font-size: 10pt;"> </td><td style="width: 24px; line-height: 14.26px; font-size: 10pt;"><font style="line-height: 14.13px; font-family: 'times new roman', times, serif; font-size: 10pt;">a.</font></td><td><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="color: #212121;">On December 27, 2015, the Company received a legal complaint. The defendants are the Company, all the members of the Board of Directors, Mrs. Shoshana Zigdon, a shareholder and related party of the Company, as well as two additional defendants who are not shareholders, officers or directors of the Company. The plaintiff alleges that the Company violated its obligation to register his shares for trade with the Tel Aviv Stock Exchange causing a total of 2,622,500 NIS damage. The plaintiff seeks relief against the defendants through financial compensation at the rate of the aforementioned alleged damage; additional compensation of 400,000 NIS due to mental anguish; and if and to the extent that until the time the plaintiff c</font>an sell its shares on the Tel Aviv Stock Exchange ("the exercise date "), if the rate of a Company shares rises above the amount of 20.98 NIS ("the base rate"), an additional amount at the rate of the difference between the base rate and the highest rate of the Company's shares between the time the claim was submitted and the exercise date; and also court costs and attorney's fees of the plaintiff.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 74.7pt; text-align: justify; font-stretch: normal;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;">All pre-trial preliminary proceedings as well as submission of all evidentiary affidavits and expert opinions by both parties have been completed.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 74.7pt; text-align: justify; font-stretch: normal;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;">Pursuant to the Court's recommendation, the case was referred to mediation by the honorable Judge (Rtd.) Hilla Gerstel, former president of the Central District Court. The mediation is going on and the next mediation session is scheduled for June 5, 2017.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;">The Company estimates, based on the opinion of its legal counsel that the risk of acceptance of the remedy requested by the plaintiff in his claim, namely, that the Company was obligated to remove the restriction which was imposed on the shares and register plaintiff's shares for trade on the stock exchange, exceeds the chance of its dismissal. This remedy, as such, does not constitute any financial exposure to the Company. However, the company believes, based on the opinion of its legal counsel, that assuming the plaintiff's claim for the main relief, i.e. the removal of the restriction from and the registration of his shares on the stock exchange, will be accepted by the court, it appears that prima face the risk that the court will also rule that the plaintiff is entitled to financial compensation for the alleged delay in registering his shares, exceeds the chance that such financial compensation will not be awarded<font style="color: #212121;">.</font></p></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">According to the expert opinion submitted to the court by the plaintiff, the plaintiff's expert calculates the approximate damage allegedly caused to the plaintiff between 3-3.6 million NIS assuming the shares will be registered by December 31, 2016, and additional compensation for each additional month subsequently. According to the Company's expert opinion submitted to the court, the Company's expert asserts that the plaintiff's expert opinion is erroneous and in his opinion and assuming the plaintiff's claim will be accepted by the court, than the estimated damage caused to the plaintiff as a result of a 4-5 years delay in registering his shares is estimated at approximately NIS 234,000 (plus interest and CPI differences) if it will be ruled that the restriction from plaintiff's shares should have been removed within six months as of the purchase date thereof and at approximately NIS 130,000 if it will be ruled that the restriction from plaintiff's shares should have been removed within twelve months as of the purchase day thereof. It should be noted that all experts' calculations are based on the share market price, and consequently any changes in the share price at the time a judgement will be rendered by the court, could increase or decrease the Company's exposure, respectively. </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 110.7pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 28.35pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">At this stage, the time for the submission of an expert opinion on behalf of the Company for the calculation of the damage has not arrived and the appropriate method of calculating the loss based on the circumstances in this case has not been determined.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0.5in; text-indent: 0px; padding-left: 0px;"> </td><td style="width: 0.25in; text-align: justify; text-indent: 0px; padding-left: 0px;">b.</td><td style="text-align: justify; text-indent: 0px; padding-left: 0px;">On May 17, 2012, the Company signed an agreement for a convertible loan with a third party (hereinafter the “Investor”). In accordance with the loan agreement, the Company received a total of NIS 200,000 with the signing of the loan agreement and was to receive an additional amount of NIS 100,000 at the end of a period not exceeding 21 days, during which the investor would perform due diligence on the Company. In addition, the agreement was for additional investments up to a total of NIS 2,000,000.</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Under the agreement, the investor was entitled to convert the loan amounts granted to the Company into common shares of the Company with US $ 0.001 par value each, at a price per share equal to the amount of NIS 0.97. If the loans were not converted into the Company shares, the loan was to be repaid one year after the date of the loan agreement plus annual interest of 10%.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On February 18, 2015, the Company received a claim in a summary judgement for the investor’s demand of payment of the loan amount of NIS 200,000, which was granted to the Company on May 17, 2012, plus interest of 10% annually as from May 20, 2012 until payment of the debt, which as of the date of filing of the claim was NIS 258,000.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On June 13, 2016, a settlement agreement was entered into between the parties according to which in consideration for the final and conclusive annulment of all claims and/or demands raised by the plaintiff against the Company in the framework of the law suit, the Company would pay the plaintiff the sum of NIS 250,000 forthwith by wire transfer of about NIS 95,000 and by the forfeiture of the sum of about NIS 155,000 which had been deposited with the court. An additional amount of NIS 50,000 would be paid within twelve months from the approval of the settlement agreement by the court or on the closing date of a public offering of Company shares, pursuant to its terms, on a stock exchange in the United States, the earlier of. As of the date on which the financial statements were signed the payment has not yet occurred.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; line-height: 14.26px; font-size: 10pt;"> </td><td style="width: 24px; text-align: justify; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">c.</font></td><td style="text-align: justify; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">On September 9, 2015, fourteen shareholders filed a complaint against the Company and its CEO Mr. Ronen Luzon, alleging that in accordance with agreements signed between plaintiffs and the Company, the plaintiffs are entitled to register their shares for sale with the stock market, while the Company allegedly breached its obligation and refrained from doing its duty to register the plaintiffs' shares.  The plaintiffs seek declaratory remedy that they are entitled to register their shares and also request the right to split their remedies so they will also be able subsequently to claim from the defendants compensation for any financial damage causes by the Company's failure to register their shares, including damage due to any decrease in the shares' price during the period the shares should have been registered. On November 5, 2015, the Company filed its defense and a counter claim against the plaintiffs and against two additional defendants (who are not plaintiffs) Mr. Asher Shmuelevitch and Mr. Eitan Nahum. In its counter claim, the Company allege that the agreements by force of which the counter defendants hold their shares are defunct, based on fraud, as the counter defendants never paid and never intended to pay the agreed consideration for their shares. The Company further alleges the Mr. Shmuelevitch used his position as a director and controlling shareholder of the Company to knowingly cause the Company to enter such defunct agreements. The Company moved the court to dismiss the complaint against it, declare that all agreements with the counter defendants are null and void and that the shares should be returned to the Company. Additionally, the Company seeks financial compensation from the counter defendants for financial damage caused as a result of their actions. For the purpose of the trial charge only, the Company capped the requested compensation against counter defendants at NIS 10 million. All preliminary proceedings and hearing of all evidence by the court have been completed and the case awaits the court's judgement.</font></td></tr></table><p style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;"> </p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px;"> </td><td style="width: 24px; text-align: justify; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">d.</font></td><td style="text-align: justify; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">On January 16, 2014, the Company received a demand letter from one of its shareholders for the payment of about $1.4 million as compensation for alleged breaches by several parties including the Company and its previous controlling shareholder (who is not the current controlling shareholder of the Company) of an allotment agreement between the Company and its previous controlling shareholder and the shareholders of Metamorefix. The execution of the allotment agreement was completed in December 2011 and thereafter, in January 2013, the entire share capital of Metamorefix was sold by the Company.</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; margin-left: 0pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; margin-left: 0pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px;"> </td><td style="width: 24px; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">e.</font></td><td style="text-align: justify; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">On November 14, 2014, the Company entered into a cooperation agreement for a period of six months with IN SITU S.A. (hereinafter respectively: the “Agreement” and “IN SITU”) the owner of the rights in the fashion brand-name TRUCCO, which includes women’s fashion, belts and footwear and which is marketed and sold all over the world by IN SITU through a chain of stores and sale points as well as through TRUCCO’s website (hereinafter: the “Website”). According to the Agreement, IN SITU and the Company will cooperate in a bid to integrate the Company’s measurement technology (hereinafter: the “Platform”) in IN SITU’s computerized data system and any other system which would enable to use the Platform on the Website as well as in the store and sale points for the examination of the Platform’s efficiency in relation to IN SITU’s sales and customers’ satisfaction. The Company undertook that not later than within six months from the date of execution of the Agreement, the Platform would be completed and operable, namely, that the integration between the data systems of the parties would be completed and the end-customer would be able to take his measurements and purchase a befitting product using the Platform. Should the Company fail to fulfill its undertakings under the Agreement to grant the license and/or fully integrate the Platform within six months from the date of execution of the Agreement, the Company shall compensate IN SITU in the sum of 60 thousand Euros. As a result of the extended timetable there is an understanding between the parties to continue cooperation.</font></td></tr></table><p style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;"> </p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; margin-top: 0pt; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0.5in;"></td><td style="width: 0.25in;">f.</td><td style="text-align: justify;">On January 9, 2014, the Company’s general meeting approved an engagement with one of the investors (as specified in paragraph 1b above) for the acquisition of rights in a Venture for the accumulation of physical data of human beings by portable electronic devices for the purpose of locating, based on the accumulated data, articles of clothing in internet apparel stores, which will fit the person whose measurements were accumulated.</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In consideration for the acquisition of the Venture, the Company will undertake to pay the seller 18% the Company’s operational profit arising directly or indirectly from the Venture during a period of seven years from the termination of the development period of the Venture. In addition the Seller received an option for a buy-back of the Venture upon the occurrence of any one or more of the following: (a) if an application was filed for the liquidation of the Company or for the appointment of a receiver for the Company’s assets or any material part thereof or for the imposition of a lien on a material part of the Company’s assets, which were not revoked within 60 days from the date they were so filed; (b) if by the end of seven years from the execution date of the agreement the entire aggregate income of the Company arising directly or indirectly from the Venture or from the commercialization of the patent was lower than NIS 3.6 million. According to the Company’s evaluation, the current value is negligible. The buy-back option is valid for 90 days from the occurrence of either one of the above events. The agreed consideration was determined based on a valuation which was prepared by an independent assessor.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">  </p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px;"> </td><td style="width: 24px; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">g.</font></td><td style="text-align: justify; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">In November, 2015, the Company entered a collaboration agreement with one of the Israel’s largest private couriers (“Katz”) under which the parties will collaborate to develop an application based on the Company’s technology, which will allow the end customer to measure the size of packages intended for shipment and to receive details about the cost of sending the package, based on its size. The collaboration agreement is for a period of up to six months, which may be extended by agreement of both parties or terminated by either party with prior notice of 14 days.</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On July 4, 2016, the Company announced that it completed integration of the first app (beta) that it developed in the said affiliation in the Katz’ systems.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The application uses the Company’s exclusive measuring algorithm and enables measuring the package’s volume by moving the smart phone over the package. This information, and the package’s barcode scan, picture and location,are sent to the information servers of the Katz company and help in its pricing.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On November 7, 2016, the Company announced the launch of KatzID app, which is an application that enables customers to quickly and easily measure the size of a package and calculate the exact shipping cost. KatzID also provides shipping companies accurate logistic data to better manage the process of shipping packages before the packages reach their distribution centers. The Company is currently carrying out a pilot to implement KatzID with Katz. According to the last agreement with Katz , by the end of 2017 the commercial terms will be discussed , depends on the activity during the pilot.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px;"> </td><td style="width: 24px; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">h.</font></td><td style="text-align: justify; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">On March 4, 2016, the Company entered a collaboration and license agreement with LSY International, Inc., a private company incorporated in the United States and which, among other things, sells luxury clothes made of fur, cashmere, alpaca, and shearling under the brand name</font><br /><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">“Yudovsky”.</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Under the agreement, the parties will cooperate for the purpose of integrating the Company’s measurement technology and computerized information systems of LSY. The agreement stipulates that the integration of these technologies, will be completed within four months from the date the agreement was signed. The complexity in achieving the correct matching between the fur coat and the Human body is still in an experiment stage.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Parties are in a continues contact and decided to delay the completion of the integration.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Upon completion of the integration, a 60-day technology testing period will begin, after which, subject to the fulfillment of the technological conditions, the agreement will take effect.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">According to the agreement, the Company shall be entitled to a total of 7.5% of every sale by LSY, and LSY company will pay a monthly sum of $ 2.5 for maintenance fees and services that the Company will provide.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">As the Company successfully completes integration of the technology into LSY’s systems and subject to the limitations set forth in the agreement, the Company will grant to LSY exclusive license to use the technology in the field of luxury clothing made of: fur, cashmere, alpaca and shearling. The exclusive license will be awarded to LSY as long as the Company will have a minimal income from the agreement as follows:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: -0.25in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">1) Minimum income of $ 1,000 at the end of the first period of 24 months from the effective date, and</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">2) Minimum income of $ 5,000 at the end of each subsequent year.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Under the agreement, LSY will pay the Company $100 in fees for establishment and implementation of technology systems as follows:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="text-align: justify; vertical-align: top;"><td style="width: 1in; text-align: right;">1)</td><td style="width: 15px;"></td><td style="text-align: justify;">$ 10 upon signing the agreement.</td></tr><tr style="text-align: justify; vertical-align: top;"><td style="text-align: right;">2)</td><td></td><td style="text-align: justify;">$30 upon start of implementation.</td></tr><tr style="text-align: justify; vertical-align: top;"><td style="text-align: right;">3)</td><td></td><td style="text-align: justify;">$20 upon completion of implementation.</td></tr><tr style="text-align: justify; vertical-align: top;"><td style="text-align: right;">4)</td><td> </td><td style="text-align: justify;">$40 balance upon completion of testing and monitoring implementation and the agreement taking effect.</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 92pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">As of the reporting date, the Company received a total of $10 in accordance with the said terms of the agreement, which was recorded as deferred revenue in the framework of the payables section and credit balances until the fulfillment of conditions for revenue recognition.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px; line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></td><td style="width: 24px;"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">i.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; font-stretch: normal;"></p></td><td><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">On April 20, 2017, the Company received a communication from the Israeli Postal Service (the “Israeli Post”) terminating its relationship and ceasing further discussions.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Previously, on April 18, 2017, the Company announced it had entered into a cooperation agreement with Israel Post which was mischaracterized by the Company as a definitive agreement. The Company and the Israeli Post had exchanged letters under which it was agreed to enter into a non-exclusive pilot program, pursuant to which the Israeli Post would decide whether it would enter negotiations with the company regarding the purchase of the product and under which commercial terms.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"><br />On April 20, 2017, the Company issued a corrective press release explaining that while the Company had submitted a proposal to the Israel Post, which was initially received favorably, the parties had not entered into or signed any formal or definitive agreement, and did not expect to enter into a formal or definitive agreement with respect to the pilot program or new services until the completion of the development and trial periods.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Israel Post expressed its discontent with the release of inaccurate information, and has elected to cease communication with the Company.<br /></font></p></td></tr><tr style="vertical-align: top;"><td style="line-height: 14.26px; font-size: 10pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></td><td><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">j.</font></td><td><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">On May 3, 2017, Lightcom (Israel) Ltd., an Israeli company, alleging that it is a shareholder of the Company, filed a motion with the Tel Aviv District Court (Financial Division) to approve an action against the Company as a shareholders’ class action. The subject matter of the action appears to be an immediate report filed by the Company on April 19, 2017. The Court ordered the Company to respond to the motion by August 2, 2017 (“<b>the Application</b>”).</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">On May 7 2017, the Company was served with the application.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Application alleges, inter alia, that the Company's report of April 19, 2017 regarding its engagement with the Israeli Post was false and misleading, and that as a result thereof financial damages have been incurred by two purported classes of shareholders: (i) any shareholder who sold Company's shares as of April 20, 2017 and until April 27, 2017, with respect to damage directly caused by such sale and (ii) any shareholder which held shares on April 20, 2017 and subsequent to April 27, 2017 with respect to damage caused by permanent adverse effect to the shares' value. The alleged financial damage caused to members of both classes is estimated at NIS 18.8 million.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company reviewed the Application initially with its legal counsel. At this preliminary stage, the Company believes that there is no direct causal connection between the Company's report which is the subject matter of the Application and the alleged damages caused to either class of purported plaintiffs and that in any case there appears to be no correlation between the alleged scope of damages and the merits of the alleged case.<br /> </font></p><p style="margin: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company's is reviewing its rights to file a third party claim (notice) against third parties the unlawful acts or omissions of which may have had an adverse effect on the Company's share price and may have contributed to any alleged damage which may have been caused to any of the classes of alleged plaintiffs. The Company will respond to the Application in the time frame ordered by the Court.</font></p></td></tr></table></div>

<div><p style="font: bold 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Note 6 - Significant Events During the Reporting Period</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px;"> </td><td style="width: 24px; line-height: 15.69px; font-size: 11pt;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">a.</font></td><td><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;">In February 2017, the Board of Directors approved agreements with investors that provided an investment for a total amount of $200 in exchange for 200,000 shares of common stock of the Company and non-negotiable warrants exercisable into 250,000 shares of common stock of the Company until November 22, 2017 at an exercise price of $3.50 per share.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;">On the date of its receipt of the investment, the amount was attributed to options to Company shares – measured according to the fair value on the measurement date. There was no attribute to the share issuance due to the fair value of the options. The options were recorded as a liability and was recognized for the reporting date in the sum of $168 according to the fair value of the undertaking.</p></td></tr></table></div>

<div><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 56.7pt 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Note 7 - Subsequent Events</b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 74.7pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 48px;"> </td><td style="width: 24px;"> </td><td style="font: 10pt/normal calibri, sans-serif; font-stretch: normal;"><font style="font-family: 'times new roman', serif; font-size: 10pt;">Pro-forma equity</font></td></tr></table><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 54pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">As described in Note 1b, as of March 31, 2017 the Company entered into fund raising agreements in a total sum of $8,015 out of which the sum of $4,596 and $1,410 was received in cash and marketable securities, respectively.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 36pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 54pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">As the date of this report the Company has $1,514 and $495 in guaranteed notes and checks. Subsequent to March 31, 2017, the sum of $550 and $40 of the guarantee notes and the checks, respectively, have been redeemed in cash.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 54pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 36pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 54pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The following proforma consolidated balance sheet is based on the March 31, 2017 balance sheet with adjustments for receipt of $1,419 from the remaining guarantee notes and checks from investors for stock subscribed for but not yet issued.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 74.7pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 54pt; background-color: white;"> </td><td style="font-family: 'times new roman', serif;">Assets</td><td style="width: 15px; font-family: 'times new roman', serif;"> </td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;">$</td><td style="width: 125px; text-align: right; font-family: 'times new roman', serif;">3,900</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="font-family: 'times new roman', serif;">Liabilities</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">865</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: left; font-family: 'times new roman', serif;">Stockholders’ equity</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">3,035</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: justify; font-family: 'times new roman', serif;">Total liabilities and stockholders’ equity</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;">$</td><td style="text-align: right; font-family: 'times new roman', serif;">3,900</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 74.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 54pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The effect on equity and on the assets of collecting the money from the bank guarantees and the checks is an increase of $1,419. As a result of the foregoing, the Company’s stockholder’s equity, on a pro forma basis, is $3,035 as of March 31, 2017.</p></div>

<div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0.5in;"></td><td style="width: 0.25in;">a.</td><td style="text-align: justify;"><font style="font-size: 10pt;">Unaudited condensed consolidated financial statements:</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 56.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying unaudited condensed consolidated financial statements included herein have been prepared by the Company in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements are comprised of the financial statements of the Company and its subsidiaries collectively referred to as the Company. In management’s opinion, the interim financial data presented includes all adjustments necessary for a fair presentation. All intercompany accounts and transactions have been eliminated. Certain information required by U.S. generally accepted accounting principles has been condensed or omitted in accordance with rules and regulations of the SEC. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for any future period or for the year ending December 31, 2017.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 56.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2016.</p></div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 56.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="text-align: justify; vertical-align: top;"><td style="width: 0.5in; text-align: right;"></td><td style="width: 0.25in;">c.</td><td style="text-align: justify;">Impact of recently issued accounting standard not yet adopted:</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 56.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In January 2016, the FASB issued Accounting Standards Update No. 2016-01 (ASU 2016-01) “Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 amends various aspects of the recognition, measurement, presentation, and disclosure for financial instruments. With respect to our consolidated financial statements, the most significant impact relates to the recognition and measurement for equity investments. Additionally, ASU 2016-01 will impact the disclosure and presentation of financial assets and liabilities. ASU 2016-01 is effective for annual reporting periods, and interim periods within those years beginning after December 15, 2017. Early adoption by public entities is permitted only for certain provisions. The Company is examining the effects of the update on the financial statements with no plans for early adoption.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 56.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02) which amends the FASB Accounting Standards Codification and created Topic 842, “Leases.” Under Topic 842, lessees are required to recognize assets and liabilities on the balance sheet for most leases and provides for enhanced disclosures. Leases will continue to be classified as either finance or operating. ASU 2016-02 is effective for annual reporting periods, and interim periods within those years beginning after December 15, 2018. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Full retrospective application is prohibited and early adoption by public entities is permitted. The Company is examining the possibility of early adoption of the update and the anticipated effects of its adoption on the financial statements.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 56.7pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">  </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, which significantly changes the way entities recognize impairment of many financial assets by requiring immediate recognition of estimated credit losses expected to occur over their remaining life. This ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2019. Early adoption is permitted for annual and interim periods in fiscal years beginning after December 15, 2018. The impact of adopting the new standard on the net income is not expected to be material.</p></div>

<div><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">March 31, 2017</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Financial assets</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Investment in marketable securities (*)</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">362</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: right; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">March 31, 2017</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td> </td><td style="text-align: left; font-size: 10pt;">Financial liabilities</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Warrants to purchase common stock (*)</td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">168</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td> </td><td style="text-align: left; font-size: 10pt;">Derivative liabilities (**)</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">78</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">  </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.5in; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">(*) see note 6.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 1in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">(**) see note 4a.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">March 31, 2016</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Financial assets</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Investment in marketable securities (***)</td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">1,012</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Put Options – DIMN shares</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">989</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 113.4pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">March 31, 2016</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Financial liabilities</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Warrants</td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">9</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;">-</td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Derivative liabilities embedded conversion options</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">14</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 85.05pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">December 31, 2016</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Financial assets</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Investment in marketable securities (***)</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">579</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 113.4pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td><td style="text-align: center; font-size: 10pt; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">December 31, 2016</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value hierarchy</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Financial liabilities</td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 15px; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td><td style="width: 125px; text-align: right; font-size: 10pt;"> </td><td style="width: 15px; text-align: left; font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; font-size: 10pt;">Derivative liabilities</td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">80</td><td style="text-align: left; font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="text-align: left; font-size: 10pt;"> </td><td style="text-align: right; font-size: 10pt;">-</td><td style="text-align: left; font-size: 10pt;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 85.05pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">(***) At March 31, 2017, gross unrecognized loss, recognized loss and fair value (based on quoted market prices) of these securities were $(93), $340 and $362, respectively (At December 31, 2016, $24, $1,233 and $579, respectively)</p></div>

<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.75in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></p><table style="width: 1551px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td nowrap="nowrap" style="text-align: center; font-size: 10pt; text-decoration: none;"> </td><td nowrap="nowrap" style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td nowrap="nowrap" style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="6">Three months ended <br />March 31</td><td nowrap="nowrap" style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td nowrap="nowrap" style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold; text-decoration: none;"> </td><td nowrap="nowrap" style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold; text-decoration: none;" colspan="2"><font style="font-size: 10pt;"><b>Year ended </b></font><br /><font style="font-size: 10pt;"><b>December 31,</b></font></td><td nowrap="nowrap" style="text-align: center; padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold; text-decoration: none;"> </td></tr><tr style="text-decoration: none; vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: justify; font-size: 10pt; text-decoration: none;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">2017</td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">2016</td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: center; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">2016</td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td></tr><tr style="text-decoration: none; vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: justify; font-size: 10pt; text-decoration: none;"> </td><td style="font-size: 1pt; text-decoration: none;"> </td><td style="font-size: 1pt; text-decoration: none;" colspan="2"> </td><td style="font-size: 1pt; text-decoration: none;"> </td><td style="font-size: 1pt; text-decoration: none;"> </td><td style="font-size: 1pt; text-decoration: none;" colspan="2"> </td><td style="font-size: 1pt; text-decoration: none;"> </td><td style="font-size: 1pt; text-decoration: none;"> </td><td style="font-size: 1pt; text-decoration: none;" colspan="2"> </td><td style="font-size: 1pt; text-decoration: none;"> </td></tr><tr style="text-decoration: none; vertical-align: bottom; background-color: #cceeff;"><td style="width: 0.75in; background-color: white;"> </td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; text-decoration: none;">Marketing, General and Administrative</td><td style="font: bold 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; width: 124px; text-align: right; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">39</td><td style="font: bold 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 124px; text-align: right; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(50</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;">)</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; width: 124px; text-align: right; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(23</td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal;">)</td></tr><tr style="text-decoration: none; vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: justify; padding-left: 28.35pt; font-size: 10pt; text-decoration: none;"> </td><td style="font-size: 10pt; text-decoration: none;"> </td><td style="text-align: left; font-size: 10pt; text-decoration: none;"> </td><td style="text-align: right; font-size: 10pt; text-decoration: none;"> </td><td style="text-align: left; font-size: 10pt; text-decoration: none;"> </td><td style="font-size: 10pt; text-decoration: none;"> </td><td style="text-align: left; font-size: 10pt; text-decoration: none;"> </td><td style="text-align: right; font-size: 10pt; text-decoration: none;"> </td><td style="text-align: left; font-size: 10pt; text-decoration: none;"> </td><td style="font-size: 10pt; text-decoration: none;"> </td><td style="text-align: left; font-size: 10pt; text-decoration: none;"> </td><td style="text-align: right; font-size: 10pt; text-decoration: none;"> </td><td style="text-align: left; font-size: 10pt; text-decoration: none;"> </td></tr><tr style="text-decoration: none; vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: justify; padding-bottom: 4pt; padding-left: 28.35pt; font-size: 10pt; text-decoration: none;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: left; text-decoration: none; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"> </td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: right; text-decoration: none; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">39</td><td style="font: bold 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-decoration: none; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-decoration: none; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">(50</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; text-decoration: none; font-stretch: normal;">)</td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; text-decoration: none; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-decoration: none; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-decoration: none; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">(23</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; text-decoration: none; font-stretch: normal;">)</td></tr></table>

<p style="font: 10pt/normal 'times new roman', serif; margin: 0pt 0px 0pt 54pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1551px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 54pt; background-color: white;"> </td><td style="font-family: 'times new roman', serif;">Assets</td><td style="width: 15px; font-family: 'times new roman', serif;"> </td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;">$</td><td style="width: 124px; text-align: right; font-family: 'times new roman', serif;">3,900</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="font-family: 'times new roman', serif;">Liabilities</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">865</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: left; font-family: 'times new roman', serif;">Stockholders’ equity</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">3,035</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: justify; font-family: 'times new roman', serif;">Total liabilities and stockholders’ equity</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;">$</td><td style="text-align: right; font-family: 'times new roman', serif;">3,900</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr></table>

13000000

4596000

8015000

1410000

1514000 550000 495000 40000

1012000

579000

362000

989000 9000 168000

14000

24000 -93000 1233000 340000

579000

362000

-50000

-23000

39000

26000

25000

3.50

9.00

1.50

5.00

4150 4250

500000

0.90 90000 12000 80000 78000 2000000

Exercisable for periods ranging from 12 month (or 6 months from filing date of registration statement) to 36 months.

2622500 3000000 3600000

1400000

60000

258000

400000

18800000

20.98

200000

100000 2000000

P21D

0.001

0.97

0.10

200000

The Company would pay the plaintiff the sum of NIS 250,000 forthwith by wire transfer of about NIS 95,000 and by the forfeiture of the sum of about NIS 155,000 which had been deposited with the court.

An additional amount of NIS 50,000 would be paid within twelve months from the approval of the settlement agreement by the court or on the closing date of a public offering of Company shares, pursuant to its terms, on a stock exchange in the United States, according to the earlier.

In consideration for the acquisition of the Venture the Company will undertake to pay the seller 18% the Company's operational profit arising directly or indirectly from the Venture during a period of seven years from the termination of the development period of the Venture. In addition the Seller received an option for a buy-back of the Venture upon the occurrence of any one or more of the following: (a) if an application was filed for the liquidation of the Company or for the appointment of a receiver for the Company's assets or any material part thereof or for the imposition of a lien on a material part of the Company's assets, which were not revoked within 60 days from the date they were so filed; (b) if by the end of seven years from the execution date of the agreement the entire aggregate income of the Company arising directly or indirectly from the Venture or from the commercialization of the patent was lower than NIS 3.6 million. According to the Company's evaluation, the current value is negligible. The buy-back option is valid for 90 days from the occurrence of either one of the above events. The agreed consideration was determined based on a valuation which was prepared by an independent assessor.

3600000

The collaboration agreement is for a period of up to six months, which may be extended by agreement of both parties or terminated by either party with prior notice of 14 days.

0.075

2500

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 1in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1)</font> <font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Minimum income of $ 1,000 at the end of the first period of 24 months from the effective date, and</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 1in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 1in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">2) Minimum income of $ 5,000 at the end of each subsequent year.</font></p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 1.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">1) $ 10 upon signing the agreement.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 1.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">2) $30 upon start of implementation.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 1.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">3) $20 upon completion of implementation.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 1.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">4) $40 balance upon completion of testing and monitoring implementation and the agreement taking effect.</font></p></div>

100

2000000

The Company's expert asserts that the plaintiff's expert opinion is erroneous and in his opinion and assuming the plaintiff's claim will be accepted by the court, than the estimated damage caused to the plaintiff as a result of a 4-5 years delay in registering his shares is estimated at approximately NIS 234,000 (plus interest and CPI differences) if it will be ruled that the restriction from plaintiff's shares should have been removed within six months as of the purchase date thereof and at approximately NIS 130,000 if it will be ruled that the restriction from plaintiff's shares should have been removed within twelve months as of the purchase day thereof.

200000

250000

3.50

2017-11-22 168000

865000

1419000 1419000 see note 4a. Represent an amount less than $1. At March 31, 2017, gross unrecognized loss, recognized loss and fair value (based on quoted market prices) of these securities were $(93), $340 and $362, respectively (At December 31, 2016 $24, $1,233 and $579, respectively) see note 6.

EX-101.SCH 7 mysz-20170331.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements Shareholders' Equity (Deficiency) (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Interim Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - General link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Financial Instruments link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Stock Based Compensation link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Contingencies and Commitments link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Significant Events During the Reporting Period link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Financial Instruments (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Subsequent Events (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - General (Details) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Financial Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Financial Instruments (Details Textual) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Stock Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Stock Based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Contingencies and Commitments (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Significant Events During the Reporting Period (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Subsequent Events (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 mysz-20170331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 mysz-20170331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 mysz-20170331_lab.xml XBRL LABEL FILE Document and Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Trading Symbol Amendment Flag Current Fiscal Year End Date Document Type Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Filer Category Entity Common Stock, Shares Outstanding Statement of Financial Position [Abstract] Assets [Abstract] ASSETS Assets, Current [Abstract] Current Assets: Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Prepaid Expense and Other Assets, Current Other receivables and prepaid expenses Total other accounts receivables Restricted Cash and Cash Equivalents, Current Restricted cash Assets, Current, Total Total current assets Marketable Securities, Noncurrent Investment in marketable securities Property, Plant and Equipment, Net Property and equipment net, carrying amounts Property and equipment, net Property and equipment net, carrying amounts Total non current Total noncurrent aseets Assets, Total Assets ASSETS Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity Liabilities, Current [Abstract] Current liabilities Accounts Payable, Trade, Current Trade payable Accounts Payable, Current Accounts payable Derivative Liability, Current Derivative liabilities Derivative liabilities Warrants and Rights Outstanding Warrants to purchase common stock Liabilities, Current, Total Total current liabilities Commitments and Contingencies COMMITMENTS AND CONTINGENCIES Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity (Deficiency): Common Stock, Value, Issued Capital stock - Common stock of $ 0.001 par value - Authorized: 50,000,000 shares; Issued and outstanding: 17,605,359 and 17,405,359 respectively Additional Paid in Capital, Common Stock Additional paid-in capital Available For Sale Reserve Available for sale reserve Available for sale reserve. Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive loss Retained Earnings (Accumulated Deficit), Total Accumulated deficit Stockholders' Equity Attributable to Parent, Total TOTAL STOCKHOLDERS' EQUITY Stockholders' equity Total stockholders' equity Balance Balance Liabilities and Equity, Total TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Total liabilities and stockholders' equity Total liabilities and stockholders' equity Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Income Statement [Abstract] Operating Expenses [Abstract] Operating expenses Operating expenses: Research and Development Expense, Total Research and development Research and development Other General and Administrative Expense Marketing, General and administrative Marketing, General and administrative Marketing, general and administrative Operating Expenses, Total Total operating expenses Total operating expenses Operating Income (Loss), Total Operating loss Gain (Loss) on Investments, Total Financial (expense) income, net Net Income (Loss) Attributable to Parent Net income Net income (loss) Loss before income taxes Net (loss) income from continuing operations Net income (loss) Loss before income taxes Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract] Other comprehensive (loss) income: Other comprehensive income (loss): Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax Gain (loss) on available for sale securities Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Foreign currency translation differences Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total Total comprehensive loss Total comprehensive (loss) income Earnings Per Share, Basic Basic (loss) earnings per share Earnings Per Share, Diluted Diluted (loss) earnings per share Weighted Average Number of Shares Outstanding, Basic Basic weighted average number shares outstanding Weighted Average Number of Shares Outstanding, Diluted Diluted weighted average number of shares outstanding Statement of Stockholders' Equity [Abstract] Statement [Table] Income Statement Location [Axis] Income Statement Location [Domain] Foreign Currency Gain (Loss) [Member] Foreign currency transaction Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common stock Additional Paid-in Capital [Member] Additional paid-in capital Available For Sale Reserve [Member] Available for sale reserve AOCI Attributable to Parent [Member] Accumulated other comprehensive income (loss) Retained Earnings [Member] Accumulated Deficit Statement [Line Items] Shares, Outstanding, Beginning Balance Balance, shares Balance, shares Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition Stock-based compensation related to options granted to consultants Stock Issued During Period, Value, Other Receipts on account of shares and New investments Stock Issued During Period, Shares, Other Receipts on account of shares and New investments, Shares Marketable Securities, Gain (Loss) Gain on marketable securities Adjustments to Additional Paid in Capital, Warrant Issued Warrants reclassified to equity as a result of amended exercise price currency Warrants reclassified to equity as a result of amended exercise price currency Stock Issued During Period, Value, Conversion of Convertible Securities Convertible loans converted to equity Stock Issued During Period, Shares, Conversion of Convertible Securities Convertible issued shares Convertible loans converted to equity, shares Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash flows from operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income (loss) to net cash used in operating activities: Depreciation, Total Depreciation Amortization of Debt Issuance Costs Amortization of warrant, convertible loans and Derivative Revaluation Put Option Revaluation PUT Option Revaluation PUT Option. Revaluation PUT Option Revaluation Investment In Marketable Securities Revaluation investment in marketable securities Revaluation investment in marketable securities. Share-based Compensation Sum of cost Stock based compensation Increase (Decrease) in Other Receivables Decrease (increase) in receivables and prepaid expenses Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Increase in Embedded Derivative Increase (decrease) in embedded derivative Increase (Decrease) in Accounts Payable, Trade Increase (decrease) in trade payable Increase (Decrease) in Other Accounts Payable Increase in other accounts payable Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total Net cash used in operating activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Net Cash Provided by (Used in) Investing Activities, Continuing Operations, Total Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows from financing activities: Payments for Loans Payment for a loan Payment for a loan Proceeds from Other Debt Payment from guarantees Proceeds From Issuing Shares, Warrants And Convertible Loans Proceeds from Issuing shares, warrants and convertible loans Proceeds from Issuing shares, warrants and convertible loans. Net Cash Provided by (Used in) Financing Activities, Continuing Operations, Total Net cash provided by financing activities Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations Effect of exchange rate changes on cash and cash equivalents Effect of exchange rate changes on cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease), Total (Decrease) Increase in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Non cash transactions Warrants Reclassified To Equity As Result Of Amended Exercise Price Currency1 Warrants reclassified to equity as a result of amended exercise price currency Warrants reclassified to equity result of amended exercise price currency. Warrants Reclassified To Equity As Result Of Amended Exercise Price Currency Warrants reclassified to equity as a result of amended exercise price currency Warrants reclassified to equity as a result of amended exercise price currency. Debt Conversion, Converted Instrument, Amount Convertible loans received Conversation of loan to capital Conversion of loan to equity Total amount of loan Share Base Payments For Receivables Non cash share base payments Fair value was recognized in trade receivables Share base payments for receivables General [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] General Significant Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Significant Accounting Policies Financial Instruments [Abstract] Financial Instruments (Abstract) Fair Value Disclosures [Text Block] Financial Instruments Stock Based Compensation [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock Based Compensation Contingencies and Commitments [Abstract] Commitments and Contingencies Disclosure [Text Block] Contingencies and Commitments Significant Events During the Reporting Period [Abstract] Significant events during reporting period. Significant Events During Reporting Period [Text Block] Significant Events During the Reporting Period Significant events during reporting period. Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events Consolidation, Policy [Policy Text Block] Unaudited condensed consolidated financial statements Use of Estimates, Policy [Policy Text Block] Use of estimates New Accounting Pronouncements, Policy [Policy Text Block] Impact of recently issued accounting standard not yet adopted Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block] Schedule of significant assets and liabilities that are measured at fair value on recurring basis Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Summary of stock based expense (income) recognized for for services received from employees and non-employees Condensed Balance Sheet [Table Text Block] Summary of proforma consolidated balance sheet General [Table] Agreement [Axis] Agreement [Domain] Fund Raising Agreement [Member] Fund raising agreements [Member] Fund raising agreement. Scenario [Axis] Scenario, Unspecified [Domain] Subsequent To March Thirty One Two Zero One Seven [Member] Subsequent to March 31, 2017 [Member] Subesequent to march thirty one two zero one seven. Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Domain] Payment Guarantee [Member] Guarantee notes [Member] General [Line Items] General Textual [Abstract] General (Textual) Goodwill, Impaired, Accumulated Impairment Loss Accumulated loss Cash Cash Cash Funds Net Fund amount, total The total amount of funds during the period. Marketable Securities Marketable securities Investment in marketable securities Guarantee Of Notes Guarantee of notes The value of guarantee notes during the period. Guarantee Of Checks Guarantee of checks The value of guarantee checks during the period. Fair Value, by Balance Sheet Grouping [Table] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Level 3 [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Financial assets Investments, Fair Value Disclosure Investment in marketable securities Put Options Put Options - DIMN shares A financial contract between two parties, the buyer and the seller (writer) of the option, where the buyer has the right but not the obligation to sell a commodity or financial instrument (the underlying instrument) to the seller (writer) at a certain time for a certain price (the strike price). The seller (writer) has the obligation to purchase the underlying asset at that strike price, if the buyer exercises the option. Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] Financial liabilities Warrants Warrants to purchase common stock Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Embedded Derivative, Fair Value of Embedded Derivative, Net Derivative liabilities embedded conversion options Financial Instruments Textual [Abstract] Financial Instruments (Textual) Cumulative Effect Adjustment Application Of Fair Value Option Unrealized Losse Unrecognized Gross unrecognized loss The amount of previously recognized gross losses included in accumulated other comprehensive income that make up a cumulative-effect adjustment on retained earnings related to the election of the fair value option. Cumulative Effect Adjustment Application Of Fair Value Options Unrealized Losses Recognized Gross recognized loss The amount of previously recognized gross losses included in accumulated other comprehensive income that make up a cumulative-effect adjustment on retained earnings related to the election of the fair value option. Fair Value, Option, Changes in Fair Value, Gain (Loss) Fair value Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Selling, General and Administrative Expenses [Member] Marketing, General and Administrative [Member] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Allocated Share-based Compensation Expense Share based compensation expense Allocated Share Based Compensation Expense Expenses were recognized fair value Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Title of Individual [Axis] Relationship to Entity [Domain] Consultant [Member] Five Installment [Member] Five Installments [Member] Sixth Installment [Member] Range [Axis] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock Based Compensation Textual [Abstract] Stock Based Compensation (Textual) Stock Issued During Period, Shares, Issued for Services Consideration for the services of common stock Shares Issued, Price Per Share Exercise price Common Stock Of Share Transferred In Installement Common stock of share transferred in installment It represent Common stock of share transferred in installement for the reporting period. Proceeds from Issuance of Common Stock Received the money from investors Issuance of Common stock, net Consideration for the sale of shares Share Price Falls On Stock Exchange, Percentage Share price falls on the stock exchange, percentage It represent Share price falls on the stock exchange, Percentage for the reporting period. Fair Value Disclosure Cost Fair value disclosure, cost It represent fair value cost or sum for the reporting period. Consideration Recognized Fair Value Consideration recognized fair value Consideration recognized fair value. Purchase Of Common Stock Purchase of common stock Purchase of common stock. Share-based Compensation Arrangement by Share-based Payment Award, Description Common stock at variable exercise, description EX-101.PRE 11 mysz-20170331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2017	May 16, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	My Size, Inc.
Entity Central Index Key	0001211805
Trading Symbol	MYSZ
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		17,605,359

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Current Assets:
Cash and cash equivalents	$ 359	$ 34
Other receivables and prepaid expenses	1,619	1,401
Restricted cash	66	62
Total current assets	2,044	1,497
Investment in marketable securities	362	579
Property and equipment, net	75	74
Total noncurrent aseets	437	653
Total assets	2,481	2,150
Current liabilities
Trade payable	188	229
Accounts payable	431	316
Derivative liabilities	78	80
Warrants to purchase common stock	168
Total current liabilities	865	625
COMMITMENTS AND CONTINGENCIES
Stockholders' equity (Deficiency):
Capital stock - Common stock of $ 0.001 par value - Authorized: 50,000,000 shares; Issued and outstanding: 17,605,359 and 17,405,359 respectively	17	17
Additional paid-in capital	14,744	13,347
Available for sale reserve		(93)
Accumulated other comprehensive loss	(107)	(102)
Accumulated deficit	(13,038)	(11,644)
Total stockholders' equity	1,616	1,525
Total liabilities and stockholders' equity	$ 2,481	$ 2,150

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	17,605,359	17,405,359
Common stock, shares outstanding	17,605,359	17,405,359

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Operating expenses
Research and development	$ 207	$ 177	$ 727
Marketing, General and administrative	879	326	1,859
Total operating expenses	1,086	503	2,586
Operating loss	(1,086)	(503)	(2,586)
Financial (expense) income, net	(308)	614	(1,748)
Net (loss) income from continuing operations	(1,394)	111	(4,334)
Other comprehensive (loss) income:
Gain (loss) on available for sale securities	93	67	(24)
Foreign currency translation differences	(5)	(90)	2
Total comprehensive (loss) income	$ (1,306)	$ 88	$ (4,356)
Basic (loss) earnings per share	$ (0.08)	$ 0.01	$ (0.27)
Diluted (loss) earnings per share	$ (0.08)	$ 0.05	$ (0.27)
Basic weighted average number shares outstanding	17,525,359	15,313,793	16,345,499
Diluted weighted average number of shares outstanding	17,525,359	15,492,659	16,345,499

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements Shareholders' Equity (Deficiency) (Unaudited) - USD ($)
$ in Thousands

Total

Common stock

Additional paid-in capital

Available for sale reserve

Accumulated other comprehensive income (loss)

Accumulated Deficit

Foreign currency transaction

Balance at Dec. 31, 2015

$ (2,613)

$ 15

$ 4,855

$ (69)

$ (104)

$ (7,310)

$ (104)

Balance, shares at Dec. 31, 2015

15,313,793

Total comprehensive loss

(90)

111

(90)

Stock-based compensation related to options granted to consultants

(50)

Gain on marketable securities

Warrants reclassified to equity as a result of amended exercise price currency

1,041

Balance at Mar. 31, 2016

(1,534)

$ 15

5,844

(194)

(7,199)

(194)

Balance, shares at Mar. 31, 2016

15,313,793

Balance at Dec. 31, 2015

(2,613)

$ 15

4,855

(69)

$ (104)

(7,310)

(104)

Balance, shares at Dec. 31, 2015

15,313,793

Total comprehensive loss

(4,356)

(24)

(4,334)

Stock-based compensation related to options granted to consultants

(23)

Warrants reclassified to equity as a result of amended exercise price currency

987

Convertible loans converted to equity

7,530

$ 2

7,528

Convertible loans converted to equity, shares

2,091,566

Balance at Dec. 31, 2016

1,525

$ 17

13,347

(93)

(11,644)

(102)

Balance, shares at Dec. 31, 2016

17,405,359

Total comprehensive loss

(1,306)

(1,394)

(5)

Stock-based compensation related to options granted to consultants

997

Receipts on account of shares and New investments

400

^[1]

$ 400

Receipts on account of shares and New investments, Shares

200,000

Balance at Mar. 31, 2017

$ 1,616

$ 17

$ 14,744

$ (13,038)

$ (107)

Balance, shares at Mar. 31, 2017

17,605,359

[1]	Represent an amount less than $1.

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Interim Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Cash flows from operating activities:
Net income (loss)	$ (1,394)	$ 111	$ (4,334)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	7	5	24
Amortization of warrant, convertible loans and Derivative	(29)	(614)	(182)
Revaluation PUT Option			776
Revaluation investment in marketable securities	340		1,233
Stock based compensation	39	(50)	(23)
Decrease (increase) in receivables and prepaid expenses	(8)	(15)	(27)
Increase (decrease) in embedded derivative	(6)		80
Increase (decrease) in trade payable	(54)	56	86
Increase in other accounts payable	93	28	208
Net cash used in operating activities	(1,012)	(479)	(2,159)
Cash flows from investing activities:
Purchase of property and equipment	(3)	(13)	(36)
Net cash used in investing activities	(3)	(13)	(36)
Cash flows from financing activities:
Payment for a loan			(25)
Payment from guarantees	1,149
Proceeds from Issuing shares, warrants and convertible loans	200		1,339
Net cash provided by financing activities	1,349		1,314
Effect of exchange rate changes on cash and cash equivalents	(9)	(2)	(4)
(Decrease) Increase in cash and cash equivalents	325	(494)	(885)
Cash and cash equivalents at the beginning of the period	34	919	919
Cash and cash equivalents at the end of the period	359	425	34
Non cash transactions
Warrants reclassified to equity as a result of amended exercise price currency		1,041
Warrants reclassified to equity as a result of amended exercise price currency			987
Conversion of loan to equity			4,846
Non cash share base payments	$ 958

XML 18 R7.htm IDEA: XBRL DOCUMENT

General

3 Months Ended

Mar. 31, 2017

General [Abstract]

General

Note 1 – General

	a.	My Size Inc. (the “Company”) developed a unique measurement technology based on sophisticated algorithms with broad applications in a variety of areas, from the apparel e-commerce market to Do It Yourself (DIY) smartphone & tablet apps. The technology is driven by several patent-pending algorithms which are able to calculate and record measurements in a variety of novel ways.

	b.	Since inception, the Company has incurred losses and negative cash flows from operations and the accumulated loss has reached $13 million. The Company has financed its operations mainly through fundraising from private investors. As of March 31, 2017, the Company entered into fund raising agreements in a total sum of $8,015 out of which the sum of $4,596 and $1,410 was received in cash and marketable securities, respectively. The marketable securities are shares of common stock of Diamante minerals Inc (“DIMN”), which are presented in the Company’s balance sheet as a financial asset available for sale.

XML 19 R8.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies

3 Months Ended

Mar. 31, 2017

Significant Accounting Policies [Abstract]

Significant Accounting Policies

Note 2 - Significant Accounting Policies

Unaudited condensed consolidated financial statements:

Use of estimates:

Impact of recently issued accounting standard not yet adopted:

XML 20 R9.htm IDEA: XBRL DOCUMENT

Financial Instruments

3 Months Ended

Mar. 31, 2017

Financial Instruments [Abstract]

Financial Instruments

Note 3 - Financial Instruments

Fair value of financial instruments:

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

	Level 1 -		Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

	Level 2 -		Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

	Level 3 -		Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The expected volatility of the share prices reflects the assumption that the historical volatility of the share prices is reasonably indicative of expected future trends.

March 31, 2017

Fair value hierarchy

Level 1

Level 2

Level 3

Financial assets

Investment in marketable securities (*)

362

	March 31, 2017
	Fair value hierarchy
	Level 1		Level 2		Level 3
Financial liabilities

Warrants to purchase common stock (*)		-		168		-
Derivative liabilities (**)		-		78		-

(*) see note 6.

(**) see note 4a.

	March 31, 2016
	Fair value hierarchy
	Level 1		Level 2		Level 3
Financial assets

Investment in marketable securities (***)		1,012		-		-

Put Options – DIMN shares		-		989		-

	March 31, 2016
	Fair value hierarchy
	Level 1		Level 2		Level 3
Financial liabilities

Warrants		-		9		-

Derivative liabilities embedded conversion options		-		14		-

December 31, 2016

Fair value hierarchy

Level 1

Level 2

Level 3

Financial assets

Investment in marketable securities (***)

579

December 31, 2016

Fair value hierarchy

Level 1

Level 2

Level 3

Financial liabilities

Derivative liabilities

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 21 R10.htm IDEA: XBRL DOCUMENT

Stock Based Compensation

3 Months Ended

Mar. 31, 2017

Stock Based Compensation [Abstract]

Stock Based Compensation

Note 4 - Stock Based Compensation

The stock based expense (income) recognized in the financial statements for services received from employees and non-employees is shown in the following table:

	Three months ended March 31					Year ended December 31,
	2017		2016			2016

Marketing, General and Administrative		39		(50	)		(23	)

		39		(50	)		(23	)

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 22 R11.htm IDEA: XBRL DOCUMENT

Contingencies and Commitments

3 Months Ended

Mar. 31, 2017

Contingencies and Commitments [Abstract]

Contingencies and Commitments

Note 5 -Contingencies and Commitments

All pre-trial preliminary proceedings as well as submission of all evidentiary affidavits and expert opinions by both parties have been completed.

On July 4, 2016, the Company announced that it completed integration of the first app (beta) that it developed in the said affiliation in the Katz’ systems.

The Parties are in a continues contact and decided to delay the completion of the integration.

Upon completion of the integration, a 60-day technology testing period will begin, after which, subject to the fulfillment of the technological conditions, the agreement will take effect.

1) Minimum income of $ 1,000 at the end of the first period of 24 months from the effective date, and

2) Minimum income of $ 5,000 at the end of each subsequent year.

Under the agreement, LSY will pay the Company $100 in fees for establishment and implementation of technology systems as follows:

1)		$ 10 upon signing the agreement.
2)		$30 upon start of implementation.
3)		$20 upon completion of implementation.
4)		$40 balance upon completion of testing and monitoring implementation and the agreement taking effect.

On April 20, 2017, the Company received a communication from the Israeli Postal Service (the “Israeli Post”) terminating its relationship and ceasing further discussions.

The Israel Post expressed its discontent with the release of inaccurate information, and has elected to cease communication with the Company.

On May 7 2017, the Company was served with the application.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Significant Events During the Reporting Period

3 Months Ended

Mar. 31, 2017

Significant Events During the Reporting Period [Abstract]

Significant Events During the Reporting Period

Note 6 - Significant Events During the Reporting Period

XML 24 R13.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Mar. 31, 2017

Subsequent Events [Abstract]

Subsequent Events

Note 7 - Subsequent Events

Pro-forma equity

Assets	$	3,900

Liabilities		865
Stockholders’ equity		3,035
Total liabilities and stockholders’ equity	$	3,900

XML 25 R14.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2017

Significant Accounting Policies [Abstract]

Unaudited condensed consolidated financial statements

Unaudited condensed consolidated financial statements:

Use of estimates

Use of estimates:

Impact of recently issued accounting standard not yet adopted

Impact of recently issued accounting standard not yet adopted:

XML 26 R15.htm IDEA: XBRL DOCUMENT

Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2017

Financial Instruments [Abstract]

Schedule of significant assets and liabilities that are measured at fair value on recurring basis

March 31, 2017

Fair value hierarchy

Level 1

Level 2

Level 3

Financial assets

Investment in marketable securities (*)

362

	March 31, 2017
	Fair value hierarchy
	Level 1		Level 2		Level 3
Financial liabilities

Warrants to purchase common stock (*)		-		168		-
Derivative liabilities (**)		-		78		-

(*) see note 6.

(**) see note 4a.

	March 31, 2016
	Fair value hierarchy
	Level 1		Level 2		Level 3
Financial assets

Investment in marketable securities (***)		1,012		-		-

Put Options – DIMN shares		-		989		-

	March 31, 2016
	Fair value hierarchy
	Level 1		Level 2		Level 3
Financial liabilities

Warrants		-		9		-

Derivative liabilities embedded conversion options		-		14		-

December 31, 2016

Fair value hierarchy

Level 1

Level 2

Level 3

Financial assets

Investment in marketable securities (***)

579

December 31, 2016

Fair value hierarchy

Level 1

Level 2

Level 3

Financial liabilities

Derivative liabilities

XML 27 R16.htm IDEA: XBRL DOCUMENT

Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2017

Stock Based Compensation [Abstract]

Summary of stock based expense (income) recognized for for services received from employees and non-employees

	Three months ended March 31					Year ended December 31,
	2017		2016			2016

Marketing, General and Administrative		39		(50	)		(23	)

		39		(50	)		(23	)

XML 28 R17.htm IDEA: XBRL DOCUMENT

Subsequent Events (Tables)

3 Months Ended

Mar. 31, 2017

Subsequent Events [Abstract]

Summary of proforma consolidated balance sheet

Assets	$	3,900

Liabilities		865
Stockholders’ equity		3,035
Total liabilities and stockholders’ equity	$	3,900

XML 29 R18.htm IDEA: XBRL DOCUMENT

General (Details) $ in Thousands	Mar. 31, 2017 USD ($)
General (Textual)
Accumulated loss	$ 13,000
Guarantee notes [Member]
General (Textual)
Guarantee of notes	1,514
Guarantee of checks	495
Subsequent to March 31, 2017 [Member]
General (Textual)
Guarantee of notes	550
Guarantee of checks	40
Fund raising agreements [Member]
General (Textual)
Cash	4,596
Fund amount, total	8,015
Marketable securities	$ 1,410

XML 30 R19.htm IDEA: XBRL DOCUMENT

Financial Instruments (Details) - USD ($)
$ in Thousands

Mar. 31, 2017

Dec. 31, 2016

Mar. 31, 2016

Financial liabilities

Derivative liabilities

$ 78

$ 80

Level 1 [Member]

Financial assets

Investment in marketable securities

362

^[1]

579

^[2]

$ 1,012

^[2]

Put Options - DIMN shares

Financial liabilities

Warrants to purchase common stock

^[1]

Derivative liabilities

^[3]

Derivative liabilities embedded conversion options

Level 2 [Member]

Financial assets

Investment in marketable securities

^[1]

^[2]

Put Options - DIMN shares

989

Financial liabilities

Warrants to purchase common stock

168

^[1]

Derivative liabilities

^[3]

Derivative liabilities embedded conversion options

Level 3 [Member]

Financial assets

Investment in marketable securities

^[1]

^[2]

Put Options - DIMN shares

Financial liabilities

Warrants to purchase common stock

^[1]

Derivative liabilities

^[3]

Derivative liabilities embedded conversion options

[1]	see note 6.
[2]	At March 31, 2017, gross unrecognized loss, recognized loss and fair value (based on quoted market prices) of these securities were $(93), $340 and $362, respectively (At December 31, 2016 $24, $1,233 and $579, respectively)
[3]	see note 4a.

XML 31 R20.htm IDEA: XBRL DOCUMENT

Financial Instruments (Details Textual) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Financial Instruments (Textual)
Gross unrecognized loss	$ (93)	$ 24
Gross recognized loss	340	1,233
Fair value	$ 362	$ 579

XML 32 R21.htm IDEA: XBRL DOCUMENT

Stock Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
Stock Based Compensation (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share based compensation expense	$ 39	$ (50)	$ (23)
Marketing, General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share based compensation expense	$ 39	$ (50)	$ (23)

XML 33 R22.htm IDEA: XBRL DOCUMENT

Stock Based Compensation (Details Textual) ₪ / shares in Units, $ / shares in Units, $ in Thousands	3 Months Ended			12 Months Ended
	Mar. 31, 2017 USD ($) shares	Mar. 31, 2017 ILS (₪) shares	Mar. 31, 2016 USD ($)	Dec. 31, 2016 USD ($) $ / shares shares	May 16, 2017 $ / shares	Mar. 31, 2017 ₪ / shares
Stock Based Compensation (Textual)
Fair value disclosure, cost				$ 90
Consideration recognized fair value	$ 78			80
Expenses were recognized fair value	39		$ (50)	(23)
Fair value was recognized in trade receivables	$ 958
Consultant [Member]
Stock Based Compensation (Textual)
Consideration for the services of common stock \| shares	25,000	25,000
Exercise price \| ₪ / shares						₪ 18
Consideration for the sale of shares \| ₪		₪ 500,000
Share price falls on the stock exchange, percentage	90.00%	90.00%
Fair value disclosure, cost	$ 12
Purchase of common stock \| shares				2,000,000
Expenses were recognized fair value	$ 26
Common stock at variable exercise, description				Exercisable for periods ranging from 12 month (or 6 months from filing date of registration statement) to 36 months.
Consultant [Member] \| Minimum [Member]
Stock Based Compensation (Textual)
Exercise price \| $ / shares				$ 3.50
Consultant [Member] \| Maximum [Member]
Stock Based Compensation (Textual)
Exercise price \| $ / shares				$ 9.00
Five Installments [Member]
Stock Based Compensation (Textual)
Common stock of share transferred in installment \| shares	4,150	4,150
Sixth Installment [Member]
Stock Based Compensation (Textual)
Common stock of share transferred in installment \| shares	4,250	4,250
Subsequent Event [Member] \| Minimum [Member]
Stock Based Compensation (Textual)
Exercise price \| $ / shares					$ 1.50
Subsequent Event [Member] \| Maximum [Member]
Stock Based Compensation (Textual)
Exercise price \| $ / shares					$ 5.00

XML 34 R23.htm IDEA: XBRL DOCUMENT

Contingencies and Commitments (Details) ₪ / shares in Units, $ / shares in Units, € in Thousands								1 Months Ended			3 Months Ended	12 Months Ended
	Jun. 13, 2016	Mar. 04, 2016 USD ($)	Dec. 27, 2015 ILS (₪) ₪ / shares	Feb. 18, 2015 ILS (₪)	Nov. 14, 2014 EUR (€)	Jan. 09, 2014 ILS (₪)	May 17, 2012 ILS (₪)	Apr. 19, 2017 ILS (₪)	Nov. 15, 2015	Jan. 16, 2014 USD ($)	Mar. 31, 2017 USD ($) $ / shares shares	Dec. 31, 2016 ILS (₪)	Mar. 31, 2017 ₪ / shares
Commitments and Contingencies (Textual)
Compensation for damages				₪ 258,000	€ 60					$ 1,400,000
Interest rate				10.00%
Repayments of loan				₪ 200,000
Name of plaintiff, Description	The Company would pay the plaintiff the sum of NIS 250,000 forthwith by wire transfer of about NIS 95,000 and by the forfeiture of the sum of about NIS 155,000 which had been deposited with the court.
Court of law closing date description	An additional amount of NIS 50,000 would be paid within twelve months from the approval of the settlement agreement by the court or on the closing date of a public offering of Company shares, pursuant to its terms, on a stock exchange in the United States, according to the earlier.
Consideration of acquisition, description						In consideration for the acquisition of the Venture the Company will undertake to pay the seller 18% the Company's operational profit arising directly or indirectly from the Venture during a period of seven years from the termination of the development period of the Venture. In addition the Seller received an option for a buy-back of the Venture upon the occurrence of any one or more of the following: (a) if an application was filed for the liquidation of the Company or for the appointment of a receiver for the Company's assets or any material part thereof or for the imposition of a lien on a material part of the Company's assets, which were not revoked within 60 days from the date they were so filed; (b) if by the end of seven years from the execution date of the agreement the entire aggregate income of the Company arising directly or indirectly from the Venture or from the commercialization of the patent was lower than NIS 3.6 million. According to the Company's evaluation, the current value is negligible. The buy-back option is valid for 90 days from the occurrence of either one of the above events. The agreed consideration was determined based on a valuation which was prepared by an independent assessor.
Patent						₪ 3,600,000
Collaboration agreement description									The collaboration agreement is for a period of up to six months, which may be extended by agreement of both parties or terminated by either party with prior notice of 14 days.
Total sale by LSY, Percentage		7.50%
LSY pay monthly for maintenance fees and services \| $		$ 2,500
Description of LSY minimal income from agreement											1) Minimum income of $ 1,000 at the end of the first period of 24 months from the effective date, and 2) Minimum income of $ 5,000 at the end of each subsequent year.
Description of technology systems											1) $ 10 upon signing the agreement. 2) $30 upon start of implementation. 3) $20 upon completion of implementation. 4) $40 balance upon completion of testing and monitoring implementation and the agreement taking effect.
Total amount of LSY pay fees for technology systems \| $											$ 100
Total of deferred revenue \| $											$ 10
Purchase shares of common stock \| shares											2,000,000
Loss contingency plaintiff damage, description												The Company's expert asserts that the plaintiff's expert opinion is erroneous and in his opinion and assuming the plaintiff's claim will be accepted by the court, than the estimated damage caused to the plaintiff as a result of a 4-5 years delay in registering his shares is estimated at approximately NIS 234,000 (plus interest and CPI differences) if it will be ruled that the restriction from plaintiff's shares should have been removed within six months as of the purchase date thereof and at approximately NIS 130,000 if it will be ruled that the restriction from plaintiff's shares should have been removed within twelve months as of the purchase day thereof.
Minimum [Member]
Commitments and Contingencies (Textual)
Plaintiff damaged value												₪ 3,000,000
Maximum [Member]
Commitments and Contingencies (Textual)
Plaintiff damaged value												₪ 3,600,000
Subsequent Event [Member]
Commitments and Contingencies (Textual)
Compensation for damages								₪ 18,800,000
Convertible Loan [Member]
Commitments and Contingencies (Textual)
Convetible loan agreement							₪ 200,000
Additional loan received							100,000
Additional investment on agreement							₪ 2,000,000
Convertible loan term							21 days
Conversion price \| (per share)											$ 0.001		₪ 0.97
Interest rate											10.00%		10.00%
Defendants [Member]
Commitments and Contingencies (Textual)
Plaintiff damaged value			₪ 2,622,500
Compensation for damages			₪ 400,000
Company share value rises per share \| ₪ / shares			₪ 20.98

XML 35 R24.htm IDEA: XBRL DOCUMENT

Significant Events During the Reporting Period (Details) $ / shares in Units, $ in Thousands	1 Months Ended
	Feb. 28, 2017 USD ($) $ / shares shares
Significant Events During the Reporting Period (Textual)
Investments \| $	$ 200
Exchange of common stock, shares \| shares	200,000
Non-negotiable warrants exercisable \| shares	250,000
Exercise price of warrants \| $ / shares	$ 3.50
Investment warrants exercisable, expiration date	Nov. 22, 2017
Fair value of liability recognized \| $	$ 168

XML 36 R25.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Subsequent Event [Line Items]
Assets	$ 2,481	$ 2,150
Stockholders' equity	1,616	1,525	$ (1,534)	$ (2,613)
Total liabilities and stockholders' equity	2,481	$ 2,150
Proforma [Member]
Subsequent Event [Line Items]
Assets	3,900
Liabilities	865
Stockholders' equity	3,035
Total liabilities and stockholders' equity	$ 3,900

XML 37 R26.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Subsequent Events (Textual)
Adjustments for receipt of guarantee notes and checks	$ 1,419
Increase in bank guarantee and checks	1,419
Stockholders' equity	1,616	$ 1,525	$ (1,534)	$ (2,613)
Guarantee notes [Member]
Subsequent Events (Textual)
Guarantee of notes	1,514
Guarantee of checks	495
Subsequent to March 31, 2017 [Member]
Subsequent Events (Textual)
Guarantee of notes	550
Guarantee of checks	40
Proforma [Member]
Subsequent Events (Textual)
Stockholders' equity	3,035
Fund raising agreements [Member]
Subsequent Events (Textual)
Fund amount, total	8,015
Marketable securities	1,410
Cash	$ 4,596

EXCEL 38 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( *!5L$H?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ H%6P2F;S"V"" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGB06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " "@5;!*NK[0<.\ K @ $0 &1O8U!R;W!S+V-O M&ULS9+/:L,P#(=?9?B>*&Z[#$R:RT9/'0Q6V-C-V&IK&O_!UDCZ]G.R M-F5L#["CI9\_?0(U*@CE([Y$'S"2P70WV,XEH<*:'8F" $CJB%:F,B=<;NY] MM)+R,QX@2'62!X1%5=5@D:26)&$$%F$FLK;12JB(DGR\X+6:\>$S=A-,*\ . M+3I*P$L.K!TGAO/0-7 #C##":--W ?5,G*I_8J<.L$MR2&9.]7U?]LLIEW?@ M\/Z\?9W6+8Q+))W"_"L90>> :W:=_+9\?-IM6+NH^$-1W1>\WO%*K%:"UQ^C MZP^_F[#UVNS-/S:^"K8-_+J+]@M02P,$% @ H%6P2IE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T M$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY M\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4? M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M M&N#C\7@XMLO2BW A(5M>5 TR 6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2. MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$. M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07 M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL! M_]':-\*K^(+ .7\N?<^E[[GT/:'2MSAD M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W MF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>( M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K> M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5 MYYN MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+ MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> , M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H: M,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ M 5!+ P04 " "@5;!*9X-TCF0" 5" & 'AL+W=O:MK2:B^* MUKMO/T"O\P+N305\GO/C( =:](R_BHH0&;PUM!7;L)*RVP @SA5IL'AB'6G5 MFROC#9:JRV] =)S@BS$U%* HRD"#ZS8L"S-VY&7![I+6+3GR0-R;!O,_>T)9 MOPUA^#[P7-\JJ0= 673X1GX0^;,[S-J!3N7$V*ON?+ULPTC/B%!RECH$5H\'.1!*=20UC]]CT'!B:N.\_1[] MLTE>)7/"@AP8_55?9+4-5V%P(5=\I_*9]5_(F% :!F/VW\B#4"77,U&,,Z/" M_ ;GNY"L&:.HJ33X;7C6K7GVPYLD'FU^ QH-:#*@[+^&>#3$DP$: AAF9E+] MA"4N"\[Z@ ]?J\-Z4\!-K!;SK ?-VIEW*ENA1A]E5("'#C,J]H,"S11P4@ 5 M>P(@'V"/'#OZ"#BXBM@/B+T9Q,8>S^R)WYYX[8FQ)S-[:BV J\C\@-0+2!U[ M;@$&16H4[;#"",)5E/HQF1>3.9B5A7$5:S\@]P)RQP[MK>*1+.R5E1>QU%K%U_8B$\DH4O 2-_345NA,RN*H\F7Z L5"YT(]B??-3,MQ:* M%CG> MY!Y'+6-F?09/,JCQ8H_BJ&L4-!T*9X-&B!XB]VZ-8RBJWC:-1\*,<\ MB](XMZ:KI%>+#V^!!%W>:@ZZ*[-T?=N%]VIJT+ MZV[;?=0=6UULAZ"ZBD0JVKJL_D?/P=DX;7FGW@ M]/H]^Y>A>=?,<]'IM:G^E%M[6(1Y&&SUKCA5]LF)#N96[ZA\.[&WYSW7;NZ>M2J'GTVN<9):N+ M1$PEMXHUHTBNDLC5OYH0K DQQ,MI?,K'2S9>#O%J&I^A)BZ2;) T@T0F,]0& MHU&\#<7:4-1&CFQ<),FD!*2 ?3 B%0/O)&&=)-0)*K)*2)$T13X8B>!=I*R+ ME+B0,7*1DA(B5F@"KJD(U"SCG62LDXPZ >0D(T5DBN1LSYRZ@/5 M6.6D1I8@&XS$,T]GK(L9=2&1BQDIH23Z2ZVI)DTD[P-B'CXQ=4+H$],IHG+ M!&)4D,0>-QX4 L&0]& ,>(Z!H/VDN!]!9W.>XW:H2 C/3 .>B4"AB$=P-6IN MAYF\6BJ2X,$S\& $2D:)R0B4>AEY+523^\:8!R-0,DI,1J#<@Y18H8F4SPI/ M1Z!X5!A*0-&7IQ@'C"CUK;_ \Q$H(!4&$Z>)L94/-;=.>$)"3OZ$R@<5GFY M\897E!50=@'&V\>:VUT-CS=!\:;0X*T$!1>HC"R!G$Q*Y?/# TX ]8/QQ&GP M*(^:J9F[F6>0A&?'1TFI,)T$A> =Q'B8>)5GGR)X5@K*2H7Y)"@&[T#&F&-K M5@>I\JS0@B>FH,14F%."W4SB31RG2KS;BZW0T M.;WTQ\D?1;LOFRYX-M8=A(;CRLX8JUW&^-YE/+@3[/6FTCO;7V;NNKTL#BX!8[7(1>\;_/_X&8F:T=[D?N-E,,! M(5$VT!&Q8P/T:J5FO"-2A?R"Q,"!5,;4410%08HZTO9^D9G%_'H&R,?=#_RWQU%X:J1.HR 9R@1\@?PXGKB(T5ZG:#GK1LM[C4.?^ MQ_!P3+7>")Y;&,5B[NE.SHR]Z.!KE?N!!@(*I=05B!IN< 1*=2&%\7NJZ<]; M:N-R_E;]L^E=]7(F HZ,_FHKV>3^@^]54),KE4]L_ )3/]CWIN:_P0VHDFL2 MM4?)J#"_7GD5DG53%872D5<[MKT91[N2[B>;VQ!-AF@VA,D_#?%DB#<&9,E, MJY^()$7&V>AQ^[$&HO\3X2%6+[/42?/NS)KJ5JCLK D1N?VQTQ\;?[+TQYLFK.3!2'HC"79!L&GU^#_5 MBB5QLB3W+,F&Q4KP8A<#\P[AB@@[B? ]$=X0X;N-PGT:X!A_V!"YA,E: MN")*G43I/5&Z(4K?2^02.HG0XDCH*^H[X9>V%]Z9276ZS!FH&9.@B@8[5:]1 MM^(<4*BEGN[5G-N[P0:2#=.UA^:[M_@+4$L#!!0 ( *!5L$HRH10C4 , M *4- 8 >&PO=V]R:W-H965T&ULA9=M;YLP$,>_"N)] M"[8QABJ)U!!-F[1)U:9MKVGB)*B ,W":[MO//#2E=T?W)H#YW]W/%WQG+RZF M>6J/6EOOI2KK=ND?K3W=!4&[/>HJ;V_-2=?NS=XT56[=8W,(VE.C\UUO5)4! M#\,XJ/*B]E>+?NRA62W,V99%K1\:KSU75=[\7>O27)8^\U\'OA>'H^T&@M7B ME!_T#VU_GAX:]Q1R*2M=M86JOT?NE?\_N-DQU!KWB5Z$O[>3>ZZ;R:,Q3 M]_!EM_3#CDB7>FL[%[F[/.M,EV7GR7'\&9WZUYB=X?3^U?NG?O)N,H]YJS-3 M_BYV]KCT$]_;Z7U^+NUW<_FLQPE)WQMG_U4_Z]+).Q(78VO*MO_UMN?6FFKT MXE"J_&6X%G5_O8S^7\UH SX:\*N!B_V1@1@-Q)M!]*%!-!I$;P9QGZUA*GUN M-KG-5XO&7+QF^'M/>?<5L;O(97_;#?;)[M^Y]+1N]'DEU2)X[OR,DO4@X1,) M>Z_88(5,KI+ Q;]"< IBS9$]?Q\APPJ9 @C"B:0A!)D)T=N+B7T)G,1(%$AYAC6" MQX 5:U@R^>_>P<8D;(QA!8"-<9 P 209%LD0.-I@#9<31^]H%4FK,&T$:!4* MXV"O6;4I-- X2U:M83,J5"#)YW-]1Q&-QV&NXZ" M76?4_)<:RYQ*0FK2V2PUW7T8;C\*MA]&]!\EN11PDY)12BF84'"Q;BAE+"(9 MI3/-D]']B.&&I&!#8KB-S/$32H?$8[0=HY0T?S#9JU:Z.?3G@-;;FG-MNPW= M9/1ZUKCGW5X7C*_973:<&-[<# >8;WES*.K6>S36[:3[_>[>&*L=:'CK$(_N MS'1]*/7>=K?*W3?#P6%XL.8T'HJ"Z\EL]0]02P,$% @ H%6P2@)1PM<& M!0 ?!L !@ !X;"]W;W)KBN)G)>AS+*&2=7Q2Y-.;CF;P/OC#_:H M';P:S%M:R;#(?APV]7X^"2;&1F[3_5_R768*WE2BY9E&EY.GOZ^?AV'Y>-/]'&!W =0"_!=A.;X"M ^Q; +-[ QP= MX-P"^A.X&N_>\-SO#?!T@#'1D.45 MPN\A7A<2$A"_"WG!$ 28$A@W2"FTNLF&B=%XVV\ MCFTOJYF+=P%I9NCB'"VH-,0T2;@1--$RS&H;$ MPY"D%]*1S2-E\[!LL)UZ:+P>Z)4A9D&J#4.BX42K899X&)+T0CJB^:1H/A8- M]/VEC]>\Y8!%'V(>)-L8GFB89S4,B8AS"1&SB )\(%(>6H@@3H.@(*4D"!!82M7_SA-L0LVF=9 MPYY!8SH#(DR#AO7.%D%%V 8J(?(-1#K".%!4A'.@8 ^M WM@6=FP>="8/Y@V MVNDQPNI!_Z QG3$YMNM!L0D81S*27/!^30@8?S NVG\QPH#!_9UA!_;$T6+$ M1*CICB&*1A#%(S!)/Z:K#6T9&>$9X7[$L,$2L/>&!!'69@11-((H'H%)^C%= M;6A;R A?** VV-'YK@V=H4;YY!+6VE!$/(#BC'!^(S!)/Z8K#FW^ "T+R' M#+LR;@GF>MZ#5+1E8M@Z"+2=$&;'Y2XLR,>["?KM3C"IIH26*88]"1M.!0%B MS(-6(B%QUJ,N1_LCAOV(0#L%=A',=RS7=L6#7+258(270#L%-A-/S+;0TQ1, MA?O&,"8BTN'I($N"ABRA8"ZM#Z<-$"<,$-QQ.'8'0L"N2A A=<8012.(XA&8 MI!_3U89V-!P[&CA12XX=C6/![D(0P7*?J60.U(^AIH"212.2Q2,P23^FJ]^# MYW'8I0G8YSAAF:SF#PX=^*%WV,MW<3C*YK9M#7QV7 MU_=!UY.Z..EW7>;MA=OB?U!+ P04 " "@5;!*,0,Y=ET$ F%@ & M 'AL+W=O^/_/R M]%2XJT4_]ERM%N5KDYT*\UPY]6N>I]5_:Y.5EZ6KW/>!;Z?#L>D&O-7BG![, M7Z;Y^_QE65WRDU1G\K"JOW._K5/ODWF):W-ILR^ MGW;-<>E&KK,S^_0U:[Z5E]_,F%#H.F/V?Y@WD[7P3DD[Q[;,ZOZOLWVMFS(? M65HI>?IS^#T5_>]EY'\/PP$T!M UH)W[7H > _1'0' W(!@#@H^ 65^M(96^ M-DG:I*M%55Z<:GB\Y[1;1>HQ:*N_[0;[8O?_:\M3MZ-OJSA>>&\=SPA9#Q": M0-0M(I&(,+I"O';^JPA"(M8DXNEVAHU$A$QF DA"+$+#2N@^7D_3]'U,$$"" MH"<(;@A8I=8#9MYCBA[SH'0<\ 4:!U@P2$4'(*,"1/,(,$,9*Q9 MQ@,FG.B*^P$ \4ZT^00F(60'E@]'PG9 P X4MP.27;Q=>=S! )54 M?!=S*QC; 0$[4-P.2+9Q\D6%/^$'@$AI;7GU"3L" 4<@[@@D&[G2LL222DI& M3,KRS4G8% B8 G%3(-G,'X1@@"$N&&!LY A\CY,@ M5!397CQL" 0V(,0W("1W#YI_)@!,S%^(Y!>@6\'8?@C8#W'[(>D:FN]V-P 4 M\">1(";;JL#V0Y'LYM;NB V!Y$XCXAL-@)'-'.PT_(!OB^\SW1X#8/?1TC2$ M7H 1>C^!2;0TGSBR?-IK;#X:F \)O;^VE2V2O=@_(WC3:2.6^:EMC> *LC2 I"L^R:2,85+O/H.YDRUX,3 M7,')(#M(R .A A$7L;OQ(GG ME &X/+^RW\?:?2UG9N%.BR=>NZ[ >XQJ:-@@W(,>OT*JYQ-&J?CO< 'APX,2 MGZ/2PL8558-U6B86+T6REVGG*NYCNKE)L'4 30 Z _8Q#YD21>5?F&-E;O2( MS-3[GH4GWARH[TT5G+$5\$VPK?_*+Q9)]BM$NPBP>[#$E=BMME_2;#0&-"\?/_FRF M,9L,I_OT@\C\C&PO M=V]R:W-H965T&UL?5/;;M0P$/T5RQ]0;RY M4HB=8L02""M MBH!G;S))K/H2;&=3_IZQDX8 :5]LSWC.F3/C<3$9^^AZ $^>E-2NI+WWPY$Q M5_>@N+LQ VB\:8U5W*-I.^8&"[R)("59>CB\98H+3:LB^LZV*LSHI=!PML2- M2G'[ZP323"5-Z+/C072]#PY6%0/OX"OX;\/9HL56ED8HT$X832RT);U+CJ<\ MQ,> [P(FMSF34,G%F,=@?&I*>@B"0$+M P/'[0KW(&4@0AD_%TZZI@S [?F9 M_4.L'6NY< ?W1OX0C>]+>DM) RT?I7\PTT=8ZGE#R5+\9[B"Q/"@!'/41KJX MDGITWJB%!:4H_C3O0L=]FF_R;('M ](%D*Z VYB'S8FB\O?<\ZJP9B)V[OW MPQ,GQQ1[4P=G;$6\0_$.O=ZE.*7_P=-] M>+:K,(OP["^%+Q#DNP1Y),A?+7$O)OLG"=OT5('MXC0Y4IM1QTG>>->!O4OC MF_P)GZ?]"[>=T(Y7C?UOC?& 4@XW.$(]?K#5D-#Z<'R'9SN/V6QX,RP_ MB*W?N/H-4$L#!!0 ( *!5L$KW?OC(M $ -(# 8 >&PO=V]R:W-H M965T&UL?5-A;]P@#/TKB!]0[DC:5:M.IL3EOG^@-CMFQ!"WN% M/73^ID:CA?.F:9CM#8@J@K1B?+>[85K(CA99])U,D>'@E.S@9(@=M!;F]0@* MQYSNZ9OC43:M"PY69+UHX >XG_W)>(LM+)74T%F)'3%0Y_1N?SBF(3X&_)(P MVM69A$K.B,_!^%;E=!<$@8+2!0;AMPO<@U*!R,OX/7/2)64 KL]O[%]B[;Z6 ML[!PC^I)5J[-Z2TE%=1B4.X1QZ\PUW--R5S\=[B \N%!B<]1HK)Q)>5@'>J9 MQ4O1XF7:91?W<;I)DAFV#> S@"^ VYB'38FB\L_"B2(S.!(S];X7X8GW!^Y[ M4P9G;$6\\^*M]UZ*?9)F[!*(YICC%,/7,4L$\^Q+"KZ5XLC_@?-M>+*I,(GP MY)W"ZVV"=),@C03I?TOJK!-'&:+"EQZ.(DK[S+P-[Q^"9_PZ=I M?Q"FD9TE9W3^96/_:T0'7LKNRH]0ZS_88BBH73A^\FUUKX =]Q[]^XXL@'-LVT!''E14MN:%EGTG4R18>^DT' RQ/9*'P#:9Z/E$R%?\ %Y ^/"CQ.4J4-JZD[*U#-;%X*8J_ MC+O0<1_&F_1Z@JT#D@F0S(!]S,/&1%'Y%^YXD1DI.Q2R":8HYC3+*,F2.89Y]3)&LICLD'>+(.3U<5IA&>_J-P MOTZP6R7818+=?TM(T65)BK^,D+[SSP-XF\4W^AH_3_LA- M([0E9W3^96/_:T0'7LKFRH]0ZS_8;$BH73C>^+,9QVPT'';3#V+S-R[^ %!+ M P04 " "@5;!*7'8;@;(! #2 P &0 'AL+W=O4M) RT?I'\ST$99ZWE"R%/\9KB Q/"C!'+61+JZD'ITW:F%!*8H_S;O0 M<9_FFSQ=8/N ; %D*^ VYF%SHJC\/?>\*JR9B)U[/_#PQ.DQP][4P1E;$>]0 MO$/OM4KSIF+3$G.:8;!NS1C!D7U-D>RE.V7_P;!]^V%5XB/##7PI?R)_O M$N21('^UQ+V8?U6R34\5V"Y.DR.U&76 M9O1%$BF>PT.*2@=C7UP#X,F;DMIEM/&^.S+FB@:4<#>F XTWE;%*>#1MS5QG M0901I"3CF\TM4Z+5-$^C[VSSU/1>MAK.EKA>*6%_G4":(:-;^NYX;NO&!P?+ MTT[4\ W\]^YLT6(S2]DJT*XUFEBH,GJW/9Z2$!\#?K0PN,69A$HNQKP$XZG, MZ"8( @F%#PP"MRO<@Y2!"&6\3IQT3AF R_,[^^=8.]9R$0[NC?S9EK[)Z(&2 M$BK12_]LAD>8ZME3,A7_!:X@,3PHP1R%D2ZNI.B=-VIB02E*O(U[J^,^C#?[ MPP1;!_ )P&? (>9A8Z*H_$%XD:?6#,2.O>]$>.+MD6-OBN",K8AW*-ZA]YIO MDUW*KH%HBCF-,7P9,T&PO=V]R:W-H965T-\=&'-% UJX*]-!BS>5L5IX-&W-7&=!E!&D M%>.;S3730K8T3Z/O9//4]%[)%DZ6N%YK85^/H,R0T2U]!V@3M0*A"AC-\3)YU3!N#R_,;^-=:.M9R%@SNC?LG2-QG=4U)")7KE MG\SP#:9Z/E$R%?\ %U 8'I1@CL(H%U=2],X;/;&@%"U>QEVV<1_&&_YY@JT# M^ 3@,V ?\[ Q453^17B1I]8,Q(Z][T1XXNV!8V^*X(RMB':K!UG"9'"M.W<9(7WGE@;WE\D[_AX[0_"EO+UI&S\?BRL?^5,1Y0 MRN8*1ZC!#S8;"BH?CC=XMN.8C88WW?2#V/R-\S]02P,$% @ H%6P2N1: M(G;2 0 G 0 !D !X;"]W;W)K&UL=53;;MP@ M$/T5Q <$+[XT7=F6LJFJ5FJE5:JFSZP]OBA@7,#K].\+V'&M+7DQS'#FG!D\ M0SY+]:([ (->!1]T@3MCQB,ANNI ,'TG1QCL22.58,::JB5Z5,!J'R0XH5&4 M$<'Z 9>Y]YU5FFX5'R7WUMN@+?8U1#PR9NGN3\ M!=9Z4HS6XK_!%;B%NTRL1B6Y]E]43=I(L;+85 1[7=9^\.N\G&1T#0L'T#6 M;@'W7H((UN2@QA MWBDR#8JD 0)Z(Q+"Q&&1+"B2!0B2&Y$0)KT1(;ON$*!:/Q<:57(:_$SNO-OH M/?AV)/_@R]Q^9ZKM!XTNTM@>]9W42&G IA+=V8([^U1L!H?&N.T'NU?+P"R& MD>/Z%I#M02K_ E!+ P04 " "@5;!*[Y:= ;,! #2 P &0 'AL+W=O M0&*?TC6]!%Z;JG8AP+*D%16\@?O9'HWWV*12- JT;5 3 V5*'];[PS;@ M(^!7 [V=V21T4U) *3KI7K'_!F,_.TK&YG_ &:2'ATI\CAREC5^2 M=]:A&E5\*4I\#&>CX]F/^A?:,H&/!'Y%8$.B6/F3<")+#/;$#+-O1;CB]9[[ MV>0A&$<1__GBK8^>L_7N-F'G(#1B#@.&SS$3@GGU*05?2G'@_]'Y,GVS6.$F MTC?S[)O=LL!V46 ;!;;_M'AWU>(2YOXJ"9O-5(&IXC99DF.GXR;/HM/"/O!X M)W_AP[:_"%,UVI(3.G^S&UL;5/;;IPP$/T5RQ\0L^PF35> E$U5M5(CK5(U>?;" M %9\H;99DK_OV+ $;7G!,\,Y9RX>9X.Q;ZX%\.1=2>URVGK?[1ES90N*NQO3 M@<8_M;&*>W1MPUQG@5>1I"1+D^2.*2XT+;(8.]HB,[V70L/1$MW' :09 M-QAD>0,@AA&7\G33JG#,2E?5'_'GO'7D[< MP:.1KZ+R;4[O*:F@YKWTSV;X 5,_MY1,S?^",TB$ATHP1VFDBU]2]LX;-:E@ M*8J_CZ?0\1PF_0MMG9!.A/2*P,9$L?)OW/,BLV8@=IQ]Q\,5;_8ISJ8,P3B* M^ ^+=Q@]%YO;KQD[!Z$)&UL;5/;3MPP$/T5RQ^ =[V!1:LD$DN%J-1**U#;9V\RN0A?@NUL MZ-\S=D)(:5YLS_B<,Q>/T\'8%]< >/*FI'89;;SO#HRYH@$EW)7I0.--9:P2 M'DU;,]=9$&4D* MVKKQP<'RM!,U/(/_U9TL6FQ6*5L%VK5&$PM51N^VAV,2\!'PNX7!+JXIF8K_ 1>0" ^98(S"2!=74O3.&S6I8"I*O(U[ MJ^,^C#?)?J*M$_A$X#/A-L9A8Z"8^3?A19Y:,Q []KX3X8FW!XZ]*8(SMB+> M8?(.O9=\>\-3=@E"$^8X8O@2,R,8JL\A^%J((_^/SM?IN]4,=Y&^6T9/]NL" MR:I $@62?TKHP0\V&Q(J'XY[/-MQS$;#FV[Z06S^QOD[4$L# M!!0 ( *!5L$I5D\.50 ( +P' 9 >&PO=V]R:W-H965T\T9M_%+K=HV0.I2LINI)M*PQ)RNI2UU3^W3(NNHV/ M_8^-E^I<:KN!BKRE9_:3Z5_M3IH5&EF.5Q9\-_549<;/_.](SO1"]F(T#H(K]_4. M%Z5%/; 85VKZWH]5X\:N/XFRP0PV" >#<#0(^UAZ(>?Y9ZIID4O1>;)/?DOM M/\;KT.3F8#==*MR9<5Z9W6N!$Y*CJR4:,-L>$]YADA&##/\H$H(BH2.([@A2 MF" ""2)'$-\19!,O>TSJ,$V/B8(@@&5B4"8&9%8P 0$)R..!)B!!,O<@#2:! M]AAR&RC!,:R2@BHIH((G*NE,)5X16"0#13) )(0)5B#!ZO%DX@"^W,$#Z1Q MMY$2LG!M\$(1X0<2.H#N,KHD Y<1#@&9:($"+B0<_4=2X2+!0)6D\338>!XL M62TT#0P7$R: T*PWD9E0%N"%BXKAHL-0U253H63>7V(\_8'HIN_:=^T'E>>J M4=Y>:-/"7:,]":&980R>C-.E>4K'!6IFD76K3#6XG&![OX!U!+ M P04 " "@5;!*ZE0['LH# #Y$@ &0 'AL+W=O7G)Y9W5N!SBE&5%S#,C9\>Y^4RF M.T<%*,6OF-V+UK513N6-\_?RYNMA;MIE1BQA>U%:1/+KQE8L24HGF<>?VM1L MQBP#V]>?[ELU>3F9MZA@*Y[\C@_B/#=#TSBP8W1-Q"N_?V'UA#S3J&?_C=U8 M(N5E)G*,/4\*]6GLKX7@:>TB4TFCC^H[SM3WO>KQ@CH,#Z!U &T"0GLPP*D# MG"; '=2[M=YM]&0XP*L#O)$#^+7>'SM 4 <$W0&LJK1JK=:1B!:SG-^-O'K< M+E'Y5)-I()^&?=FH%E_UR>4J9.MM08)@9MU*HUJSK#2TI:%=Q1I1>%W)%DJ\ M22.Q9(Y-HA1-E*IXIY-HB!LXJ(&C#-R6@1-J$ZTD@9)D2A)HDC64A#:>A8MF MX8(L2-!3!P\U\& =^C+P40,?UH%H=:@D7FN2CJ\M^0K:3%RM5M#&:\U5:3;0 MAH1:.EL?U)S81,MG-VS4J4N UB5 #+1!ME#C]M0^1,<(QS_$$]1@ A=/J^@2 M2EHY5FL')?K:;0==.HD2&P>+_?A]0S0@5T1#0D?GSZ!1-]T>#A)D&+THB*AW M&)QBA"+#>#T6.,>(,YX !(<0@10"#$ T<&V@!D!@A,\&T4 *C##:/3#JU@;G M*_%&<* 6M=$V"7LP3G ,$W\\"PA.+ )Q!&A0:]J9$C_4UQ$: 2 @1GT3QME' MPA% ",$@^B_P"O%!@ "->M\1G+0$$A !P@16U\6'H3@F*88WO\<"1QS97$$L "(@& '1 "",\-D@&@B$$4:[!T;=VN"\I7#C"(& B/I^&2C.9.J. MYP'%T44AN@ /$ U<1:@!.!CVZ6:+ Y B&U&=!X@&9HOM_'0>#!MUT\5A2['] M(:C*^ TBU2G9[<6A1!_OW):(AH0!GH2#0\G!H*3S !7U_2/#R>5@FRY''P<3 MZ3\]5NO_;LKRDSK;*(P]OV:BW/"W6JOSDR69KM1IA]:^)M,-UKXETQW6_DS# MZ4ZN)>R1"R%[)EB/8T]WCHWV-,%\<:%X*GZSW[D7#!9 M(_M)OHUG%AV:FX0=17D9R.N\.HRI;@2_U =-5G/:M?@'4$L#!!0 ( *!5 ML$IT]Y1[!P( '\% 9 >&PO=V]R:W-H965T(5G6P(A\X!VT>N?"!2-*+T6%9"> G"V) M411N-@EBI&G]/+6QH\A3?E6T:>$H/'EEC(B_!5#>9W[@OP>>FZI6)H#RM",5 M_ 3UTAV%7J$IR[EAT,J&MYZ 2^8_!?M#8O 6\*N!7L[FGG%RXOS5++Z=,W]C M! &%4ID,1 \W. "E)I&6\6?,Z4\E#7$^?\_^Q7K77DY$PH'3W\U9U9G_Z'MG MN) K5<^\_PJCG]CW1O/?X094PXT27:/D5-JO5UZEXFS,HJ4P\C:,36O'?MA) MXI'F)H0C(9P(P?\)>"3@#X(]330HLU8_$T7R5/#>$\-E=<3\$\$>Z\,L3="> MG=W3;J6.WO)@MTG1S20:,<6 ">>8>\1AC8@?)PC2 B85H4M%$:[XX:*" Q&[ M*V"G3VSY^,YGX$X0.1-$-D%TEV ALA@P6XMI+>;3#B^,K#%AY-81.W7$#AV+ M&L6 B6;5K3+S=+82@V?_,0%3V MZ4NOY-?6MIU9=.HN3Z%]#Q_PH37](*)J6NF=N-*ORO[[%\X5:"F;!WT>M>Z& MTX+"19GI5L_%T!.&A>+=V.[0U'/S?U!+ P04 " "@5;!*V(\DC1D" J M!@ &0 'AL+W=OK4[=F!FX!J8VH[H?OWLPTA!+RN+_$'YQR?>\ W2/Y1?W)U*YJV6,!&2._JT*6:_?>=0HXX!.1SZS]"GT] MH>OTQ7^',Q %UT[4&3DCPOPZ^4E(1GL5987B]VZL:C.VO?Z%9B=X/<$;".KL MCPA^3_"OA.!#0M 3@BLA,FEUI9ALMECB-.&L=7CW=ANL/Z+E*E#IYWK3A&V> MJ7B$VCVGRX6605B#Z?5FP5B#^15OS_M.:0>5H6S"PM-+HQ%/C1="/A MY.Q42_U5C7:'AO?HZ1LWV=\L5UG7MZXR71?]@?FQJH6S9U+=9W/K#HQ)4!87 M=^J%E*IQ#PL"!ZFGL9KSKGUU"\F:OC.CX>\A_0M02P,$% @ H%6P2M.X MKP>P P BA$ !D !X;"]W;W)K&ULE5AM;]HP M$/XK4;ZOB<]Y(0B0"K3=I$VJ.FW[G(*!J$G,$@/=OY^=I"&Q+Q2^D-@\=_>< M[7L<>W+BQ5NY8TQ8[UF:EU-[)\1^[#CE:L>RN+SC>Y;+?S:\R&(AF\76*?<% MB]>5498ZX+J!D\5);L\F5=]S,9OP@TB3G#T75GG(LKCX-V&X5;#.U[\GXB?K*H$+\3MBI[+Q; M*I57SM]4X]MZ:KN*$4O92B@7L7P?QMG-IM3&78??_P_E@E+Y-Y MC4NVX.F?9"UV4WMD6VNVB0^I>.&GKZQ)R+>M)OOO[,A2"5=,9(P53\OJUUH= M2L&SQHNDDL7O]3/)J^>I\?]AAAM 8P"M 807#6AC0*\U\!H#[VQ +AKXC8%_ M;0Y!8Q"<(]"+!F%C$)X-O&H"Z]&MIFL9BW@V*?C)*NH5MX_5PB;C4"Z(E>JL MYK_Z3\Y8*7N/,Q)%$^>H'#68>8V!+J:/># 1_JB%.)) RP(P%G,P[&4Q]6,L M,(S&8XEA0..*86@?\XAAO#[F"-(4'7I:.: ]!P'NP$,=>)4#K^<@U+*M M,6&%R2M,Y.(Q?#2&C\08:>O#-V*$&N2AAO@=R&B 1H#2"! :^C(-C!A4@RP# M@^D77UMG#Z:;+T!QKB'*-32Y$BW(/#2GQ=?&;&GZ\72N%R$]JB.4Z@BA2G ' M$>H@NGX-$Q<7(!?A +H"N<:D@.\:$O$IK$]H0!$)0D@3B*<&I *VHJLBGX8 M7+D((EU$ET=B"A.XE\87ER=RC3X14WU@:.1P92&8M.A2BX*B@3BX+!!$%V!H M1'!A(#T7?KQ6>H/AV\K "I M&!A:0WC%P.B&0<$K!J)K!B4RTP5S4#Y!]3].\>JC6/4-9$3QPJ+D^D&A>&%1 M9)/4J^*Q 74U@ QI !WX%L>J+QQP@9<6]6[(%B\MBFQ99K;FY[:>J],Y_66L MV%:'_=):\4,NU)&ET]M>*-R#.CUJ_7,R7M;7 FY8O&X;*=L(]1K*]Z*^':@;@N^;FP^GO7Z9_0=02P,$% M @ H%6P2O[!1[LV! X!4 !D !X;"]W;W)K&ULE5CM)Y9A:0#X@\=[;GP#9 ML>09"O^)@?1,:Z3IEF"V4_7O9B-EZ_TIBZJ9^YNVW5X&0?.VD6767*BMK/1_ MUJHNLU;?UN]!LZUEMNJ#RB*@8U29/KG4U[+HN@RZ7'\ M:Y+Z!\XN\/AZG_VV+UX7\YHU\EH5O_)5NYG[B>^MY#K[*-H?:G%-%T__UWCZ:5I4FBQY*F?T9?O.J_]V9_/LP.(": #HU@)D M=@B@9#0@,@'1(8"-!\0F()[*P$T GQH@3("86G1B I(OAO& U 2D4X=$POW* MA5,'10Z+32:S[)>;3%YOLE]PPB:'[)>=02,VNFL&P@3P2PQS!(#&9R^NXF! MN1FIA\-,'&!RNO<*P@B81< L LC@>@B$26&6!&9)3C/$3A?<01BD;U.8)04R M.'U[EYZN#>,CB],A0>\- 3+FF@L$0OJ-8"9/@!RQZ^ 0B"-$B&\0"N00+A$] MT:I>26SN$'\A@,'$)X8*@9"N(X@E$$#OKOL\@B"D\0CB"@2P!4Y=HOC4Y]"I M0TR! (KGS"7B !'"@]@" 33/(Y=G ,4G/H>1(>Y .ESI\6?0!#6XHA!$, A M..*7%!$^#:?OKQ31- 7DRAT!/!F0;55CTTNQ P$@;(XHB2*2I>R,JA$U4DAH M)U5'9QHT121) 4D*+ >B-LK/J!I1$H5V3\<:'@S(JIHDR5C9B)8H(!.!#1F1 M"4W/.$(B,F' UB>!'/)R(E;D3$N1$T,4)-PWTX,""@, M8\..XL N*&*7#0(AUL@0<3) G,+9_1\-*#FJ*KP(0^<]\-G "+5P*6*T#!$P M@X[:[E8'@B)W/.,@>S2(%3!@XQ4)D@.Q B;.T!6B;P9M@XZ)+@W(;C].\9,: M0YR 1NF:UY+!IRI1]_?$,N((,MPWJ&7!F3U%M7-Y2Y%*^J;579?S59*]5*G3.\T/VQD=GJ<%/(==M="GU=#]\>&"C%_.\."!M+ M?^U? Z_MN9$Z@*JBQV?X"?)7O^=JA6:78TNA$RWK/ ZGTG]:;W>YUAO![Q9& M<3/W="4'QM[TXMNQ] .=$!"HI7; :KC ,Q"BC50:[Y.G/R/UQMOYU?W%U*YJ M.6 !SXS\:8^R*?W,]XYPP@.1KVS\"E,]L>]-Q7^'"Q EUYDH1LV(,+]>/0C) MZ.2B4J'XPXYM9\9Q\K]N\TZUF#E/\,"5V07>@P"-T&D3/+ MR!A$=P:1VV#C--@8@\V=P691IM6D1M-931"X(;$3$CL@\0)B-?$])/B,DS@Y MB8.3+#C)(R?^G),Z.:F#DRXX5I/?<*)5[(9D3DCF@&0+B$N3NR&Y$Y(_&N3+ M?WG^9;_Y;;A_<#\W';".S"I M'K=Y@B?&)*A4@I6ZMT;UV'E!X"3U-%5S;CN-74C63TT4S9V\^@=02P,$% M @ H%6P2M3.='Q0 @ ^P< !D !X;"]W;W)K&ULE57;CILP%/P5Q'L7#)A+1)":;*I6:J5H5VV?G<0): VFMA.V?U_;>"D! M9YN^X-O,G#.'(SOO*'OA)<;">:U)PY=N*42[\#R^+W&-^ -M<2-/CI352,@E M.WF\91@=-*DF7N#[L5>CJG&+7.]M69'3LR!5@[?,X>>Z1NSW"A/:+5W@OFT\ M5:=2J VOR%MTPL]8?&^W3*Z\0>50U;CA%6T4 ME1VE+VKQY;!T?941)G@OE 22PP6O,2%*2>;QRXBZ0TQ%',_?U#]I\]+,#G&\ MIN1G=1#ETDU=YX"/Z$S$$^T^8V,(NHYQ_Q5?,)%PE8F,L:>$ZZ^S/W-!:Z,B M4ZG1:S]6C1Z[_@2&AF8G!(80# 00O4L(#2&\EQ 90G0O 1H"G!"\WKLNYB,2 MJ,@9[1S6]T.+5-N!!92_:Z\V]=_19[*>7.Y>BB #N7=10@:SZC'!&'.-6%L0 M\!KR.(? [!JRL:AD?R-YTL=@)K":";1 >"40V@5"JT"H!:(K@6A2C1Z3:$S3 M8Z)T4K*U!02@;T\ELJ8265*9U'358^ H"HA!/$G% H*SOQ/-\OT 8#BQOK&@ M@AC%_%#BV9A);"AS;!1*K0')_MZ56@?2.;DMG MQ0@S_X;/S!HELT1))E&R690TAO8@P+??(_X=_6I 5V[\\%:@&Q<6^'<'&4SR M?M6\T1VIGL5OB)VJACL[*N1UJR_%(Z4"2T7_0>9.^+/U!+ P04 " "@5;!*'F3L4+H" #F"@ &0 'AL+W=O M=Z MO8TBM=[SFJD;T?+&?-D*63-MAG(7J59RMK%!=161.,ZBFI5-N)S;N4>YG(N# MKLJ&/\I '>J:R3\K7HG3(H3P;>*IW.UU-Q$MYRW;\>]<_V@?I1E%YRR;LN:- M*D432+Y=A!_A]H'8 (OX6?*3&KP'G91G(5ZZP9?-(HR[%?&*KW67@IG'D=_Q MJNHRF77\=DG#,V<7.'Q_R_[)BC=BGIGB=Z+Z56[T?A'F8;#A6W:H]),X?>9. M$ T#I_XK/_+*P+N5&(ZUJ)3]#=8'I47MLIBEU.RU?Y:-?9[Z+QFX,#R N !R M#H#TOP&)"TBN#4A=0'IM '4!=!00]=IM,>^99LNY%*= ]OW0LJ[MX)::[5IW MDW9W[#=33V5FCTM2Y//HV"5RF%6/(4/,)>(.0=!+R+T/H<4EY ')4OQCBHR. MLQB"BB$V07*1H, 3)&B"Q"9(!PF2.!Y5H\?,+*:Q&$AA@B5%65*$!48L/89> MQ4)1%NJQD&*T*2OJLV20C3:7^H*IM[T^Z /0)!WM,((B&22XK R5E7FR()NH MRPQ-,+N^27(T0>ZO8#9NDMPO+(449RE0E@)A&3=)X;&D@RV^(($8MW^,T$QX M#B9.$+B^H(#[%L@5)76@H5I*XPD>W-[@^]LOJ@-=5'6*!O MA38W"_O_OQ5"MNE='Y:KO\"U!+ M P04 " "@5;!*&UL[7UI<]O8E>CG^%>@^CG/TBN(%BG)MMQ)5RFRW5'&V[3DI'I2[P-(@B3: M(,!@D:RN^?'OK'"?U?)IO:G29%ZOTK19YT\GQ\?/GJZ3K/@F M:HOL;VUZ6;9%\_MO3HXGWWSWNSK[[G?-=Z_*6;M.BR9*BGGTNFBRYCZZ*GC. MK"RBHZA>)55:_^YI\]WOGN(W_-U)]*XLFE4-W\S3>??7=TDUBD[&<30Y'C_O M_W@?C9^%?]NUG;]>3.NF2F;-_^U^*8-_2)<9CH IWB?KM+?V?72=_9S&,.EL M-##%):Q?)3D,F:=?HG]+[[OC;JIDGA7+Z/I^/2WSWA(_7O]']V\7<*8YG>M- MGBR[ORZ2O.[M]+*M*OH@JV>PF1_3I$)81Z^2IC?VZ&@\.3H9#P+SYG[3^V9\ M?/3O@Q]\3*NLG ^NI]?[Z#>_V7J)[M[?P!][6-0=*>L&Q_Y[[WQR7V^R/*VB M2]CGLJQZEW6]3G+\_8=T4U8-7MMEN=XD16^@WGZY7@.B73?E[',<71/R1Q_: MIFX )>'SWCV5@"9%G<[ARZ(N\VP.&YE'?TCRI)BE, '08@UD].GZ573P^#!Z M'&5%=+,JVQKFZP,DG1G">3:$$A=U#7.^[/V#A?H$479P 7.9(L) M;;$[YJJXA4GHP@$(ZZ3ZG#:X@:A.X<.LR?JK?JR S55P+[A%/-,&/X^C(FW" M.RC*PFXB#6R"AX4WJ!#.LV2:Y<$-(?>2:YQXWWZ'PV0Q9;#_W^"O#[%CC9 M;;IMB;\D%3*P.FK*:--6LQ4<))HQ7M:(EYT/4#Z\K#?)+/W]-W"+=5K=IM]\ M%VV_H2WK7WYX]^[JYMWK]S?7T<7[5]'EA_+K)<"=T%*",2^=D4;D "CD>'1^/ 895!!C< MIC#FHFU6906<>_XR.CN.CX_I_T0V?1M=U74+>(DX4EI2?1F-G\?/CL_BD[-S M^@W^>2K_A,\VZ0QO(N]Q@HOY/$-I WM$BC@"7)WQGGLC;Y,L)PP&$1750&Z1 MP#^ &>VZS8DWE$1_<*%P62N@-4*'LN[=@_O-G Z@/-UX ["(YU;)XCL\^5^ M'.[@8X)XM4J;##CY(=S9X^CI@/)PW< ,Q ;@NM]D! NHL+? &$_V5L1Z\N0#<-:$ M1.(6G@^R>\9B99X"L93$?P/+ "N'F>+H^[1(47O"+Y+Y.BM('4-""V-DN7,3 M=ILA(K'H/1F6Y2VB\-X?\/QW<)@5?I?< GR7:52T MZZE^LI6$=,&A&8" ?@DZ)%7/L,+7?4$6'7PJDA9$0SH_W)L^Z3:V,9&'"@K! M6H;^MH]?A25&&*V UP):]6^.67S21*YB>C8PSG+:'>-#*!JB;=(MCJ8)7AN. MAJ&,_E7*9P0%J=P0K49+5)GX3T#,=9LW24#U)8(L]]0]C1X&JG(."F.VR'@! MT7(2."G*>U@+D3!!(R]%!3JM9AFH;!M0EU,#Z"W W0EWB_# O[A[_ZJ/X@%Q/H F^YQDZ_@?T$+9H(@$ULF:M4/L*&#>IW= $&I4 M]#;VUW%/@7CPG&H#[GE]/6-XQ_7UQH.=BBHDN4 I6B#8**!,;""/SP>][P6 MEK-= 0%4V7JKIH&FX9N\O-M?PZ!/%O0)B4HKL)%IW!+E] 0?BMGMG&K^4RL0 M1@0#"@.[#0QYE-G^E_@S_I&LVA;/B22\SR9>(2A!-0BQMHLU>@-^9G8"@+EC M6H\5[QU*0*2PAEO_OE #Y7D^?KJ)/FQ"R[FCLH=;P<0(HSXC#+@/JA2MQ0, M(?T7"OT'F_I7A4XS3YUI4A"W\SD9(T/0&/BRV68TFV_P7DGB)3O,Z/?[H,,N M/.9KV(%"']7\!A39!%T1._<66F?7WA:LU.[86W)/2(2Z9$*X.C@"YURV"8G( MH(]EEJ9S61MM:5R9^56LE,&8TZ..P>,#M&XS1);I?? X/?<;*+0SXL7I%P!Y M ?H=7"F(3_IOXM>S?1UFQ'2^MOERZE%DZ&US(LZ,V$=+W$4I#*@N)33+F!/P];Z6%_ MU/L2;G,<_>__]6(R'G]K[<11)$YY\LE'!P@,'#0Y_E8\M?2O\;>':H&B"2 1 MC6@-E]M6[$QHTMFJ*/-R>2^L$G7L90>H4<.-+U46#C"_%49 M7371CV5;U6F^ .OAZL?#J(;?F\VJ+.!%9'W!*,-;+YHCH!94]S!/<4J0^L<;I(D""J_23XC"X 0#^5J-7>AU#]A M40)4@PQ<,&W=EYB/(5E&;L3-CC"L'2V95E>T2 MEF^+>95D-<**-K$A<94**RXK..@%J4/OR+FAJIA_U!2U*6+A %6<,M(YDV65 MNK!LV G7KLE[^2(&BP=-45(KZ'YP6OWY-#X[?T:P>#R.3\?' /A:!#3+"\.E M@II!['DN&43!@804:A!DZ(2JO^=T4AFSX" N#. MQJ<,P]/S,]R+$6Z BL!G1%BMTMGG(,3,<)IOF@*YN?(*&&A;+%%GF3O;SPK@ M(TW;$&I>M],:."RQG3*(1WKA9V?'LM5C/9A=WFX6_\X;]O8+&[Q->8> C(AV M!DE&$=CR+#O::E.RDF)%K4,CGN#5JP/HPV6F?!-M ^S!AS0PN8SE+FVMS/-T MIMIR^B5CE8:0%7$K$UW>4:V S@02Z.B"KP;PU*4LZWE'B@,Z_6-YATR0)@($ M!/98 (\#%01(OL%-+I.*F&((&]G7?<\^ =J_[!4QF!:(HW**4W57)M$.V)GF M.!T0<>H!.D#$T^!%\X!B1#EE<=T M.)NR-)QI/(G6[.I=P&'*.STUR!' 7=BX2SL6;6MC +" .G!19/?A,]-$W2@ MCG2+'\"?4&9.03[PABO4*?!SY\@(VQ:O(W?V/>H%GZZS99$M0,IB_)+5>]S_ M1[!39R _OP+1$"4C,F8-WNF@(4#^//0[U6C.B9:SR'H/B2;AQ-% ( SME^ MS3PH1_,660QB-ER%I72RSRKF12ZL,_995'/BL:3!$)]LU; #1VU:8O:. M-N_<.W!<$,<(RU%TR3P.)K'9+T)_A!>?1M>C:,E*=$[3@[Z&Y&I1'6 .Y]H@ M!7[1'T!24@!HL\ M,LL1N>>DA-\Z\I_G)5ZZ3NZ18:++@G(0"/( 5Q9=8C[AH707]YAU(AHSV(,I MQ0IT!X31]=?B=+TJVWR.V\%T*Y+'9?%36[!\-'39$T=VJ5U$(PH!JP#]K-1$0:WE[!U3])FS73 VIU$[>=9/0-;P"J66\'B,5^"$1#< MK&F3W.#,C&Z(PV01;JS*B$[4CJN=+8\BL#NO8$+V/Z R7C2(D9)58"F*HDN@ M.%(S8[2O;ND0B$SYV@;RI]-.P5%"JUDL2HH BP"I41S'/GDUAI_2VZ*RW=?0(^7[G#,!B4BGUO M% ()H0 *_YP.8)$"T3?1$5Y$(SDM*_A)IK LUBQS\4B,=PA;Y(177(GR*H MD>B$2D'I2#/RZ(OGAI0.U1M22=;9 MF7HRB2"K >A;DJX9;&O4=?PY_;)U\AM6 <44D)\A]!1R[=? M;CLR2MFV2(>H6-%I?!)W)=XE7 78[&_990F+!$6J^KH<@0>A $KG>7W%MP M69)#9I]5NMB:%-,N5Y_>"XJ1=V:]A@TA<%S1XRAMQ")PR^)E-8HORK\96'$1 MF.6$4AGF\J(+E%*DLD6*-P?WA> 8HJH0"0&R+3@->S_Z.>^)!4\&_,*KO6!\ MS(R:QJL*-A;IG57.!(6<2#*YC1H/AM/4J(6]D'H0-_8:M,LQ<1(=A3$/73.: M[NJI!(XB]!*N]!)TO&,C*^BC/]-'[UP7/X6L+;\661)3%FF!C-TN)H8SYZH0 M%[NSQHUXI0%,,\;1#]"(OL$7VW M9HO$I)JK#;=*G0Q$ ML-_[>ZC,?\K6^^!GY&@YH(KW:;R0BA@6"VRXSH3C9$IRM+ '$CD%VF0U*/4S M\D[/4PQT"2OUG#J? K#H;KI*%[F:FCT#W#%+DRF&:&3GYJ__!4=FH5\WGB?' M!D%$Q,^R:M:ND87-4M&1'4RRN)?D=6D-<*"?E,M6R YG3-L?T7;A&:%,"+4I M8I/@&3/6$M$:RS M!(WD%K5B"]1X@*#(370$@K1W2A7# &P,=!J2Z! =_LE2 M\#H%Y6^.450)UE_:TM43X0H^+H'HM.Q@L^:X:X MB4GN*M@-!;I!*D(0&W] _UP-%_MGRW$RC3'T!QJV>(G%!\9Z73,A'7O MGG',\=I;>QB-ZP<.Q+Z8BOU6Z'2S#CX2Y"Y6)IW#QPZLF3 IQ;&G)P$Y=YH,3>X1$-1;.!L3=4(KG MQB%Q1Z Q^1MEY;9$]ZLJVA106W$PEN A#*_N\#*+E9C_ &2$"+MCJHSB\'59 MP-Z[#EGK>&6':U.EA8:_9DE5D2].?7OH7AS*?8F[25XV.PV3),'8.T(I3GDL M<2\5C&M\@EEB+,._D/8L>K$#WSD;J'QFLPB,U7@(9H$BY_*(R\M P'B?J0[! MP#^;3_G]4<.Q8O7U'PV$UVT@W3>2#=T= >H>4;A4'$XV3KHMU$\1!"5I58(X ML(L $*%&<' 0U62*=(25@Q+*9;O:E@1MB\^\?^5+S ]'76__FY @TV^4#2B1 MO>F:37L4#48'_^C]8^B\;,7>/7!&C\80F.>XQ < M7DOT/WHVXM_,'TZ3#@2?_4,@B'L8Q\=CAN)'4(X^B%*D*5MN$/PH.G]QWH7V M5V\T"&U88AB<)A=UYB2_R7[A)D[IRTYLY!\&QK/GYP3$7VP'[LD' '(4O3@F MU,(-7#2]E)1EA:E6;6%\%IQ\%4>=/Q!I.WSSH*M*J(I,(N/0J@(.%.XP5>/Q MP?G)81P]/CF5_!<@4#\7)SJX:/HP@D\FIS$F^4Q.3OA+@*?_92^=G!.D_Y!P M@<]P@O30N%UV.^+3X+?(F&LG0UO2JBD)NURGARZ(MX6W*!\*- <1ZV)\DW64 MKC=Y>9]JMEU9'-F_9!20O"ML8H_)#D'T?/GHIA^/_3$<0GQ$+),P%?_GT4!= MWX57UQ>=G$<'9\?1870P.8D.'W7^F8P>@6EN5K&NNV"B7:+5.UZB'3OYS6^H M2?EYHOIGXUS06"EJ*6R6< ;W;48!80-FCG$6J1.Z7>NA(SIANJ2TNW4VJTK) MRX/_.L*"A1+^R,Y'(1O-QX(K*UT_J!SU26TGCZ-I6Z,SIHZM%DW*33_[Q\D@ M=7-5626P0!);+#'!\$4T?J'W3MFJG!E&&/5AUI1Z'^0\41..<5J/8@#EWAC' MM_#"J M3?J\5(.1H$ S!14N_!C,*X]%OT#/%MKS?O48S/K^ZAI^->65@1,8WQ;B>E.6 MGTE32>Z]>(_L;^":)47/Z'^US3TR,&@W1H/FW$;8V1E7XL.F'CC] FX+G5/ MJJ+SX]_ZOS[1TXM&2L W=0'R5R?=+>-$TKA[ WENP."<@T.R6D K)HQ\A&DF M\W0&1X@HRP]P[JX@J[Q*F46L4K(^-/&!; ;)H#?INZ76M8ZB#WK/$R\[5#)W M0+-F5B.)!%Q06.:M!SZ3X8=N;^U%@$[_ME!(8_33>&*D^%'X@W[,B<82X]*I M&=_]J]E!LQK-\4AB%+UB7PL?<5;6CK] MA#>B\$+P.OE,,FU/S):TZH[P$]UJWTY\DO4$2$K!.D6[<9EZ:;*RRNC<76P_E3ULEP\VD=DH==7VR'S6E MA=+$.*(V>C3=+;R7R1*]RR2@D7T!>RNHNG=?48TWRA%G3RSWQ#!#3D*6E+_! MWD5.TZ,(<8EU$APUD0QD.Y#3I8E<'15#5PRQCB%9H&!SS<%)IR=)#PF2AJ(. M) =\'E^C);TT@OGQR0A$%\S]^'P$TQF^SR%<1YH@"6LTS9M!$X6C QCQS"0- M^.W+!3FD"SA[C5%XK(>?:*?@G%RVR8,)A3?;!/#"*Q@\R MU[V&$GWS5NPIO=7+OI @+H'(NI-(C;>PJ-7V470;N,!=Z59#.-N\6Y4FTN"2;@S3 M+>#R<*,:02BK;C([GYHA (HGGC%=IH'(T6U6\E9)\P1)MV0:HOPNY-5PHE5F MO-"$]T0-AG)NTCRZN,UNQ5UA,OQG2%3D02:L09)W M=UJG*54DY5D*VUXF:&>QHF%A8^KNC+[A->N0(U:.9I)@\9%38D+@F,L6OG6O MP)L)#3N1LK1CELXX#SDFEF"+K;[E;),%4V\IW*8AZD-H8VI>;OE?XYUV1GG[ MFRH]:C Q!/^+4_)!W=IPE33UNG%0!IB*5DZ(=$MO.4*('R6 '//D-A/;'ME> MU6@9 ME8T[)9<;PY=4L!B&!22L/ZV%8H>QNKB;15\X29(MKT\\2Q95$788YI M:R,XTTA2OB@B5!9E1;+U3^T<<./@AV8^.HS^" 9P$GT/N-RD>8S(M4ZYKB'S MPO'2'_-5Q@T!>4,2GS!+ 9(N2Y*VA4UGAXMPA@#_KV4H]C2=M[G(*\KQ.G,R M]?L%5K$?LQ"(JFA7IM."C,DME5593=HX%TNX$@NQ<6)\]IB1>;:*;2P7Y3B5/*:1G]$& M>,SIS 8EA"+3,DA!AK T';HZPV.@5(]S46";I_97!_]J3O7(&:T&>*WQ&"A'!LZCTZ$PR1G?@-AW'+),T+L8 BN"E M3TY.29DXV.1MS1FJ:*.05OSQRFVR=X@:1=98E"!9905+E[<$.+84C;GUW&LR M""5UO&/W1^!?FDM10I26K-L$#C4]8._HOWRR047Z;;MWO_2/9[@A[ M8IB2N4<%11&9O>>YX&#]Q-!W/X?)D*07>XRU(8TA(A)2FJR=]9,9Y/RD]R64 MB:3!):5SM&M[2,NE9-I0B=1\;;/4(SF2BMV. Q>X+N)EDRS%1TU[L%:KIT(6 M7;JDC-A5DB^ZGD2=P &=]0,266$F&B5'517;8ZYC!*""6,6)MR$- \*BE5IS M!UP];0LLQ-%X)1Y 6\-\%78UT,1FY4$[UEA-Q#C$"C&34(Z7K>GPYR2HHZK' M53HI56IX+0>DSYO,/I;9_29!)JS'F>QBBT23,=(:2')Q9=N.(^H#E016^!HU M>K*:YAEHJ&EA(RQNW;0?6W)BL(G$%^V^W98&'!WJ DK=HB,I9/*FC#O[3'P= M1Z[?@:BDESF]'MW;H@"R.EV-%];3SO&^/ET'6DRCB(Z)J0JSL'Y7[-"0&R^/ M=U/'H_/G)O3%W>+(_R;*LS10I'UY&"_*ESF8( ?Q($JLQU OE?E:O'8]^QW\ M(O$EM19&BF'T]_BW1'NF^FW\8H>WAJ4X);>!G%_C-Y9/FIB10UJ45SU/UPDC MJ0;"O'UZ(!/2B1T+:. ZRR[3\*4TGT^.G5,W3I)F^ V62. W8NUW=C5/IXWI M:M.+G(B+7%V9K-; ,-K\V0M&Y@]2B(251J(#@CG; .8RP7M$XR4XJ I*TE+, M?L_EROO*A@+RJ)/G*OIF !'F)D5K8M\H56G;I,0])7F%]U-3FY60;>OZ=9Q> M$[1W %J9!U&*2PFZ<[L.&49?LS9X##-BCMP(5%6-O1/!Z#4 M?!Q_SKD$E![-4\.7BS2C#-32F]Y^-#[CKQB0JV2N(FF#_<4U5F4$/,CG+;Q8 M-FQJ8H@Z@TJ0VR&L<@W/(%ZX*@9518I\!9'K!F@TQQ2]C":-I4Q"^22Y#1/CWPXF%(U7"-;C(]$2.,V(SP:E.@"$+*EJK M4"&8$?UL/T;MJ%/T ++2( MWK8_DTL8+4-3+!.(.3@MO>082J<&EVU4R7B./5ROM>K3R"_COVDX0\%Z;B@? MPBH/=$>:90^@SOT6.]:NG6J;M(Y[F+U%0*NVGF9>:A.H>F*P5+5M):W7%+5>$L/4FSQKY@!;(."1" M"UBWR%0ZW+E&,^D([ A2VG.\TCTKW'=AN79GW$(5:RED(&)"G1J,N_G;H?X3]1$*(/224FA7<[#HCNK/$HS5P8\C\H93$PH M)7AY0"3G")I:&WTC@QPC&F]2?:"IRCPWS5LE M;1@6&WGPO*#U5'6?=GTE?8 M RBP@IEMW.'9YF3N&N(>>JNAN=H8=9_=<:M/##;@+Q$"!%43JVK38E[A6.=A78HRQ1]CX4GQ%LM&RZ2J9C:SQX6R;-STM4643OTB;!LKQ%]D53 M3])9Z_J>0ENY$^ R4F1^3ME8%P,@H[V+PM5MIW0B*BI(&FUJ:K(@_1UQ*AVR M?5^BCZ+4EYZ(5WWLZJ6BFV3LGF_*YE@[CEOB7E?OH^NKFT_1]>ABY+NG7+?@ M2]=9=:&3:]<7A(WN2EC1V/#R78S1ND;3V4O GX1103[6#':A; (U,@1M1@&S5@Q] M!8-F!R3(S#)"$G0>B&)(FO &=-7&BZKK1[QUL\F[=(HFG =5 N0C =9?>(!U M^O7"*A?6^:0[[.CUI'4^TKOG6MAHRMT.4.8O*_'%]^K+!YI1]W:K5_LQ3QKT MR;DM$9SKICF1:%H,;OQ,P9(&3+I[8/9KR8V]EV)(^:,X54@"IH6FSZF,U_74 MVA1HN8#/3,13,@[="U(VRIU@/'^S>Q3:=[K0AW,X1).;1);N"7$%:=C;PKIK MX#/R6X2,N%ZPJ/05#R?5'>5_)[.^'U*Q%H)8UCVN=>%[)0VLC.GORS3"#JI9 M[>4"*)*XK2QD:;T]&S 1&3*PBOA_CQ0R=IQ)C<0D=-0,U]T&("86 ]@+O+&1 MGI!4:A)Q,I![4,JD:G.?%- ,XMZT^8+*(YK:S?YS\S\-_' \N?387P06C]@A MZ(J"B:BTV"4C"^J__]K\#%XCSE-#['["X[-C^!<_?!*];JNRELX&GK;&^4.D MZ6=KJ?EKM!VQIJ?KPU-!!Q\[L[E+EB-41M'"4WG. S+)D$FO8D 32JD)Q#(Q MP2P00:('NPTJR(H\( 6[C ONN$^]^UG^Q&[UT2)K MU""OR=^%BWLD13XN9]$M15.!LB !6L=KBBLK.:6N'8GM=E!+>?';("X8#*(< MM1(W#^HY>PZ#30PL(>GMB1/"4V12?'> @^MFO!23>[%%^Q"@\[4SN1=&HA^N M^3Q6>]=J7=&FINW]T32QM1*ZRW:CR4(S>4>+W:(4'K =(K3@02L?7P*R'W(2 MH-<3C4)8F::9,7N"JYI[QS/Q!]M+%N9 "6AL!SV('1%H-8,UP^)VTDY3Q!"8 M=\ TS@*4!&80!ELII04[P;J\Z8YB>Q9Z1Q]!"MMW299\N,6BNA MHF(QVO1&@[$98]YY]R9\])9^) X7YR;L> &-6_;9]33A,6WHW?++Q.G=8N-N M;IOQI/ Z+R%"U759C:(E$;/:32&?HQI-"77GAIWV+*:N3+JJJR3-#6QS]''4 MC7FF UT#&5J;VHK\WY+F9Z,CL\9A_7Y&@^)>E+H#8J?"J;ILP),CW9NVBKLG M(-"HO3/D8/0Q2J]-.!<2^39V5:(XZ.QSPFDHHCJ0VW_%;T9I;K(F \"5@9[E M]J2:E1SAK*6!-1^4YG3$(/DY8$4M80Q#/U 6S+%ZJV?I24V3;=DT(H:9![[S MDI61=8EPX*&"MIR707=.#9R0%4DIZ_B4\%[BIT#4IW&@IBPIBK*EGJ/ZU(+K M.;"ZM2ESJVJ2[<"V )"'YBO;C$N5/G+@+C#"JT^QT=\5O\CD8/WC#&J5)Q^Y71&TZV MK $!9M)[V3V8;TC5(L\2M4CS_2W/=UTT1I;AOU>X!$Y_]0JA'UN_0X>&N>&J M -88CKAW$.BSS]+;"@"./7%"))HHC*1+D3Z;) ;NK"%RW= K)T"-([.KO#8% MB[4[!L\DT?R6&!"V(L.GIU@1YMA_0^W(\6$"OB9TL];;>"Y7A M?D?1RBFI#G*/07%$[9#%&/4/\/;Z1WX\LQ"E.J:WR&).!A*9I&D1 ) -"1C# M5OPG-HRS+,94 @0W<46R1H#1HF8/(J_]TH+!1U8*,@9*Y%]@+"BF"G* &"8X MYG#OB=0"KBA"3Z^-J,E-/C[R/ZA'Z<=V7M[6G_7)M"U95QVQJQ@%V-)"WR=Z?J9^=X*0F/A^=4<<)#.3DN=(ME/IIA]]5 C%? KJU/5>@+-O*HLEZUJ] MU"K=D],>#[*]N9$;,?)-PJN#S&>H&"\9:* M5;1)J[%4C()@T<]>L,$T'U"/,;I,WAM-C?8V-,)C/C[1(8WX-OR51M$)#)K( M()]E=4>>'M(#>UJ('OA"^1>U<"I!9)?2B-T[G$F0MQX,KN0V+,AYYT2+Q_GR M7*B&$L7NL0=XB-AJI[4I+=3+L/T*;YI&@"8$V]I-F(ULFY%Q\E"([A MFU*/($G2SX=L%7SZ+YGO%ROF@#!MG/;M7.8:-K)*L-A>]*-N[QM*\,&&[1F_ M[6!IY\;;U[P'0-Z?Y'QJAD3M>4XRUG;$BV22?N0PU&#.\%FV%$!@@018^^FF MU@WCK<]1*NFCI!V3LL8$)G&I(EV632:"R$G[48QQ'W;<.,]PB]E$42P\O'NJ MKJW!H'+A#^I6E9+1(:6PJ$Z9FV*RSM-$-5]CR_6,;$QMI?B%U"JDVA34(G?W M(;!1]),IA3E1''N+D17X+CK@;1Y&;YLYFAZ% >G,:8W@IK&2:R?9DAL2F]Q9 M:4?7[Q+@%W%'![;GY*N,7^RA;C 2;(JD*;237M1#63=?1)TJU.XV!SOW:<;2!M9=472J O'#R'W^3S ,LB<0,>)DW+NN#!X=^Y#=W)=N15 5#."!]EAT4>1D=9(>126<7/,:4*,HML8?6#,[:GEN% MC? !%&'RPW,EK[O.TV&:JZM1!4G1F]YSOB.9 CC;01;<%544H"IK"\0#6_$; MS?A;&MJ1W0@^H9(4I'S-T>FF:J)M7\W)Q-*)GTQGR5(;RD D+[5IIT)>7+V. M;I4L)0:^&+T(O\*-\C*]$S)R49>D%-7AT/EZ!?VV"M+-,G0J(G4%;19@\-Z\ M^LMW1D=BLU&[=@;2W"R1&/]A,\AU/!)4_<]K25([@!0O-[,T=/4;#.^5"DBM M :5KUIHSX#,W?,T8/0EY/UU$MP B:D/B2/>B>P11E]FGTG0X+N5=VA-I[(XW M9]0DCN_.1WAY]]@3$C[>L\5+];RH>AM!8X03UAAM>]_X-47UM'\B?O.#L2P^DO7X M]WV]JZO3L\YCR7O,F/0>U1/1U^_2Y.2I=+*\;6:*=,F0!]@I%&E:;7/HBHTH M6YH%5B$94Z:P"8=-MG?@ZX:;I9&RZ*&8CW*GKGTC4LG3K-"OV[,M'47_^U\ M>^>W\$, 1"P5MQP"5F:6]F25;1[H/,+0[RIG.HG>V']TVH.2-F)?V]&ZZD"[ M.]\X[W4B??;BH7WN>C1H93P3S,X!N^CP.=)A[Z./57E$IH?V&KQ V[^> 9PY M D'?CJ>Q:$:=YP]"D1'":'IM'@M"O4;;DN+%Y*;0>A$?C\\H:N05W.C/I_'9 M^3.ZB\?C^'1\K%?"%K^VQ&5>'NB9W^N64'NXWW"+(I+E[F'0_H+USL:GO/3I M^1FNM02&A-7$Z5P>3R8?P"J=?<96<9Y>UNV0[Y[I[$R:UI\>*S*8F9V)29C0 MY/XI8J]^:XZP-9"0QYU,DW;,WZ+[]5ZT]5_IS#IM&#J7[ _F@D;G=2%VW!CV M0;=T;ETO]O' T!'Y>#S:Q ]-"-_R9KG2S.AE'TZ3X;('3O7H)3ML&(0KB8"XIAG2I,5HXR],YE4TPH(U+ M02^@2\3X0J]OQ;CZ8X93B %LU3R&PN?ON:M].XD"?JG MOV(>?L+<>_C[Z]YNE_('3%G I'R'4-UT*)?3#/ALL:N.Z=-F&M?(+?LAX6O[ M- 8E&JO2TN8J-%C"Y*?I&%)&L?6+2=5F(.4HIO9?R M7K4;JW;[$W\:78\T$SN_MVVNG#?B >9PKDU.;I%:R^'TZMA(:B1[H(M76W$* M4 ,T0WT].=*7[E7C:?JO?'3$A!;M*B"SWB-?+ YX7GD"4A+"]/$OK:/F1\ T MN&436>_E81'<8;=3&OOCZJ_%:;>P,YE+AXR?L#PUY&RUN;%VJ5U$HVTJ2VDR M5Z5-V3M9.N^W@.MQV4\L!TR[RN[O4V"#G2',X9@)F4#;/OP,!R&V9IIU]_W% MQ4?[1F1;F[<*S%J1:>6FU@'Y^L3-9,P)5;RD&$5> +>)+UNAZ/%J BG&[QM^ MTYM1C#MK<9LUD^CLI/K6SI9[(+Y:ZTO J-M0AI.\ ^T0HWD36'42>6>A.]D, M>-??,]]+>IK:5BQ^]1OS8_>-^?&A>>@W]&;PT0=Y1O %-N&7XB?G!V-CP]? M@LEN7Y6F"GS_.6P[WX5]+-[^T5'1S$/TSK;TS7M]1C/1]%?.C[3LJUVDT8LJES=^&] \CUS3^C:Z5#OP M3<.K;AFY"Q]^2H87(F/&GI(JLQPP1)Y#/;&WX>B[(V_RH3>]N\W,:X9P]^%M M;5Y#%2[[O;W]O/?2]XZWXZE@G=O@BT E[TYM[7LG0]%_5]YY%YY,\(VVH!ED M.,3SBI):[TL*@[?9GJ_JJXESXA+GY%!;2#$QF"F#_-8.&U3X,;YR%^RFMHY26<<)T' ]'&SN]+J0NJ\ M5'.6>R)OJHEFM470CJ(W+?FF.SNSKFF,M92K;)JI $\?1,0["'53PBU/S6.R MG;E]\C4Z0<'/:N.&'$*G]NCFRVU'OI*^:P-4K.B$'0,Z$N^2,U[>ENSY+Z*@ M2-5L&T=@Y+:G**YWE]Q;<%F20V:?5;K8VN\U)/3H/=ONAK2MZ'$40I.DD_.6 MC0Z.\@_3$DP] '=.$A].GBVT, #!,415(1*B)]=JS,GV+!DP&_\&HO MY"$:HZ;QJH*-17IGE3-!(2SYE!0Z::_APG":&I6SIUL&<2,ZN*%$JO[CD]*\ MGD+;CJ8QP(;- [S6\=YT7.T5.@P(3O.+"6$PGS_"=9>[4T?.FO<.T M=[VA3]>OHH/'/8"9.6_2+^B$Z@VXWC8CD%6P]E?1C^8&*^1 HZF M_:DN4'=O,* I# MF#7MDLA#5+,34A8C0(X!SGX;/35OS104\@6B>1S^XT/%5YC;>".OWEY3V!AW MLL?X9P."$8FA>^ZZF';MUMUV0/4"7'* ?1ZNWKDE^>CKPZJ73)<75 M+@?IYO7@@ZJ#G[QYT*.EH3W**Z.# CO\N+IJQMVLQ/\< /5K/P'Q/WOHO.>Z M\JB[8+N9)DS%O!:_^EZ&GU7;P+8P+++L0?8M!YEA2 MZT@L#X#M'_KV\AY( J?5>M$AO.E=^##-#BR0?-FZP!ODJRCT$JX#99#='\=!OOQ#*GVV223A&T ] MD"9_EEBQ3Z'_]832]O7UZN"GHYE ]MZ_GDUX:>_VT;>C[Y![7R-.O\VL3S%V_B^>1_ M;OO.GLE$D.QSRG#GR"T\\F;U+]5PLK=]+G!R&S]]'+0^GX_.^DH.-M1!MJY- MH7;W@0*SJZ_E&0#C;G'.4$LB Y*>_O4OT9%HQZG[S80"Q_S_M9]0&#&M6J=H M9MHS!5HO!1#K1IL.]=H$!08;/\I =>N0"8ZY5)+\MZ2''JPZSL;$5BWKQF?0 MOSY7_NMSY?_4Y\IUNSV2W.4C^MC!^GG8.[S+733H:@K8->95[+?XP.[6@<[K MV8-BQ":R\T#5ZK>,7M9)B%EHM1[F2B MY,X#3C#R#TXF\:/?_ 8O8DM4"%T]IGF!$QX* #"0"?3@>*WK0^PY+OOL9DL@ M]B*8-^$F!#V1G)X><]3DI,%;:DPC)D-)+F3I%+C&*"W.(46?LNK[#$.$P"GC)+IDJ MP$*47(70;TW GK\0,0[AS='+KZ50YR^ '4>O1B/WYOB\;S^J'<<06(T/<0@] M_S5T_ESTQ'5W"QMG3WSZ2/&'M'O2_A[IG]]_[$A'Y_EM0D[W"M_M%+Y[2/C- MXXBWT]&'OI^0,R/O-!43!8G@7>%,H#7H^(AAL$0TA!>(DKDDYE2"&*$K:QX; MPT)0(8'2%:OY/&,I;JW;LRM3S(T.(US(.K:-8'_GS?:>8[TR@(32%G ,K2$* M"S3SV2K7A*E$*V\\A=V!>M!!YD+&6+9A/+@V10'%B<&1 M),W,J$3N&*=2@NE)3% J.*H9UB>:B99=8$JOS9O^)=G2KA)@]YA'XD)@*-93 M?>MFVCTUMT;>5+/:F[*3@W1!3I9"O2_U=7B]-K6#KR1.2%6OJZ0%T.HHS^GJ M'24I9]A>9F] [\" 48#6<4 F)+G5>J94%MJ )01++!59;%J^293/<*76Y50E MAS*/!\C\K_.<8HXEHIO0NO:?/3&DT_08&XW,5AO36L&\)%01WN!F)(ZQY3%]9 @_FS:6 M;C4373>CY16:ZZ^A+7U]-L8)*JFZ,E>LG2'LYA\-N.>WNV:M1 B[^2<:C+0*DK703TK2A4>W=)!>P<&QF&]K] M^]V$LID!5WMQ>8KC.,Z1[7N/X\&S=>NYM6OV4FGCA]DJA$T_SWVQ@DKZ]W8# M!I\LK*MDP%NWS/W&@2S]"B!4.A>M5B^OI#+9:'#H:^KRT: N_%#P[/_6U[=, M%D'MX$G.AUDKPW9YU+#I]'#=$_7=_S#9Q4(5,+;%M@(3]E .M S*&K]2&Y\Q M(RL89H8;+Q M"[988S[9!T:%/?F3'-VBDG0K>434$PJFGLW&)TA9J?#O$'+2)(E5$B_"QUU- MQL9;5Z_#L +V/<:D7,(3RV2VG7OXN84_E#$8Y0^>6"!D$/-.C$D9A"=6R-DP M9C>XR]+@W\64E$)X8H=?4(U(ZA,(6(,B7)!Z4:DULU%1/8$+R'&I'0C M&MWDA[.)$A;*0/D5/^&QOI"ZF#I67_:[J$ZW3FV+K=8/6/?-?+&R.4VH^S@< MA(Q^ U!+ P04 " "@5;!*1V40-E8! #3$ &@ 'AL+U]R96QS+W=O M3?W;4^P<5OPMB]3@(PT$H'K0. M!ZW%@S;AH(UXT#8:^! 1ODQ0:&;) W&QBT05YM8-@&>;>!@1ODY0:&;I"W&QB\05YO M9/1&>;V1T1O_X:S-';;E]49&;Y37&QF]45YO9/1&>;V1T1OE]<:9WJ[6EHIW M;YN^P$ + 1 3 6T-O;G1E;G1?5'EP97-=+GAM M;,V8W6["(!2 7Z7I[6(1MKF?J#?;;C>3[048G%HB?P%T^O:C59?,=(F+FIR; M4CAPS@.D;%+RCX1$T8#AL7(>;([4+AB>=BP>= MV' X(L+9!#8-4INCG(Z?H>9+G8JG[7B;>E)R[[42/"EGR)4GE,7+.F>)>6Q2YF@LR1$5#A>V_;SN;04A* G_0G-UK01()Y8F+ZFB M#\!E; "2T55L> #YGH*R\QWOC(?TRDU.3-::_)I078XC;33T W21=^ _P4BZYK13/Q\'0\)QC83C!@G'+1*.$1*..R0<]T@X'I!PT"$6$"Q& MI5B42K$XE6*1*L5B58I%JQ2+5RD6L5(L9F58S,JPF)5A,2O#8E:&Q:P,BUG9 M!&UL4$L! M A0#% @ H%6P2F>#=(YD @ %0@ !@ ( !^ @ 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ H%6P2C*A M%"-0 P I0T !@ ( !4A$ 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0#% @ H%6P2I]@R%"T 0 T@, !@ M ( !IQX 'AL+W=O&PO=V]R:W-H965T&UL4$L! M A0#% @ H%6P2E(SKE6U 0 T@, !D ( !9"0 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ H%6P M2EB)^D>T 0 T@, !D ( !)"H 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ H%6P2K<$A;*R 0 T@, M !D ( ! C 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ H%6P2NI4.Q[* P ^1( !D M ( !3S8 'AL+W=O4>P<" !_!0 &0 @ %0.@ >&PO=V]R:W-H965T M&UL4$L! A0# M% @ H%6P2M.XKP>P P BA$ !D ( !WCX 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ H%6P2M3. M='Q0 @ ^P< !D ( !&PO=V]R:W-H965TM. !X;"]S:&%R9613 M=')I;F=S+GAM;%!+ 0(4 Q0 ( *!5L$KJ8OE>= ( '\- - M " 52) !X;"]S='EL97,N>&UL4$L! A0#% @ H%6P2O^NVUQS M @ =Q$ \ ( !\XL 'AL+W=OP$ M + 1 3 " 2&0 !;0V]N=&5N=%]4>7!E&UL4$L% 3!@ C ", 9PD ,V1 $! end XML 39 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 40 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 89 147 1 true 22 0 false 7 false false R1.htm 001 - Document - Document and Entity Information Sheet http://mysizeid.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets Sheet http://mysizeid.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://mysizeid.com/role/CondensedConsolidatedBalanceSheetsparenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://mysizeid.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 005 - Statement - Condensed Consolidated Statements Shareholders' Equity (Deficiency) (Unaudited) Sheet http://mysizeid.com/role/CondensedConsolidatedStatementsShareholdersEquityDeficiencyUnaudited Condensed Consolidated Statements Shareholders' Equity (Deficiency) (Unaudited) Statements 5 false false R6.htm 006 - Statement - Condensed Interim Consolidated Statements of Cash Flows Sheet http://mysizeid.com/role/CondensedInterimConsolidatedStatementsOfCashFlows Condensed Interim Consolidated Statements of Cash Flows Statements 6 false false R7.htm 007 - Disclosure - General Sheet http://mysizeid.com/role/General General Notes 7 false false R8.htm 008 - Disclosure - Significant Accounting Policies Sheet http://mysizeid.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 009 - Disclosure - Financial Instruments Sheet http://mysizeid.com/role/FinancialInstruments Financial Instruments Notes 9 false false R10.htm 010 - Disclosure - Stock Based Compensation Sheet http://mysizeid.com/role/StockBasedCompensation Stock Based Compensation Notes 10 false false R11.htm 011 - Disclosure - Contingencies and Commitments Sheet http://mysizeid.com/role/ContingenciesAndCommitments Contingencies and Commitments Notes 11 false false R12.htm 012 - Disclosure - Significant Events During the Reporting Period Sheet http://mysizeid.com/role/SignificantEventsDuringReportingPeriod Significant Events During the Reporting Period Notes 12 false false R13.htm 013 - Disclosure - Subsequent Events Sheet http://mysizeid.com/role/SubsequentEvents Subsequent Events Notes 13 false false R14.htm 014 - Disclosure - Significant Accounting Policies (Policies) Sheet http://mysizeid.com/role/Significantaccountingpoliciespolicies Significant Accounting Policies (Policies) Policies http://mysizeid.com/role/SignificantAccountingPolicies 14 false false R15.htm 015 - Disclosure - Financial Instruments (Tables) Sheet http://mysizeid.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://mysizeid.com/role/FinancialInstruments 15 false false R16.htm 016 - Disclosure - Stock Based Compensation (Tables) Sheet http://mysizeid.com/role/StockBasedCompensationTables Stock Based Compensation (Tables) Tables http://mysizeid.com/role/StockBasedCompensation 16 false false R17.htm 017 - Disclosure - Subsequent Events (Tables) Sheet http://mysizeid.com/role/Subsequenteventstables Subsequent Events (Tables) Tables http://mysizeid.com/role/SubsequentEvents 17 false false R18.htm 018 - Disclosure - General (Details) Sheet http://mysizeid.com/role/GeneralDetails General (Details) Details http://mysizeid.com/role/General 18 false false R19.htm 019 - Disclosure - Financial Instruments (Details) Sheet http://mysizeid.com/role/FinancialInstrumentsDetails Financial Instruments (Details) Details http://mysizeid.com/role/FinancialInstrumentsTables 19 false false R20.htm 020 - Disclosure - Financial Instruments (Details Textual) Sheet http://mysizeid.com/role/FinancialInstrumentsDetailsTextual Financial Instruments (Details Textual) Details http://mysizeid.com/role/FinancialInstrumentsTables 20 false false R21.htm 021 - Disclosure - Stock Based Compensation (Details) Sheet http://mysizeid.com/role/StockBasedCompensationDetails Stock Based Compensation (Details) Details http://mysizeid.com/role/StockBasedCompensationTables 21 false false R22.htm 022 - Disclosure - Stock Based Compensation (Details Textual) Sheet http://mysizeid.com/role/StockBasedCompensationDetailsTextual Stock Based Compensation (Details Textual) Details http://mysizeid.com/role/StockBasedCompensationTables 22 false false R23.htm 023 - Disclosure - Contingencies and Commitments (Details) Sheet http://mysizeid.com/role/ContingenciesAndCommitmentsDetails Contingencies and Commitments (Details) Details http://mysizeid.com/role/ContingenciesAndCommitments 23 false false R24.htm 024 - Disclosure - Significant Events During the Reporting Period (Details) Sheet http://mysizeid.com/role/SignificantEventsDuringReportingPeriodDetails Significant Events During the Reporting Period (Details) Details http://mysizeid.com/role/SignificantEventsDuringReportingPeriod 24 false false R25.htm 025 - Disclosure - Subsequent Events (Details) Sheet http://mysizeid.com/role/Subsequenteventsdetails Subsequent Events (Details) Details http://mysizeid.com/role/Subsequenteventstables 25 false false R26.htm 026 - Disclosure - Subsequent Events (Details Textual) Sheet http://mysizeid.com/role/SubsequentEventsDetailsTextual Subsequent Events (Details Textual) Details http://mysizeid.com/role/Subsequenteventstables 26 false false All Reports Book All Reports mysz-20170331.xml mysz-20170331.xsd mysz-20170331_cal.xml mysz-20170331_def.xml mysz-20170331_lab.xml mysz-20170331_pre.xml true true ZIP 44 0001213900-17-005341-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-17-005341-xbrl.zip M4$L#!!0 ( *!5L$IBTR,#$W,#,S,2YX M;6SLO6F3VTB2*/B]S.H_X&DT4](821$\\E =SU)7=?;H>LI4]]3LKLE ($A& M"P18.#*3M6;[V]?=(P(7P1L$029LIKM3!!#A[N'AX7?\\K\?)K9VQSR?N\ZO M3_16^XG&'-.UN#/Z]MH_Y)QZZXSFA#]O M0^9;QJRA?3!FFG[6T!0 _?9+O0\ R#D>!I[-7^)_:X"\X[^O7E_?]_"45JN-X(WV]T7^'@ F*G7 M\:G%HP^2+Y^]$ ^C5^>&ON_2N_KEY>4+>AJ]ZO.\%V%0_<5_?WA_8X[9Q&AR MQP\,QTS!PI? GGV?^VZOHY\O^T*\H3YP7,<))_GO6X'W(IA-V0MXJ0EO,8^; MT7>K/TI_0(0+C)?9##T/ M=L&B[^33G \MQO._@0?X>B_].GLPQ_GOXY.<\;ESQ_P@_Q/Q##_JIC]R#&[Z M^=_0(_Q$3W_BRQX:]/4#(UE1!J/?C6DQ=* M@KYVG8 ]!-H-,P,4A"GA9LJ'W/KUB7SQVY7_[=/PFW[^#<3C-QBS<]MN?Q/_ M?_LI__>;L>L%M\R;O&&#X!:@O'K@_C<8\ XQ&=@,?__ )@,FR",F!['-@UG\ M;V[A+R#$/8U(EZ:4XI37U__UY+7N M)T9,/(_H:64_.$].J)[NQA]"%K0OO_W=<) ->BGVR/N]G"7?9A/1F=J^W-LF M:NM'2J4,]PDZZ>MSWQQAB^*^%835SQX#8?6SO1%6[W[[Z-[E$+8W_WNU"0MZ MH][=A+#X06]?\E*_^/:.#9!^_31=:^L4^E8[CI%*&^P2= M-CBMYPA;O+R4VS=#V/[\[]4FK+Z9O*0/DBM1,&$[_6]OF#E/V,YYWN\\L-FG MX;5C\3MNA89-:O(;-@2@8!?YQZ$AYV+QY#>T-U]F<2E!,X85[C0[&^TU_&!O MFG%7S^>(O-\KM=4RDAZ(U$ULM*(D_>9$^G83P.H@D[S],P0,7KN3J>O /WUI M94XFKG,3N.;WX]@_2]%)6IH9O/;N4CB>-;^R+(Z>*\/^;'#KVGEM3'E@V">U M_DMQK'DAXH4O+#"XPZRWAN=P9W0DA^B:3)"/7+WZL22X,[AM#&SVSO5N#)M] M83[S[MA), %I5$L1?%2,<.V8[H1%-'OOF@;*1V(#( [C(^>U#*_]#IOFO>L? MB2Q8@E@L"99B^*CX8(5 ,,UP$MJ8:O I&#,/'WMLC#2_8X+2Q\$5ZZH)Z^)[ MO#P2^S ^&!XRPUG:F=Z;_[U2AE7&8#UKMKL;^3#$!WMP378_O$UXTL^R6^_8 MJ+J99XBHFF370U&UMF]+\Q6=+)/4!G'-/%LS3VU!U^RRB:RI3>Z:O'/'WCY,@=KL ME*331A@_*L:*G)"Y_J7*>T)27K@Y(A7NJ5V;2+5CHR3/Z_&L>>VGJ'FA=CO4 MJU][$1X1(]1.@<,%[JO$![6-7QD;O[(\\L[@WC\,.V2O9M&??X,E,3QS/'O/ M[IC(F8^>73O3,/#I@7X<[+$>A@GYL1C5FC/6XXS.X^&,3LT9FW!&]_%P1O?8 M.2-1^AOF>(#U[OSOE7+3S;L_SS9U?YZE2EJ+R M%@]%U=I;6N7(PW$P2>U>K9EG:^:I_;$UN]0.W*-. ZL*Y]0>WR-+ SL&QJDS M=HXP8Z@6&\T,;O1/'P37+6J]D<:GY81D_?#&A2^0%VU"2<' <# M1&#'0B(%?[WH:RZZ\7#K9@_,C4E5];7WL4*YFL>RYK4S ML>:%VC=8KW[MZGM$C%![[@Z9JUD=/JCS\*J5AW<2G%'GX=6<4>?A/4+.6,_[ M?JQ.V8*\\FO/=P@G\ FQUC&Y?JO 6OMV-9?)6IWH(I'S]'4-.;]7UV]\CK>% M=/9W#4M;/U(J9:(61*=-HA9SA-U/ZY+SK%B3-0U'0]7-8D'GY32$64W5.LA1 M6L#P9)FDCHK4S+,U\]1AE)I=-I$U==REYIP%G%,':@Z98GVBC%.G6!\ZQ?J( M&:M.L:[Y834_O*/N-H"%;2-ECI\IRQR< M]AZ'JM1:UU[K>LUK)W2IJ?G'PPNU3_DQKW[M(GXTC%![? ^7FE\E/JA3\ZN4 MFG\BG%&GYM><4:?F/T+.J*,V)[V\OX>&!U,S]FE@\Q'I5?ZKV4'Q"JGD'E4 MJWLU\AA11IS@H6-],;C/G5'TH-HK+*S\)!(JL+H0E4>UOOF[]R8<^.S/$'Z^ M=3^@CG,[YEXP^^2PVWOW?YCGPE\WH-,XU5[\%=M;1%$W0_5XF2.NOKF:YG"' M?IGS>TR+I^!H)B MEL,B.;]7.I[>;^IG^Y*RFQ!ILWUTK(7*A>^OM6<^>,GR2?#:,54N5XO72JUA MWI'7_E>SJ7UU>*#=,!,-6TUK-M7O/_YP_?_I__>[?WS^&WM@;_IGYQ=_?&%_ M\M^NQ]_9W=OOW'NX__E7L]?KF?U^W[S]?\>__>WWWW__Y=W?_ZY?__W7<_VB M=WVMO_OU[%S_Y6^7Y[__>O:WR_[+GIQ 0!+BU,CA_MCP&!!1_CYAA@_6]6^2 M1/100:^>J7_C&#DC?KUY,S<<]]U>1S]_"<\V'^T;T/';#8(2C4L.(/9;XN6/ MX81Y1N!Z6TX]]SW^^(8Y[H0[><.N2Z#4$"_2T"_'_/K]33&8PT!'A_E"#EJ! M3,YHTS!!OC02^&C#T=Y^_;(0-GBV:C3*/F_\14Z=&5U->P>)8N$#O;&-4T)1# MP_:9F#,UO)I3!+R#=]PW#?L/9GAOA251T/1-T6]# +!H+@7+&]<,)_(P+VA^ MO=W\/V+RY.#9"3_3<5DLYK$EGYX_-5<6D)@T[^ 7OT!0TD!DYLD'0T!:)"#_ M1\\#(S%/6@J\XS;S7@.91JY7E RXF1@VC*I]85/7"V +:I@69#BSI$A(39R1 M3'':*!V/_J#=REHN023N$M2?T'WI'X> M)JB;)=!H=I_\=JE?@D3^Y<5&D!6,RMJWP"Y'I=?I'QR5]1O6+T6EVSLX)NO7 M!+\^R4I9$[[7U%"9K %8H'@4MB'Z6 MV?$;XO&%@;[(S8!9U=DN9YT41AN"N#?L"EJQL[.BL#O$KKD\3T&_D*_*WPF= M=J^W'FPP\'<68((R&&VAQP/._(^N8Y9(R/YY>M7P%,(V$5IF1<7!8!=)J&[^MDRB L"MC"! MI&\([!OF@8*([6[>_+BB!#JK",W3W,MNR6N95%:WD7)"U%J!=O2A:!PW#O7#1PW8$W]FU[ZTNQ[ MFV4Q[)SJ>J^U\;+4Z*;7^Y^&AU%,'VR;+WPT#M8,">QROBT1#-M#4YB7+\TI MRP!* GX@Y> LX[I?SLX'$K879YL B:$@'DR8(#K"!*1FC@EOE\^/6P.S->E6 M ".#9.6YB/6T!9^%87OXBMJPZ\.WH&E*XI-R*-KM]C)ND96 %8E&483OG6?= MP&NAL:QQ12GT;UX*K]DR0'8#=!^;'RS5&7T$L#OB=%X5?MEE/8J@W;(B9MB4MF7Z6 MV;:K(2L2C\*6IMON7NR !\FCL6M;S/-%AYU2TD::G3,][;2?!Z04,#=NG+?\ M,.@? 4[+&\,M]QM>](\!PP7MSI9SY#GY1"N/V_)F7LM1/+NL!(+;-ZE:=4SU M*H'?B@5K];"3"/2,X7A=,. M)G)^B<&T/_CW)L8OCX'W"A/C>\6V*%]-OU."WK=&>*Y8*7Y^!#CM(,7G/6S5 M1'$K,3YOP%<3N5WT]#_89>^6JB MN)WHF_/Y51.Y ZNP>VV7O9G#_.#KLWV*:[N[B>:7B&E?.=:!M-6YO.954!6' MP;YRH2N(P3[RIS=!,W'B?3:\3QZ!8U&T^S/SJ'QV+]R6Z*J10 >P:;?:;3TW M!+$OD+1V9+U]H^.J&2^"H.QZ_&_F%7\JBRHL"8IL"@M(@M5(-2_%V WFO&X+;$7M1 8&O@RR7[ O!1D\3$ M4#@DWF &J$NU:+($>8TF$[N&-?3SM'ZW%)[= '_WQU+ -U2-SCNE ;YQ6X\5 MQ;9; D[.V157-Y? ,=U.VHNP#EB%H%$L_^@7F7X,I>%1+#M=G.^(QA2;GH%4 M4I=_E\!"_7;:'3@'P^8 %LLGLK"..4MA*6N;EPG6,PMH&R MV+5N+E[LW< L=L&;BU<\'TSEYOGD7#MWS!=E?FPK$=H 4O/"B= M%_L"M>#%[[8WA/0C"TK=Z[J>=O.DYM\,L()7N=?-Y.WL %K16[I[N29HBP+S M7QV/&38:SG]S;;0M8L:(&XI<>72MQ!OXIS,2[>T6)5P7? "NNZ28=JJ)$[D3Z=\Z5-$A6\I&W!3L"NK5I6;=UI=-+;, M+;TL12(4O63;B\",DZ0J^.Y+ ^MO@ZUB(97I] WW Z#!2E;^^.)_F*()4#;PGP8 MOM@1Z,/P1@[0_V38)(Y95W?,,T;L8XB"Z=-P+J=K+W(D/U6NW]6[YY?=1$N[ M36 L%KD=F"L?N;-NK]^[O*P$,7N7G;,U MT%L$9=$('HPYRT+P8 RZ#H+;I1+OM<_1HNS=.8E:)&)E-/8X"&)EU+HOS+?. MIHOO8<7VZCA8.Y%\*6)Q#,V_=1<8^TKK91:"!_8165\$U:Q8B;E'E]4)D6&'LNN:'\N/BSX2IBPH MK[#(V'* M$] 5#IUV1HDBP9!UAZN^P1X&W MX]I>Q11E]+E(Z[G+H"D5ZCU:.(>&O:AT]D/CL?/1/H.?BZ M'2BN)"]=7M(,L^!N-.V>OK$7(@7DX3$\L*>J=(1VZ9%_^LM=BB.H_#4OT:6S M!^2J$JDH?]TJ>XX4FVEP>;&Y,WO/A14VVL0HQ(8EA'@* G1@P<_*K&@6P5&+O7^V=F:D9&-=O@;!H:-R8W" M,K]7=<9/RJGDY!L!M=<.M5M#56S&P/E:0%U-7%C>O^CW3\-WW#$<$_CAM>N7 MT@R]F>V&O@R>G> NNC?Z1:<7:\,DTW!-/KLS%#=KSU#*N,2^0RG7C7 M@ZL@3(IEOXL#8E)TC_]>X:B0M,M\5@)[==:2PAFX"L*DZ#LJ#HA*P95JW1TQ M 6'VVO#'GSWWCH.4>S7["@H9?*;N0;LR0>219HX(<">$W^1#URG%VN]E+F/< M#>(]XUZTG. MV#(LC/0>7A^V C$JEF^[9X?'J&#;M0"$%K"O\(A40M1F.'$W@/>,>L&2-L.R ME4:]\'LP]X.YVB7O7.^]:^R)@Y<8UFO-7_0=Q[ER0D&P(W4V7^EEU/%Y$U(2W[!!Z;Z/]8'8=9WV0(F=KYO6>VGE+A>0R+^??(IA6-AW(O8JTZ=\ M.'<2H==2MURQ !8<6>E*Q_/60.Y["79E)%7#N!."*^1_%.8[@):R9._N =JB MN2\3K-X-XE)7:F=X5X[]@7?3/<<6%?]-W*>\,^_RN1BY5U_Y7BGLO>"+4! M?(7B570$[*)?#;P*=F1T=D.+= RE2GQAIFWX/A]R9MVZ(O/P"G[U0QNX_0KL M&Y#R;Q^89W*???:XR52NI5YFP6I1,.\=_ST8.26N5R'F:4'PEFKX[ G<_93= M%01QN6M5J.<#K>K74;ZRM(50#_7A7?3)7$TP6K8?$;4ON(IEEMY%+^T/71>V M/=&Y.-$299TE_&_[3B@K$I9]'1&[TV7G4';_(A90*\!)LMDG;V0X,AT9(/-= MFUNBQL.Q/GO,AZ_3JT_[.!GB]_] MQRCX&?^<:GXPL]FO3X8PXDM-;T^#%X[K ?K:3P&? (4==J]Y[L1P?FIH]$M# M\T$-&_ZL30QOQ)V7&GP#_WGX64.0FH;-1_ CEE?RX>QG -MVO9?:OY$SJ"U? M"D V^T.8YZ7FN Z3OW*0Q0@%#6:S(&!>TY\::(+C>PC5S]J]ZUGQK_3J_9@' MC'YCB?>XY=[[@-+/&N+6A-W- G,&I^YTUX:-@+$9]HD@T MP#\^N@'3=.T_C,GTYW^[Z.@PZN_, 4/(QE=>#-3++Z8U9=>C+%%2/VNO(%NW MU>U.']:F7 5HLBY?Q3A3KOD.[")'U_MGYQ&S%(QS=LGY7ZQI4 VU&G\[5M!, M9MMR+KR7COX]-2Q+_CLBD:?H0QYBT[#5=@C<:4S3P%*OR4EZ%PL8+K 6?M/I M$76XPYICNA,/\.ZU.F?X:X2]6*)X9GR07,+FT)AP>_9R]>KE#FFT"$I\%O%+ M'LBY@N&PH'^8:3?PDP9F>DM[%HQ9)#4[[9\QI]YP9M$O^L_/X;R]8[8[999F MX$G\9\BT"=CU#\83 M'Q@U&&L#SS7@U^G4YJ;TK7$'!K\S/,Z"F>8.-0,]!PUM"'AI""*\##_9&FN: M[F0"U@!#(?R=P?2N]L;5K@/M#S?T?&8/M6=OKO]XKOGP/)B.@?<%?O@?C79R M@*/Y+>T6QDT SWW-\O@=<[3!# B(MRS:VA00 !I.F;BK+HG)F)MCA%,CZ0!@ M -.;U(A%,QQ+\Y@)^S1)J7DL'10;W41 0$%-*[4>D,,G%]7)V\<#3 M7N3]73!QKWP4)V!.@$CJZ@T-C8HTA4'^,"0N=T!2(2::0L48>2PIGP(W ,'G MAQ,<\NE%HZWW-3<,\%]"YN&PZG&OT;\\HR5XJC=Z>AN$&1(=+2Z:3"P$[QY,$_K?BUZKUP=6.44S95\VWZ<) 7W0+>'^#\UW6JZI>@FSG@\GBQ4.N3?'INZ7C"O3<%QW-=[ MXF3N7?;Q9!N%!H9<&)QS>-&%T)Q .S*_YY[#T>LTWH"!8325&3AH(1D.&(,C M+#NS$@=J+4B'Z_+4%M*\3BZ6-@\7 M !!41((05!Q49B+5HU5S6[U+3^=Z,V[T:>A-79\$W5!E^B4M-#1= MHL0_I;D#?J#+,Z&$AT'HL;1H])B-;[OB;:"3C4($_@FSL =.I0K"9D$3@XL. ME,+:BZP\*;I O<>O%I@K20,K:I='AI??TO[FWJ-_B08"^X/#XKN:R3QL$!<@ MD"/#(W_3(F/$&'";PYOH=1(X2'C1B*%)&IH[P.$2L\>L2:_@^&BF,-NF>=!" M4B96,#8"H+4V=FW+3QO,6,XQ,0+UDB"CFII';5K0U0<##\ NM^ ,P!-+&9X9 M*UN9USB2WM' K@O&0') R[U7-#"F>/0 9-'7WSJ^%%@KJ6] QL,EAUGDQ2@ M 3)K@ 8P$W"M.E@WC(GFJ<_^L=5YE MXV.C %U&+FX4D/OQA\4$A&>/4DK&A(W(&4F5ZZ%FR$V=D0KD[@!]2DD-]-9[ M] /HD;9A2M4NO5D G886KU\DLPS-!X+R(3=!3],L-QP$^:+KIXS HDQ5EI8# MPJ,RFJ$?+:Y M@(K\4,(;-#%F*+*D$+! '+JA;:6$P1#% H7@ISEP9WFZQI!J MTQ0OB2S?QY:+,(,):):;K#" PV-W!T+14K"I!JS$-J:\A8[6U!+KIL4+IZF5 M*REWP6;#X-@%XP(%O&)!?+$,S<"=TE)$/PS<(' G\K=3BO2W6W@2Q[;ED@!_ MN]6)WI6!]G6#7(NC5]F0R5?'".&8$YWC8<%\\9<4QBFG1GSPO*R$/[]XQ; J MXK#V2N]*P5L1"17*"IX@X39\KA0L2T-E#VRHV,,&"A6F8I"BF-2+T-0T,>6! MHF24YT'^R=!6YC ;8726;#YIP7UU"#!2;GSM)FT^JZHGG&'"?4P&3D7T;MZ^ M3@;TA+:X';:H%2/)/$[Y*XO-2_5,(6U(<]8/!SZW.&9V^)%7@5R3'ALRBFJ# MRFCXR8];VK4#S.D8(QH[9=^[4^Y$07*.H5L^20 $J!BIJ"4MED]:?U(?=IC) M?-_P9J09&ZB[IC7BEG9EVV("4Z$DFSX)ARMRO6&*18MY@-E\ L# W"WMM7!; MP""X.X2>'>G/P"-?6S6\A>P2$N+^OR@SSBTI9F CX.QQYAR.%"A0<9)'9E+BI#<1D:W*&WI+N&# M%^.20T2:$.QA*NPKHCS:#>2-TJ94(H5(*2AFS/ TF5_T!N;!/NNQ'%2@[,61 M71\I]9&RUI'B;RM9I0%--K4AHC*N\Z_0$4[7Z)3(]7'&TZT2WS(T) )%Y)] M7V-F?\'7"[?76;V]*KZ]3IB"M9EZ_&;J8 LS]:L(;D4!E9>U/7FLTNFD#W]I M\D4N]'6L1WP)L4.?/YWROU]=?59V@:^%/MI#$^,[2\03\1@W?#^<3%5@$-1I M@WI@B!C>1!@F(N4%30CXP!+N\#AW MAH!YG P758K@)T ^-JT!6;027%4[:P M7TW*/L>TAE.Z$BMRH%P2D?JCS\L MH2$\W!\5KQWM[X83HFL.S4_AZ'MW=?-*,7W9U\U7]XWFRDB\*'6MQYP2_^8G*VFSMV4TX@%W/3>VBTV_J[>[RH.H<<_OH^#Z:V$6U9+@ <'.,,Z3FX59%+DD:(: ,>IGDDR+ GTCRJZP9XT4?2@!24Y$>;XQECAX M-I4A4WXRE]302@W.?8V1+H6.2^&4=(3>@]H4N6')->D+"BNGL_R1E#C2L# E M#UTJZ*>%3>M0AML07HZ\*W#\2I^E]M;PT.>+PAB!'LRT:3BP@>LP]4KD[?DX MA?3ONEANA;#)7#B1<.Q3NE4J"0V1>3 FW%&9)@*UB)="L5'<)2HA::6.JTUM M[+9)BY4"]MATN_J .!D*PN'PC@V\G4^'3O)TZ#Q7%6]""D=#YH[UVK5(\D62 M#5NYX1:]%8=&K]-('C;OL<];6O!_!;)ZR==M!E)*5O)% 2*0HU*&_L46B#&U MB],%>)3JA4+:IJFE@*3R!+F;G;$HZHRE* @1 :B0M%$B&@ Q8%K@%R58G/+#%#&,4 PE@"$6 ^SU6%$B*+U@ 60# E MW.^8 K&Y]M=(JL."FF+JRRS$9$[UMZ[/3Y$;D-8!Z33VD#)$X:C/S& M7RY!N3Y*=CY*ZD.E (LC=-BB T5)-+W;R&K^KT$:\$![+\KR@<]S30N50IM0 MFF%CB10.<=K<&[-XQ\92'Q5>[JG))A0KSVJV@YF4[!&%CFC^/:?,A0>(#(0'(L$NQY4ASDW1". M&7BZG@B_G%.-4WIPP;-=")'((T^*F%4*1-P@D?]$2C$'3ECN@&"7Q2E!BH8# M%CE&5^8ZKY>/G,Q@?@?<\ _##EF&L[2/).$9>EG3MN;.PU#PZN:U=M%IIXQGXE@Z\9*:ES!I M$V=@PKAN:!8#SD9+-^9VF5TZQ1[)PJR[CW.O9$,>.+RIWM-P9,L:K) R.#T0 M)&28)ZJL[YGVC+=82ZB+"8C!7@S$1*E&<9B>"8J8!X8_MDV*LSIE MSS8P%X5!16@*9V?2=8K&UYZ-IM-EL7J3%F J62Q ;9R4ZGB/I6O)0[0M5# # MGTMOF?2R" <\;7>T3(R!S?TQNFRT,6<>YAD+7S=WIF& *1$BAT'L@_2\*K/X M@4_ 8A+[/!390^X EHBZ&ZN!* X!D,^]&CKS+Z<,JZB@FQQK.2\S >7]&+9R MU.RJI7V:A\&+_I2@S^][(9T0-G+TI?/NX\9ATO)G<,\,)6G7FWK-43E<.U)*TB.RQA!B+!9]A^VZ<#@9: M SF&9B(K3(BY]:7<*B%'\BI/KM8[H]X9!\SZGJM1O9?-6>5 JNV7@>*?B[ 6 MYB]P4+ IZRG$<%Y\WC06Z!M4Y]0,8/-E]Z%RVL(YA'V-(XTAHY/@3[&",V'! MV+6P:;)LO).WM7(J98\G %)Y=U"E\R0?HA\\P<[)G^+4R8='D3IY'I<3K-W@ M/D_JBL_0Q%C)&E?-4B@J:408&>0;"?DO;"D?74VN%6(LW'*9C!(YU"4KTQF(88=I_.Q? MH35"P+-IP+G]VK?9?FONL[UOK'5A*'_&/6^KS5KR'_,2B^W862([]RTNL?79 M8CK"TQ)$)EZO09E8(%;FQ*>2FY'@(8DFQ(HL@)0\TS]JY8IM4PY]B46,J5[0)ER:!4LZ7_%[9]RYZ"^DA03,@G?E34- M"4=3(IBT1"[LMP1([^F@QY]N!DCM RK".QKE5=VYV+Q&I:52A^&QN)R$CE,9 MC/ S,8;8_,#[MER/+),50W&Z%L=W'>#^;#N;N&V-:%<#:&''XGJ%ZP360],2 M=XMI>![5;JM:<"Q'5S<,T1\LOHV^H;FD+T8=K;SH)M@&-J;Q<#YOHMFN@65E MZJVI,8M.F\P T2,,\3Y0KJG,(DVI# MZ'#;*G)=8;MWU0.>+@,3A1;V#-&QJ!F3>+.YX,JM^%*M=#E-Y%QJ DF:U#M? MUD;&3?.77?]%O>>4WTHE9X@N_[CS9*"=-F!">XQN9,P$T!/'H0IO9-./9 =_ MY[N 7SG?A--OS]OU$>:WI@(:!42%&P:&^7WDP2%E-25[T!)N9<:;5 "6"+]L>*NGLO94I$=O$2]GA]-2 M$4],N2\4VISAU3H*P!2A!C;0+OM,<: /?V,@'BI414YKJJ+B^K\^D072YCN M(%DZE=:Z^O2D&*E0KBF%1=[E9,3LEPHU5U28*SK)6&Q9>)\V&3LU&8L@8_?1 M2"7ASL\%_UVF&'7A>$4LNFBL-0](=GW6&'9;<&HT#H_&)CM#6[X/4E"D$XQ^ M_&'%M\50:\50<1@[LOO0Z-IV_5*#K+G%-QBV,S?NEFB7!&]-RYJ6AX=W1WGV M;Z;)V'!X0"7@.NK@%B>V9'V4S_[S^5Y/H]T895W6Z)XM5IZ+@^9XZ+$B%Z.F M1D&PE)&7D2L@CSIZ4_O3"_6GE[[O:F?Y$3K+J\HE1^1E.C9/>+WDM9N[>F2L MW=PG[.8N5N3$7NQ$:]W3=)[6:%0)C4IP_ZD3N4:C2FCLS]N9*1 OR?GY3\/S MJ'=1X&K3$'1TPZ?[DB>N R-AX?(RU^?I><]7ELO7 8A5)-3/+FHB'@D?%AV, M+E8XO6$>OQ/U2\E+(Y[]YTE$8^KH0W*H\\5"8W=@XCR$XR'(=NP!F%8R("/@ M/.YXC!WLIS#D%$N/RJJ.?(C_(ZZRW(9JXLM*T VT;4!2W'>O[>?J^@+Y3:\0 MW9*$ZQG[*^,ZR=V:(E8=8-XJP%QRVE(=@=XH GU6.I6.(P7^44:(CBU$7?-$ M'<,^0C+6,>P3CF&7+)/J4JT:C2H'^RI]6A_U*M1H5 F-4PN KU?]LRSB='K! M1[W1UA?K;G4,MUHQW)J$E0N#GZ8&4$[ MNO@*BT%7)H*_*$^DCD;7T>@M8*VCT=OK,*? 1D<4ZZFCT35/U-'H.AI]'&2L MH]&CNN2Z1N,(PF^5/K*/>A5J-*J$QJF%I%5-]L)QZCA?'2J=]_;6)#P2+JRC MS?N'H ZKUF0Y2K(AQCK\7/-$'7ZN MP\]'2L8Z_#RJBZ%K-(XNRK;FO95EQ=@>97SC\/#6M*QI>7AXC]['OGO1^O'X M3OOG=173T88:CI@:=4U7[5>O_>JU7[WVJU>)DX[(:W4R?O4??ZBYHO:L;TA& M8)K:MWYD_%C[UD=U:5>-1NU@KQWLQ^'(K&E9T[**M#QZ!WM^$GOM+STQ[_%% MNR;':3G3'V&2>M$D5(IB812LS#5G%!+5K@(MU8OKO*'!B>+[6NAXS'1'#C"U MI=GP2T/+_* 9CJ4-8X?>LX'APR/7T?X,W0#^$J%8;>IQD_G/-7>H!6/FI^*R M]\QCVM-GE]WG#>UIM]>F,9]VSSHXFS]E)IXZ]DQ[!G#.^9?ADTX/_DMO=+I= M\67__#+]Y?,T>[RP^!W^_"DN] M<#F^L.&O3UZ+O[]U/[S]UM:__=UPOB'M;]OM;^+_;S]]Z^K?8&72OS_Y#9&0 M./SX0P[#HY=\=Z[OG[7.BY0;337@KISO>M,Q3/12Z\2[H+/E+A @6L#4'BVD M\@IQ!W@3O\\^EXBKY[2+/M(-BUI3NZ'[X6GMM21[Q/Q7KU<%UBOOW,A=F-,\ M.2JW'K=C#'WCUA&G!WO G0.'"7=,=\*>)P\=[N !H@TCGZ0?@.0E,0L8>+@8 M=WC4X#<,I#^<3K!<&IM,;7?&F#BP@++-^!?N:_[8O7>BL5W;=N^!B!HI9B_W MS22%:VC-SD6KVZ^W;KTJ9:U*9BV.-9ME 6'W3<)U,F,D8=>*$LEW=W 112,X M[KUG3']](O[WR49AN@S:0J0+J!!' M@<[D8>XQIDW@W;&O,=C15II& T][@>\IB_,Q,L & *V3V57T1BL'O+GP(<"$ M7R_W$B('X1]_,,/+8Z\7@^A P@&B;R37;3:)\C;$4W3UQI)9*D7?%^["A.RA$=IWU6B"V/?JV2<#_:13M:P*O(;6?UHITH MX(^%VTI8H%HS2 Y8XGAK)=15!-8:]Y/ O9"]OBIA*0OZSOF7RZ2"2,98UYQ: M0K4/%+F&01K:[\QA'O86<2SMRIIPAX-,I62H/4CX5-[9#N+^QQ_*.Y%7Y,H= M_' NC0 +LQ K08+N9?EK?P"-\B#;K7Q@CW^?G> 6>]9OE[KD17'L\WI7U;NJ MNKNJTSV17;4OA3NA,I=D=2L:(<5>:E%RPUZ-\4(&7)VZ7>@4"_++CP&-8X2Y M)GU-^J/QA.Q9-*OCBYHIE2FOB_!L]_:M(^X6>"A6-^PMU(TL-QS8U4"Y8(UP M%YSWXLE8K0?NG2>KO6,>UV8YA7U2N#MB7WND8/]#O37JK;%J:Q3M4RAO:Z1T MU;A\N"Z$J%HA1(%K41>15: RZ(@7X<2&JSGIF$A.RR5YD=12 2469&U04D;V:-M45.& M=4]7@( //-[0QLR^8P@1< 0O)EF@W:KLW#Z9:J-G9/VOW8166Z1@-$B_):E M_V^-[%I.G14H9V1?[I#K;(9]T>_:B9LYB$8.6'N+5?.&,],HJY/*?0-7,[!O M@A_:F(RC&2./4;TOL$0PCI\9\,LS'$(PX$6GT_[Y=?0H^E'_^3G5">.;'M:/ M>#BH.]2FGGO'D$ZXZ;F4'30QX*\F M[%#'A1\U[ONAK#E6D\(\$Y<&%+TP%,H_^?'@#6T0^MQAV' #WK=",Q"#N%,F MMKX/GWIN.!IK/GP53,<@=31C.K6!E^AY2\.JZIA87)1'&QJ,P%T+)]VC3;$5EW<\0/#MD5Y/'S=:^C]ML8,^ S9R=!\_@!:"\T( "/U/A/]9G#4C]#@S;< 0"@LBYW&78T1MRL0:S+.G#J5H//YQ(@O3;;>0R M6,T-AQ\"D\ DS';OM?_J2(+KHHB#5G#R8LUBCZU8(%E)]QCZ9H9!<> M^$B1(8$'?/9"+UA DERK#@4&!X$,&^<^TP)8! G0&=#-X&>0%J MGC'E<$C!BY/04;)J"F*2WH^50*7YJ(_O#>P% R<-GHMJ:'%0I87;BL,6S\M8 MKLFSK+57=J/_U.RV!KN]"4F-%XQF8AB\YS MV%S(LX YHL,S7G#@+G$^&]^I']":)[3@N6S/(@7*^06 #?X&5HZ:FUDE34@7Q-(YVC\=&(6A@KC>+MA?L MMBM?39(XW!,-FCPV=;V@D012F#)B_K%Q)W2[&0M M6".0,NJMU8UMM;BH[5V M[9V*:V\'=]SB'32_<,J#Y8GN%:G?4HN43E4JW[>7X?F]^/@R#LU3(^&@;/=H M6;0JR[8K=;56.6-'Q@C.?^%P12\+R%\'%VICURMJ4.1H92DWZYQ;56@JTW!@ M_NIX?O]C2WJ$YCV9^PG6L9LQS.2QR M72DU!0$/P: Q?*9UT'NRS$]G!*"Y>9S.Q[1+"F TG%'D:'W:;?7;./;3RQ8, M%[FI"/ND\PL-%^&YS8P >BTY<;5G\,:9U_YK1%/,<://ZC52:YX MQJ,4#ZI,L[3!J&Q,^ >ZA(BN8]<&%&@UR?0D;@:(@AG.@_P$RNABHW*M5TFC M%J#$>*9F=^>-8]++D5U7JL4"$-$AU8\M&&EJ)*(,J'4G7*LH!;*62.=L*[MC M+>\D[(M O1&!"_.+">E[DB>9.7-,)\^P)%?=(8_$#F2%QF7_8LTHQ5JB]Q!: M1>6 )0?.3,.C0' H['(?^!_W?+31B<50%I-D:LQ9FMDP $#.R*@V0'98D\18 ML4#!Q9U(B5/?S1>LNA*L_91@+L*6+0*I]WM?:^ZT!>/,&<69 MJ46GO91@BH4=#_=Q T9QJZ?K[6(:RA>V@D43['2)MA>$*7=8)34\P:L*Q.-X8;VP0.SY6;L@N+C&-K_ M\)&%N0=&TA:AD\43&HHV-3PP;M(! W@?C0R8%/XWN'>C) : .@'F_=@E4-%@ M29HZ#1AN"-H9 NIIEH(M,XG 6E" #\EL9"/*FC&"%.'NN"M I1C_ )9-V!R@ MYPGK%C :'T#5O3$&+$LI#YCW\GMP!F /3(PD4:$0F+:J$2M.")B)M1#3:+H M)6(G!@!.RC \1RXA-0NZ/?Z85YT.A MGKO2.@M(O49JAS"I'=N+00I;,[4Y08WWD3$BX]I721Z+B/SLB9A..D3(,?'D M>0/!29+ R*0!:1Y'V]$8@$$MZ#-Q0Y&IU&FW+B$6S$VWA]"X^"PAI,DE?PH MA]QQ6@D8VL$]VMJIL2)39@P"#ZW:Y,=Q]IY*P4D,$='0!!I.5*@-U#B*>TNN%UJ[J*@D MA6LQ/%>87N0QT#)P)TYQZTY@8WHS=)F8C.'Q[2>%'BV8[\L-AN*7H?L278\8 M!P7Q9AEW7*X1.CH\=!IRA[PX@QE6AH])M*(B3UX=\N:0R&=!*LY9+]M">#Z' M'OHD@]A#"YOC)^$JPMQ5RTBD).+&%7XDF0Y)8M#B0DQ*C]S8A?%)??U[:*%P M^A)8K>?:W[AM&]KO<&(%S&[@$3*!0P7XQ*=%C[8]_(V)+&_0I.(5D&R^?-4WQ\P*;>G%^WOH@&$IO"_[X9&C9XK;9(P" MWIZ (61HRL(A>^:MJ+R BM]*W3@[(H5##AA*%7",$TV#9+.33R(K1GYK6&* MV*$;GXK<(9V#1'Q#->=T%&5*J+((C861UH*&O%+E(Y"I24B^\S2=3 M-X%)(G&D(+F MN*%9+JZE&Y#+-^!!2(?C+*':@ D[U2\3Z6&]S?WGH$!E$X:'J#B=+?1FDG* M&KX?3I2/,$D%<=(J#_$$'DCU#-2,%NAOJJV:BIC RPG5<@%M M52ZVX*.86^@L!P@"# PPPY.Z[=0#GM6&8*_'7!@QCCC_:432![P0XR/J:8+_ M$H56 Q;L-4"-3-*JE/*)"C]&,F(> F)&2.8RR8T.44I%DQ"P")_( GN#[XRM^*)0=5U>CT&NNWWY'L$%+S*QAG3JG+"+I+/A?C+GK:- M.8$OQS$-V\3D1%EL0_'7!]((I-VL))\](V,_GBB6I,ITZS:[K3-M L(,(4/K M,G7\#]^SK$R/S">,YX'/.:&0@N1BH]Z3F@N/Y97'(]4UT.\(94YY?-8N&(8 M::Q@B2' ,L@HO>Z?;(F?)L:H<8NL8U]@,1 MC/E\G7 ;^,_1A<&#F"5(BX^URZR"D:.V^6,WM*V$@2C40Y%T UCX_$$E=QBQ M[:\R4LB5 K]XS!U*9T$.0GI7>(?V#BQL(_N.+85W]N,/"N"6=AVH(0>,VI8' M"B*RMXD/_9^B/4ZF-;H;4UJC2)Q)WC*FB8G/: MX<^]LES6QL MV,-LF8L:('%BQ$4JI%' ,426JN%Y(A27S"&$PP /U D+QJ)4/AI'JC:VZ_OI MT\?DGAE.?/(=R:,%G4)X!*BIZ*2T&) =5*0].7YCKLES_(JN5$?-,D>2B9"N M10ER:E&"TTI72%:"Y&;AQ\GU&V8K;%DAD9E/UB/DS;/;P"I14D3Z.YG<\CCC M,97@2%U+B,#(M;9K.*J;"8@-3X7BGZ%^S!UC&,BTZT1^_;5,>D]FUXOV##GY MM31!!,'"9(0H]$W6CPPE1X,@+C*?>GY,DI_HM";'-HV8'W^5H^MR=*EP,\<2 M]IOL3H+B4C@@J4)21X,!]JJLF!0N_97+1?UI* BUBK4K!;_. MUVPT,EO'2 <0I&1*;'+:N;XV I03?B4E0*A%DRI_B>IA4J$O%"%?;[2G0.=V M6T?I)K/]T?75(&>%-,#C"A@PV6$U57IX2GBT6Y?G4?,2!%'60E MA+&,;$2(27E%=OW4X*C+,?(>:;'(3=8T9T0>N84,QPE)2DCO$/95:O_[ 72[ MTV#7>L/O2D'01]ZQ@1=B=HI^L2+]4+AEL2H'BVDF^$WL](J:9614#?W\9W2O M3@QQ:*L^.JE-DMJO4I5H)&+;"V2)FU6FTJY7L;GDGD-OGJQTPV\Z;?&-3&'+ M0&6Q0:#F-^8:%LA*.57/%"5K$?#]B_APKW=TO:-/PK?Y&'S"( DIB4KO1I$X M($0 >HZP6%):?ZKA9#*'4Z7NI0HEA2#AB_K^87J$K8(/)H@P80XY8=1B#^,: M)&<:$ 6FC;B^V<0_RG&L:GK\T#5FDHN!@3E09)5.J>)!$9,:D(O(*;'T]&;+FR6 MJ_K5(4+?3;G>9@]'#=:4.O'OT\KK6%&H*;LIY%7.)GY*W>^_%>;F\N4/%7@&U M>>:*VKRE[O3#@@Z:X TF'%%BUJ6RB8=XKJ/6D6K. ;:@,(U535ZNYD7Y3W"H MOG[[2?O@M;0OP*R.]C[\BTKL,--,A J-(*_G1:1B^.I 5AIGI)7%74VB2KR4 MUB828))^NR@I/!"]=>-T<.KD&_OQ2=L0>3)D$MLLC5J4)S?PT#\W7VXG4M!! MZ\0PIM"I+"ISH"3R,)AEP4F _9-JLJO%6^(VC1@6U6$"C6UXHMF@S,%7*4JS M-5&/*JED\K[,L086Q&_\J+:PQ?98L,HV_?D[[[\K'_LXWXTG(;';' ]G@'!^]Y8$!X!OC<$*Q'TYK ME "KD8"^%%A5: M2(,C.Y"#Q1/"L$&\Q#_1+^988@LHLX[ M?+MT@@*4:<4K1V(0:1>7';+B' I M:E+^):8TD(%&4@!S+U5)KS)VX2BVR9>6+#+.A , VN^.>P]OJ5S<[&,RQD6E M@:158AG2P(N\P]A,@Z]E&8O\,2O%T2H6PH7%*8:)14X:GME5(.X+;6':W[E< MI8U(5DGO) HK@!'LS+DY@5TC#K=GF8@Q510O*N)0XB8'-ESC?"EC9=-D!2L8 M9J)5FLS.Q(*CJ&$454B"3>I1^_8LH"96LJ@Z&547FG)PA:0/"^(YCK<>B8YT4,BZ4_$WEVRU( MF#P"-VY-TEI!.#X%X; ':EZGSN/1!2)G":H!\\K W.V&T;U^G)9J"[IWT,L*^%0>H(HUJO66@&R\RQ T?.:#8/?1+V MS[81H-1,K3U,FV$)&A_UHA K:_^B2MW T/R9'[")O#IGIKGD5Y(_RN0O\HTP M1W7[5MX?-:\*LDL:)A>&1STW9(/TY (J39D]&.A 2*IU690(=H9]Z3AS3%DC M;$>=Y/(PQ9D$TY@@8X"!/3_Q7$.]VQ\*ATK:/96XW0^]1)D[#.=K>V.'LDPN MF%-2K])IO!'=HNR'M.>#.&> U^S-=:91#$3;-J%Q)U8RKMR5)L."660.?U-1 M)WXOZNJ.]^ZA_S#!E+YL\B^+@H&S014.1$=I<>NI)KKR)1&EEH:AG=XHZ#6G MYB>A/>2R)UVB;7FR=7U$/WR?TA!%R@PWE=L:LW%@('N6V6(QJ7=?MO3E Y'U MQB)1D.[4?M:&?X'1@_1Z&WJNN'8IX],3C?S('PR'E-"IR#9!T:ENLL(*-9)" M>3E.(OL;%B!DR4.I=HP=AV-LK:*SC=37DLK&GBQ5\=)U8/3N<+-JKJR+YC)' M*4O)^[E["M5U#EB#2K>AQ#=02]]-,E/:UYZA.0]*&!]RX3: +0:JG3$=:_I MM+*,[Z'.7(0;*U:&]@^8!L.!\:MF.$E4M$[',Q^I+80V]J@*@5%@TAL4 D]U^&F9C%Q\?>)[:) M'"'(E*OM,&H_8<"Q*A6N*/<;I?.0!RH(Z5/>&DZ>.A; M7[SPVN^GR%90RV5S6"XKA5Y4C^(E;Z-%2R-RPRM$XC?R M5@D;+ 74_%I<5(W6DO3 "]T,ADI,0BT?(\8Q #3FB!SA]*=I,'-FC.2MJHOS MV!WP<)06#0HEEM1F%%>1^T)YPJX@TL_:LP%14;JE9:%N+IO$.F^R:"YV:"1< MX<8(?AT)BQ:4WVPWY8TYV?62L?')!#LJ@ZSY*[6H4R-0'GU@$66#81PZT>YK M<:NMM/F(]8O)GK,R]B'*&C$HPD8@Z["\6]Z9%''W5+6&A7>YX,++[&JD69UQ MLJ,3BH;HA8V+$-UWG)?W@:C?B(]W0(O 3-5E3K(*4S8T,/,DM-F4D=8FI M?-_UZBJHW4_;V@=>^\#713K[<[/$HPH8=CL/=9PI_Y7T;P5\J7*3Q!<:U,Y-GBY(A1T) Z M)K6S"^?!\=HY&OC+J3&Z)K,NI^0$I15VM^-T2?.NG6 MH5S>,9]<2S39 S!O<]F5Z@#@'1<6LSYPHQB_'3%AWE'( ,XI39-%J<'\N M'"%Z8<0^,(7IQ,"^SK$O"@^3:!SX+M4/']4>J5R*5^51)_J?$ _ ZL);H,)P M<1CJ/3HKRP^,;]Q=_U0.K+K\=/OR4U!6>ZKZ-)W-XK@AJ'Y0'J223V"^O MK!KN^>12 74<-OKSZ"LIH>1-F2@]*$5XB!7M\@X"\7M2#E+(0OCW#WG[Q%&O M[I'NCQ]_*(>&,,\Z5+P5AG5TLE)-Q$*;ZT&54HOCDGP7]LCUX)@0,4<15O03 MSQ.'7FJL.]<.)Y0\/''OHL;.$[2MIV-2.U1067XMKT3@#E)6&GXJ\I4WP<#P M3!=ON38->'/*3;)3*>_/%<@V,!O,3UQLFAB;KJI.7.^%NS>Z-4%D0]M3#O,?(V\O7U&Q0!C3C+(Z-MTU&G=G84 M?L=-\V?(S>^VV!"PX\%+C$D!1O_SO%ZV88?9.TQ$D.-C"\0+RC*.-Y$=X.H:S: #^N&!@>6WJ!/ MR8\#2P&_PSO5D[5I".^>I=GI[L6RI-GC.P]J#UWMH#QWUK?7@B,FU M3QNA4WR(X;*;D9HL,UU2[ MFSCMLX&]?O H([\0I1D08L".FAT^A-Y,I!^@UD^7G@VQGK6!U7YC.(WP#@A@ M5-,0VKH_IA8Z,%Z<$$89JY0=-[>6 T][L2?R)UR4?X26>^=_GR73G2A>@K9/"+*K-$]G'*=LY3ET%F90(C](H0/QI M=%%43B:LL+@Q*UE-QRE]2>JRL9M.1M*QBTA^&F@Z^DT%7M3L0[G:<: 'U'VI M0\B8L\@1 =(1(]T8]#?'V61-$&_P@A%$[H>_B90OUR(S /##!%@GNBZ!2[31 MB5%S>RTO#D-!9/G/JI6B)RL95+*Q*.8$6S"F,S*WQ4PNVUN(V[R":-\DG>.) MW5LS^+;B').LEI(6];BS=M/"98@%<8!WJ*$K0\0%I90$PC5D#VVIQ/GAX%\H MT:1S0>;I)SOTQN+6I+87CD@=\^=:].,4E"_'AD,8LE[R6J8=B()S/K,%5VR( M(H]!NF=5XA:)\U;_WRG/"XSFF:AJ&LQ0=Q%&"QI69C)E%+-$#:%SV#-5(O)4 MZ[3ZI&;AI<5RH;Q*(%.[P"=UF04FY<;?D^)H?7V98^R^/*Q6TJ:Z1JH:X M."K:/18Q^QB*5O3GV@?$DD7K_5--S;N.*$X_BK+].;\[7(=1PRD$T G'G M;KTX-7L?AH*=?/;NY[ WQ=?CMJY4S5+YOO=5I7O-N7MQJ*/>%IE\2:WMJ8[W MN#O"OD.CC_D8"N*H+\KD\"C;(]:58STT4HF/59^KSL(=2;K UOT/JI-3D,L[ MFR4:Z%GA0<7V2C5:E7*@]U,*_$;M!YYBMUNJ9547J:;V^I(*]V((L #ISCS2 M6^+75>@%LD(U+8 .A6"W, 0[$L&TF[P:6/868+DZFV8QOKVV-C!LEP%3!UY4L[[ _1UN.P\KL.HUL,V<S'PN7E8:LOX@8U+^_^D*C01^399BOMDQ=MPJ@N>0$-<34#WNZ%S0 8]GA: M='\<:)LBW=IG9K2-3?B2!THD^/*>S9QH7AR[(\U438:0P,&WH*%4K7A6@5,S MXJ->H?H^KN/)'SYP0NVRO;,JC?E)L7OK8<$Z[0MUOG^!7C9*)4K"+&H__G J MR*EJT\>RI5*I_ MVSZZ-O^$:DZ,P^/[6=ZD MAY>"N$Z,O6!4_2*/4>-&+AQO6[76N\I(W%=$K$F-Q-,C6_N 1%5+'!.XSV%5>_BZD<-G(# M+O//$WZ.Z*46%:>0E*8A\$JML(Y;'LG_MN&)_A;SEOA]*:4N5 MMK2^'O;G ;E(%ZBS![HW6I#>((ZUT_=4(W?YX6#" [H%!U=CZOJ&K0H+$OR> M#,@1(^.]S['0'QIW+E[2,TM74.,$V+H[M<6P!2A5$8MKY<5*N5[N%A'E0Q:7 MPSQ,9=E#BLF7#R%84EXHIC!+[03\$AIO_7BMXX)\CJU%-GIG75D?,>5QXX M4GLF-L!S[7U@84<<)U(4Y$G?$!]H;9Q(+=?XU7WVK-W'(M"4>*^X7<<5?OG5(DJ+C>BOGLRW6,$1Y\?S"MB MR3N5D]UD3=OP?2UY 9ZJLH,-&\2PJ_&G4[HZ@CKET5T#H+!8''>YR)"1N&5T M05<=ZKJXP.E"Q]+1SUQ_:GKFB5C4\DK6#@JW $/*)UQ$BIGN$D M)' ]\8NKN!4AL? @WEKR:L?'(<8?V[$E]_)YCO9(K5RP0:L5;[I$Q\J*,,3I MA)&K@_%M6B (H8T?T;5G\$]N-.8J['_RE50#*9@68 D##Y6A[-5R\Q8EUFL8 MMKBG$FUG4)0LNJY-&,!&(.2TO!\9SH4*S:XS%UA(:-VL8BIKJ MN P,IDR#M BB&!"P7X"#R*:QL&NSJHE4AXZ8^B=Q.9#L1T6,8\VMC!J5[H3 M?KI^=&>"6@[0"S#U>D+-\V#!\0(C_:)U$=U@5(W-^-B$3QFB)W87WW%V+Y6= MI#R*G0O$M"A3@,^HGT[H^,QN:5Y3-2;ZHN7.P4#=,R555-B"WB1);\>Z0%X4(Q1-O M2XG$%OEM8(&&?BP4J1T:R@Y?78F;5D$=5WB"[/G;D!4(8*9.R215L"@8)[!H M09R$+5_'J=+6YD;\FF2^$CCJ)Q(K@JVB"(&XAC00-\%A5OJ8>Y:\F@7HSL&L M$=>R/$\8#.H5+AOYAXYMW ]#&U5_NN_%A5.+H@I(L?C*&#J0T..%5DA:BKI9 MGB)Y2FWOY3FHOD=/ O7)EBUVT&Q)<5!V0CH!8Z8B(T.L8^+P4T/$C)7V/5.! M9L;.2&]*T06$3V2J?62K1/8-&##+Q/8Z%3(O+'Z'?__R(O2;(\.8O@3X)IPN M+/2O'.NUB[W61@Q.&^:#96C:+G96O 7!]LIVS>^__?C#+Y.9_]?+&RQ/&P+P M3O"6+IA[0ZVYOZC2A<_DK8N^(Z+#/[ZPX:]/7HN_OW4_O/W6UK_]W7"^X1%Z MVVY_$_]_^^E;5__VP?#2OS_Y#5&0&.0([@%J%KLDFJK1JFEBV?1R/CR*3OZ2ZJA.F8(INJ5J(@@L;-CL:EY=! M5**PH8#&Z/W6V676]ZSOT?=L5-SY>^UH[]C H]O@8P?/*Q>,<3SRWY"2BQ>Y MQS>_JY"8#-/&=[V3ABD;Z%GBYE1\1&:\N#5/U/,9$U#"R0GPM".Z-ZC@-+T& MOU&7$F6H#BF60075;GPK-B2#"]*PNBO3S]2E*_3WV1H M89='%[ITE(N46@ZKP97^A=AT6_TV&L%B_/WT$-S 72E (DGJMN$*85/-$BTEO*E8ZM;)-ML((2FX'J.YP3:*ID]Y-"B*3D6I5LCRQA9H26B%SJQ ITNF MD[6I>->U,> V]L.FYO^R=A64F[\2=W6G"VBC2^]D"TS][&(YMD-IDX@KU^=23G+3- [ KJK1,:JX'5[ MMI,VOH0;NF>GR0WU-JI02^,C[WN^2==S91=2<$X&S=+9QCZ*@[[>$Y*A=]E' M43 *#;3Y,7O=<=7%:>:8F=_!X+I)1;73@JR1$CE],.#%L&UE)$4C)P:FP @- MGA8RC40T!00BBKY(4.U+ -7[J);7M;S>GG#HC1&M7^G^'L\52KCI.KYK,5AQ0>3,S?D1H<_C@ U0I+'F8$-99Z[$L*/1X+?HG1.&;V'4,# M-VT_[K]?U8 "Z4VZHG3J UG47Y5N924Z[@+TAOE]Y+E@-S05^Y@F8\/A$M^ MD$;S7Q)S;.0 6&VO2_7$9](3MJHQ[DJO3&+8]3T;8NCYZ/T&DSU=.4=G;A+1 M6W636;J-RW:[!&P6DFZM2I7%S)=DH13HVW+;;H_S^M,2K=;EGP6=Z M+]GT)>[S]S+ZPMGBS5[L_M[/)EBV_IM,<''6+QGRJFW?0K"]0?4LIV HX>M] M[)S6;;2[1\9K>Q19BZ/JZZ%\2YY6.Y9F(K__Z-EPL0XSSWT__K"[WH(7Y97$ M@<6'6SO\XB3RL7F)_D@/1H&&3LB/\K&RG*51CL!K&:QLV)@.-]C M/T76-TJ5NU18Y:DR=N'M:&E7B>(L=<.:Z[&12S5<"7]O0DCY2>F5^ET@@,U; M1/L)T8NO*&S>3^: ;74"2FV6031_X MZABAQ:EI(^RK0X#=X+R^=A-E(M#[;U6.,Y4C4>E7JMG"S=O7J6X*E":Z';:8DXHD M\SA%*=0-ICEOYB138T(NAA&XQ0T/@5F]V.)LDBKY#0QJ.X6)))9:+!\+SE*A$X?A1=B8JB[2R2FC M57XG.@YH5[8M)E"=PW 10R(*M5D"KA>]-Y*EW[("%.9N::\Q(Y8[R2X[@#0H M&))'OK9N6MJ(.'XNP(X1N8!W/G8SFX M0.VJCY3Z2"GQ2/&WE:S^F%H6#G"3&"*UPW7^%3IF;I>ME Q,3+=*?$LK2H1] MJ4P[<.?V%WR]<'N=K;1JEADL2-B-AGNB=HOQ\?@+DE2=+^L1(GB4?V?U5I"5_]ES109F@ M%2=0*8ZSRDL2W%25V <;)4'5I_0AKO$61_>BB[PW.*<:.#S!T\Q%C^]K7*54M?'1;]%6SK6O/KFZ^JG\\3UY,$?>>O78 B)". MO^:G._(G:<]NP@'L>&YJ%YU^4V\_?ZE]B:\+IC/]0Z)$'79>/)[(4*1WXA\3 MZ4RMA'M12X '2@:8D[YV9WAX"P+H(^CJ25S5',W?2-;'-U*>MT92,T''$)JK ML5["8UQ;VC\S?03=T%NM8#5D_-$/J.^[ZO3#A0BBCF7,5Z7N7H9FR;)^!$Q& M/.-& Z@36>*R9M1\&BGZ4%\K.1&5J,18XN!),FBI)I-&O"*)1(Q6:G#L8DCZ M'CK@A'/-$;J9*O"77>$%A97S5/Y(BB9I@: /DFL _8VP82F#W!AB6SGE)8"C M5W4+?FMXZ+NT1!<":MT8#D#WPDH^X;'&SGAX4PKY*5W'%BY74SI'J;)8"]N@#IWGLO)52N%HR-RQ7KL62;[D9?0D,F_%H='K-)*'S7O,NT@+ M_J]T/TKB=1OO(& B:!0%.JAAN&PZLD",J5V<+G?!#4M"FFXN\*6 I)9 $A2KG8.(%F,4[ M-I;ZJ/!R3TTVH9AO5K,=S*24HUZYB;LK8O4[X>VGTPI!M@7(44P9;0"\W49S M[X14XUZB#M+F0^K#!2(#R;%(L.=)<9!W0SAFX.EZ(OQR3C5.Z<$%SW8A1"*/ MO"AB5BD0Z2XIY3N14LS!.DX'!+ML0AVD: B'I7+>KO32;NJ+3?IQWP%?_ /[ MB F+4[*E])KT@.[S"Y$M\BTZ/6V:.'?YGR/;=VZLZS9:V+M,LK?!R MSU4+)FDL"[H=K3&61"GRZ.JM_C28'T[\<"\;?&*#Y$*AS1E>K:, 3!%J8 /M MLL\4!PK0T\\(B)<:N3UP55U<5.?7)[I8PG3J3NE4VJ0RYC08J5"N*85%WL4= M'<<:*"G-%1Q2PXM62FEX6WJ=-QDY-QB+(V'TT4BE1&)@% M_UW&>EHX7A&+GBR_30Z579]UB^>W *=&X_!H[*N6/DH@$&Z9(G?0(EJM.=1\ M(Y9=!UES>V\P[/(N*]6#MZ9E3M=JS_WR^UY-H M-T99ES6Z9XL5Y^*@.1YZ-&MJE$*-,G((@B%P5O*[@J#SHI>^VVCU^ MA.[QJG+)$?F5CLWW72]Y[=BN'AD?JV/[QQ\.Y=J&F8]7[,2^:WO=_JC'ZC*M MT:@2&I7@_E,G[O^K0PYHDU,\N:B(>"1\6'8(N5CB]81Z_$S4RR=JF9_]Y$G&8.NZ0'.I\ ML=!XC.0XI3",@/*$HC![H]1I5$V558&6O'B3=.9MJ":^K 3=0-,&)$5K02W; M); @DA7';WJ%Z)8D7,_87^GHB>_6%-GJ4/-6H>:2TY;J6/1&L>BSTJET'.GO MQQH3!ZIHGZFCV$9+QL4:SZS*M7622NA[NL19JQ5?;'3DB)X%&U79''0JO MT3@T&J<6"E^O FA9[.GTPI!ZHZTOUM_J:&ZUHKDU"2L7$#]-#:"<&&A-EL,# M=7@(*D26HR]R_AP&VB=YFXT8]:*CZS]K;ZX_?-3\L>'M.6_\V',GCI$:EQ>7 M-3U.)K.&_E?7NZT>NO@*BT97)I9?1Z/K:'0=C:ZCT8\OUE-'HVN>J*/1=33Z M.,CXR*+1=>%UC49):& K@E/9(,>\#G6:QO&A<6HA:56=O7"<.LY7ATKG/;XU M"8^$"^MH\_XAJ%#\L"9+398J*#,EB8<%[1OPFCW+P@L'70?0\>DB0A&4/@'& MJ(//R:'T7DV.TXH]7_1;[7X=>ZYCST?H:WKDL>?HBMLZ_%R'&NOP<\T3=?BY M#C\?)QGK\//H\91"UVA4!XTCO+.RCFU4#=X,+=?+>*BI^9@Y,\ZSJ%( [O ^ M]MV+UH_'>]H_KRN9ZE##"?O6Z[JNVK=>24NS]JW7OO6J<=(1>:YJWWK-$[5O MO?:M'P<9:]_ZJ"[MJM&H'>RU@[UV"=>TK&GY:)WK^0GLM:_TQ#S'%^V:'*?E M2'^$2>I%DU IBH51\, 7GOWX0^K"N/]\KET%6JH;UWE#@S/%][70\9CICAQ@ M:TNSX9>&EOE!,QQ+&\;NO&<#PX='KJ/]&;H!_"4"L=K4XR;SGVON4 O&S$]% M9>^9Q[2GSRZ[SQO:TVZO36,^[9YU<#9_RDP\=^R9]@S@G/,NPR>='OR7WNAT MN^++_OEE^LOG:09Y8?$[_/N7%Z'?'!G&]"7Z(_^!\%]1^M@'9OBAQZQ/SD<7 M*1!Z'BS'*\/G/KYE8(76+3/'#O\S9/XM4/B5[9K??_OQAU_4B#?FF%FAS3X- MWTZFMCMC[(9Y=T"#&^PM^@J)]-J=3)GCTVA7-@Q ?WT:?HDH_!F8TH7W_""> M!&O%<$V_L.&O3UZ+O[]U/[S]UM:__=UPON'RW;;;W\3_WW[ZUM6_P>*F?W_R MVZ/9**XW'<,D+[5.O&DZ6XH= 9X%Z^/16BDG$G> D?'[['.)M'H>Z6^KHGY] MO>I1OP5DW3!NL#% MF0]P_GZJ AH+X-V#$WD!#6(_V1G1XW;L,:9-X-VQKS'8QU::0@-/>X'OJ1/Y ML2W^!N"L$_,N=H.5 ]R<:Q5@PJ^76U#(._C''\SP\ACKQ2 Z?G" Z!O);YM- MHO2P> I0R);,4B'J;NZI6<#VAPG51!I546?)CN*C#%%QVN>"V.2HH)>"^9$N MV)&"744^6YR252_8L8+]./AL[XOSN,]_-5QIH^V81%!C76-=@D9?L0:IZYI$ M2ZCU@;SR,$A#^YTYS,/*:,/]7[:?#]U%E<4',]^VH]"74H'[\AV5K1!2KW4.A>M[L8J]!:9;CL.MSKI MK, )%N3%51V%8X.W)GE-\LIZ,O8J>M6Q1&T>RI/'17B=>U5S5.Q/V^LMU'8L M-QS854"X8 UO%XSWX(M8K=?MF1NKO%,>TR8YA?U1L$-A7WNC4 ]"O27J+5&> M3Z"L+9%;P!075.RM_"&_QN*UB_GP,.@KPS8 M HNM8N9B0^QJ=JZJ>Q',0*-=+6\7/E_YOMZP!=67KS?9TY5S+/2*;S!+MW'9 M7JR\%8=-Z>U MN6VW1XO=!5M[\7:VCMUK+T+-N"J]^LV+2AL?^]G$ZSV8JXW MP<59OV3(J[9]"\'V)@#- M*]LCO@'*MVZ0;L1&:7O^T;/A8AUFGUK+WKEON6F\AM6:-'=_=UWKGMOV]61J M<(]95Z893D+;")@E?L+>]^^Q)T.>J7OE?_LTS#5J%QJ[6@A6 0WR]>;-$PVL M!@XVB/_KD^;9D]_TKC!-8\36AB^)U&O#'Q<$[[>KD<<83G+UP/UO[V"3?C&X M#X9+]. #U2PN0:S[Y+=>__(LA1>"B"!/9OY?+W%4_R,+J@7S15OO$\PI&)-T M_A#=AW 3-]ZH% YZ3T_S4Q[(T3K\'AI@MP<,MM%'-R@.EWC< <@%LI']5[./ M1A!ZC-#[;,P0H^B]M5#KZ[UX>;*@[QVGFP#V( )]8S+'\+A+B-R$ Q\."/CY MUJ5:\]LQ]X+9)X?=WKO_PSP7_KIA=\Q9!\-^O[T9@J_'S/Q>[57K7?9S<1*@ M[Q^I$I:ME[]J,89J+\:7J_A1KYPWW#=M%QOEK(7QV0*,$[]'0[^:17_^3?4' MIY:\0L*H9]?.- Q\>J"O@:[&K5^?O'/=P &N;':_Z; SVWHG)726(WI4).GD MD^3!YR\=;H/VXX5LCB:=)R^."LGN-DAVBT/R#3-SD9S_O63F[H%0/K\\ &^7 M0I&M>+M_9,N^%6^?%;Z!USBJ2N7M'@KN[MD!Y?9^*;(%;_?V(+?WB^06O-U3 M7$9:XHQ^-7$:"W>BE?CGX:' MBF\5(-^0CRH$^7I<%/.0 KV*N.R3?PYRF"Z7JKUJXK(.1V51Z8-%=W91%)=5 M\ 3,:'=O803+8E;T:,GTX;"]K4( M*0#X;X=#9@97E#-%SN?IU.8JB3!&G+22KX['#!MS"C'^P+XFVUKGD>#='\F\ MP-56WO)%[B2"VGF&L.+KUZ/#6?$_&LG^OUW@SLX@%X"2V3]>>L#5R!*!:]DQHVS M'4HR?9Q9^=GE;Q_PSWRO1QJ=U4?="GG63X8^*)K<\P,RJ:\?B=]P*#6%WP'!^: ?&>HDHG;,=$::LT&O?#\':"O'F&%'( M1-_[XO=WKB<+HO)=$?M'W"=HDKA??WP'R/=3R&^&2HH(B5<^X^4_\"7]5E1@ M;3V,OWU!#8(>?8 -, DG>2SP;0IO$G1)@G2 ^5O])#46X51QQ(V'C1&_;+5+ M0GQ]9]O&/'[]_B8?P3;85Q? 1JS>?1R?X\S>][>87K/;,HR&3_T>R%\ MK9?#U^7@OP5[]]=G;V%DNI.)ZY T_#2D1[=4-L@\CUG7SK7C!X9MTSF\3WG^ M#LYN.5=N6N4"H=[3^Y&UO#XB54/^AC\$XVVP[VR+O>*/SYYK,F;Y[SQW@ER" MR=J8OAT-=J S'.1;1JKU,SG9*R&/%IFH0"O(:PV=BX49G"H M,I+% ,]I(?/](S"J.R*Y_6H6OR*SOJ_N#<]ZPWS3X^15+)4 O[U] /'#?6I< M,'0];4H6E*\AQ&!0:4,0S9K>$3?":<_@C3-U.QP]&G*TY#4+3%"\/=5C(VG& M R*^,OZ?:X&K==6'K8QJLR.](G9"QRO2"^!ACCE[8TQ IOJ+=\#KT __?;1OP*)MU^_9,^.LX.AT/_VC@WF=[Y^,?_[\BW=OS@0 M"F4+K\/Q&VR:JVF.YJA?YOR^D;&^7#SH%Q?;X+Q$F A[_NU#@'=C68=?XH5N MB [8,!=+Y6(.*JGR6=>ANG90+MZPP3*[0#]7+I=.>G7S?K\9NUYPR[P)#AJM M;6:R=4[BS,)F1DCJU\G?KRR+!ZZ##9VJA8_>3EL/_W][Q]K3RJW\*RZ7JX(4 M$O813CFW1:(]ZA42]X"@[=?*V3C$8E_=!R'__LZ,O;O>9.,$$MK0\N$<$:\? M\_*,/6./.X&NL:(2B47-=+(VO+4*V&V>A0_9D#YN1/Z#X$\9K;G*_BTDH?IH?^C]-39Q6^%HS> M(1EL.A14Z*>=4N$*D .=6]S!WHJBJ^,UWB\]9SO6-!NL=3H=6\[I*HQLP.T< MI3^!LV^$_IU(U5XVOYFL-(P[7Z0N6+M%("PKM:\\@D7%;<@E%$TFZ_8V9<=^ M#;8+2^4'%[],!<.=/X_G;):4X9@!3*R TK0>#'_E983>A:]7]PSVSCW YT5 MQ70FBRD;05N9"59H9SG6Y*.D+*C^^9"J8R*:D>H:6DZ$Q,OW6-/HOFGD#%6K MV50&4S;ET%:(&.B9)KD$MC(:&)L&29D5_96+PP7*66A\S6=Y*8N?R9_R!=TI M.Z/R93\-3U:^SL6WQCEP>M[A'+BXHKZ: 2I)F NPA#FDO/=O\T&W^8L M2?58( $@"!,);,^DXBI,PZ (Y\AP&=>_:LFI(!C380UD/GD;$< 0"@Z=I36Q.!N5\Q/, MG+5(IS+5'21!4&89B(4262!;$@O$,4H:'3))PC"94:K5(W[,)%;$J5*=\64S MGJ.W% "H>!1*X-&XA5[%%ZA1A#'-&(U(4Z/A#:>$H=@:.XE ;C.) M;.(P":%F)J #HVL9D3[3XW, "'A TZK=M UN/ MLU.8YW.#GS3KX8^Y:I(GBB#_84T6PQ,.>Z%B=D@#@+I#'* FM;K MG[$(IAM4[K/+18W4T%: :BVISYX:BF2O8$_D*)"8\>LAE ^X9NDS-*"-_"JI MABI05RHY.U_D05N8P0Y.T6+E'">A\)'V1J_Z)N.,%/8,(CH6:H/!QA YZ M)3HU^)5T0,TT@\5&)L@$ SDP?7$J*()Z8NWEJ_M@Z48_)@<8TS_Y9X MD_\WLV/P_7&^*&,]3U$3J%OGMT%L,2;CJB*;I4GL)A/4\,!AZ,Z&8%#IZ4(GC M41&[C^IU6?/'\JE*B_BR!/KM!PZ://K/]3\'W]E&T#[2Z-O2Z./H6U!^]>,0 MCGH= BLL9\9\LU%U)-58>QPR1VU%"W.50VM'F>7F&@=4\/ M][-MK%H/$7R(\%Z(L"U7:Y<<-4_)=>5P_6#UWY?5[C'K4AC##H4A."R[\CJ0 M21NDOD5 !MJTZ174AJ:UVQ3_(H)I#!1YF-_/\T)$N[D>\O86N.\./\3Z+Q!K MYQBMWJERI>1 =]KQFAMVF^1^B,'?1 Q NQUZE104VJ,DHU1YC0F4#SGX!\B! M!W+@:CD BP/\KUQG'\+PCQ,&'X3!/V4C];I EU 4(B\H3@ +']@/R2*AL$%; M5NCK@@^8/V(]M65Z[=)H::EC.EZ,C]JU0>\ OO%!>W7$IW&NK("B'6FFX_<* M)3P&AE>)[M"[^^;7 @A:,]R\&I*-KRJM1!U=;^HD*4QX%3T UH!>2TKU?(N,V53F M]7D@HHCC$$&(M6>WCH8W%,1$=K0P/2.R!4\IN.$+. E MAA%T2*0Y L!S"GOAU045J/)/ACHP-!8AGR.,ZN:!BB$CO(J5A$X]#&!/P>MG M^AW.U8$"SZ==UE$: L92'^$@/'^ZO6)CB9%IC)?D%*.218U?5F(TKR8J-LND M\B23W\:DC 8GGU*@?6I"9HV#'9&N8DI:H.KX&<7QB!%="#F> MBNF_.;#M\P&=\,XK<%>'VHTYL")'L"56X]:G8-KSO*M\35Z%A2ENC+_JGO'N MX5K6/QT'=TP0ZFWZUR3^*AX2L-BC4%1Y),W+/7;G_^Z -9_:6 =4*Y81@E:Y MF>A:-]D=OJ:DZZK+D_7'7']=D0-J6\G8,-W"JP!&C"5)EB%@#652J=9@&YS_ MV1RY"_QYXC@GKOO]8,/!EZ]XWDRJ5PKG:[*I;2=577P3:K"X@>Z-$MP\S0MBO3S8#";S?K/HRSL M)]G# )2\-\#/ ZQX4'<=)D&K1\KVDV15A],,T?Q7G8/7^=VI/H5\)$)HP$>_ MMSX/EL"^S-IC\"RH.H$_U\"L:PPF/( =H>[Q@-%#TS\<./W3JJLB,7(%UU#B MVL,*Y(L)X-H)X+X' KC;$,"S$\![#P3P7D\ USX%W'V9 JZ% .XV4\"S$\#; M%P)X%@)XVQ' J@.\?=$!=@)LH0,\NP[P]D4'V FPA0[ !Z:L!/#? P'\;0@P MM!-@^!X(,-R& &=V IR]!P*K] ,&/#=I$+NN M>Z [*J7YWDD()3VV4$!1H F7F;X>=%1?Q/FC3##D%=$SY7BM@@)8*D*3X_6^ M^IUUNHMU>'3N'??8H>>KN[*'WIF+H^6I.G8N#\V< MGNMYJN'PTWF[X?'^$=TW9/FL2RC:)=?P@TIQ;/D9_X>?_P=02P,$% @ MH%6P2LTS_8J4"P -V@ !$ !M>7-Z+3(P,3]X=9VSP'F__O+V7_W^I_?7Y\XQ=Z,0F'(ND,:GX#EW5,VOG>W7^[O;^\-=Y^K"Z?=U'=*= M04@<1<04U"4)0]F5+S_<$@7$CZ%:BWY?)PH$5L[^P,4=T M$*G7(3' MX),H4 >]+Q$)C'8]!^UCH[R$S#,NG\B)X4@* M--Q[_>UA/P,\9>D3I>K9L%#02:1 IFPNCY@2BS*@$MRM*;\=)(66VMQ(".S@ M=7Q)J871 VKGP0)-_JI,#O?NS$ZO2RSR*;L%J>PL<9EFVBDS,4)=:>8@K4UC2BRV2#47-95@B:46 7YM1]L;8&G>"G,![HJ. M281K^J9/7-6'^WE &$'7M#C%]PPYSE@4VH5X2@RT:0,DZB,5".IF?*N9$@;M MT0AC7!&%_O#=6S*?4^9S_5F/LWVMXA@9'/WP\?K,[IZ,(:G3/63>"5-4+PML_.0EG%>7!5%_[;A+97A)T?^$0_1SAG2T%LXY[)IY#3SV=OK5;OV MRD4[W'=*PATM_6>+)?#BW: ML)TD>ZONKMVJQ=K^[<3U.2_R&G]S7F25;N+X/&,*0Y*P=K@1.3L-^-WR\&S- M9F_'O=IV3 0WCE(4[ACIF]->'X"!2&>T],6.[6L=L5'I!EQ& O E(=\BW301VE(?+*)=$F*5S0WVO3C2" LUS#GPCA=G.ZY5_'*3;3V!GC9Y)YC<4XLS\$%F9,)=6*I&]0B MT43"EPA2D!/LE[_:4=ZIH)SQ)2!O$)!Y!R/9]#]/9O_T;Z5G-Y#:(7^U9MSA MO$B?-FA!8PLTQF020$,@DI3;4=]M%8XX+V(A&X2T/?8H8MU(84=[KVV,LHF M9QX6C(-51:CM97:0*RO#BN_>0'23U?$Q*$(#65I@I]_L:%:6@PF7WETR?!L$ MHLV[EA!M(K##VVXY^!/L$I9CN%=1NDW4@LX*_B>1MD%-8)_A2CV^ MF<0.?&4-63\+;EZW;P2TU/%;4=I;H+J(7-4"&]C[&S9'2D.@!9V]%2J+S,:] ME(T<#*UV2LH.:2T6>\,T+D57[[%L9$LM1>A>J4UJ"NWH5Y:DEOA]DP%.NK5M M1FBFL<-=79/6POW_,@GH?W1FZC7XCDGYW-=Y:P<]2<-YH%-%S;>9R;/] M-$7V;S1IZSX,4A(MN2'YU#3<,@I)Q:F()%6O.245A? YH(\!.4B5[PV>P!X$ M?%U[RFW4*6L",EG7&F2!H'.&8+]>UY"EH?"TY@S2U$U\RA,ZL0 MP:G/8954 M]:9,[#C+_9R[1DP#BW[KIWQ]_:D_?-G?&6[=2R]6;(WZ,XO6K#_E6Z]^>W9[ MRYI3!EWE;HO*&G/,:^HT]5D9!Q HF7[IYZ+:6MV0L]VDBX4M>>[G(M;5P98& MWT:)(E_Z\@@HK%GUK?0H,F9OC]"DDGO?1HN,R3P]HO9J2GZ;ZG.N^+&?"UA7 M@>44_S;5ISSZX3%5+R?^MZH[93)/Z]6^ZKY*&V<4"%'BTA[IC7:"P[W':-#2 M%19J5X^MN?E*1%MMBE).:9-KTAY]$,_9UX7E\J%C58P+',]HF'L MUTS64X*SRX?HT7R)Y^%SII%E]9#)+3VC2_-UE<.)5,)T2[VHTY'AW^W(X_#2 M7(G;QV^43<\4A'KITW-(0G704R+2P:>AFIL-B['A\R*1Y%XQ&@3Z@"REE;@B MQ$HC7?I!\&B>5D)1/%KG5,P[O,7UHA9QRL4-"3 4E2!NH6!1+471B)#CR"=B M83/#)X&TVA$'C"HMFL1W%0YZK@"/JF]HW06$$Q"K;4SI8DOC>UC['@\)93^J MO:[AE@21$7<5J=$\S\$SAMB+']U2N07?K*D*FI^98%*7G;$+(CZ#.46^ 8RJ MJ,I26);M77Y\XQ*\R"M3(/T0.#[R3>Q NE7"% MDPT<):'XL #3DTA[#H/J\88^*6K/ S0S8O0)VQ59F ,=G!309J"WA407@\A* MRF6V;"YRER$&EWQ_8!1YO>9(29)*J M"F:5/W_GAO+4_@PYA1M-X*PVD)L*,.^'][0X I>^?W_5/1KJZYFIX+Q1UQSFGOB@^P+3,.W4$W3%!#PMY"6II MI,2?OMFJ^P,B_Y*H4\%2+GI4Y1S-P/]?8DY9UWZ!L85]:^14^ M=M^$="EA65T\BWTEZ^V-6H_5BKH[[NLH"LWY]"V<^#ZXZM#[7Q1OK!S.YP&- MMUI'_BFAXB\21!#WNX], GH5_#T[U2 ?G4Y1LM?TY]A,%!\ ]G/8(WU,*OE MDMEZX?U4B#;*?@Z(H@E1H$=Y)6:K%G4H*#O%=M)>@ 2!/:*VEW?(@AMZKV9- M)M01=,D&^X6P6@?>DKY#+IR'.'"-VB/?[%*-<7*5/@BA?RLE:1W#41HY:W"5 MC#5[S#]L5\.H:C8:3U$_.8I-.+EW9X1-X0J$J]/ZIK"\<]>*)>FVV&?G\=9:1=X\@_!WV""-FO MSAC[;(5%D])>]<.ZHDXOT(",_/>$?=8;:7K,P'M@X%-U#E+RXHS0CKS[C7;$ MM00>XY@?X(!T!5U.QFE!VVZJ^$[3>:;7R+^@C(9Z;+D\!)U-8AN#K3FZ:N48 MW!GC 9\N;A9RZ8QD%6&';!KY/BYDQ(A5$]NJ11T*Q!+EQG>\3N]"48?T;I\% M4+.=\##^[H25EYQ=PI0KJL6D&_=)QL]2:L%JT@ZM:/)-4O\<%:8!50OKINLJ MPN>P (V[7O&$N_@CY/6]=TV^[O3:?&=B DY>R@4M^J53Q@ 0\INSNHW%R?^A\K7SZ_ M^>/3G[[_X[!U[AWS((F!*>\"9=H40N^>JHYW\N"?A%1QX7T?EN75MW:W:ELU M#S]>)R!#,GCG79"!5]]]YVW7ZA^\VH?]][7]^GOO\L+S?5U'1-FO6R+!0YN8 M/*ATE.KN5ZOW]_=;_5L1;7%Q5]VNU7:J8\'*4'*_+^F$]/W.6+9>_7%Q?A5T M("8^95(1%CQIZ6*R].I[>WO5]"V*2KHO4_US'A"5HE1HEYDDB[?-4!4++BZ=)O6F>/+F I] %HN!7PN*I?5BU* MJ6H[ Q(%290"\6)5I=/!@HI9(\\'%)"RC2E+0VT3> MIL@GTK\CI(L,U'>K$"DY?J(!W/5K]1$!;T>/?S:DQ%J/$B$PTL<51.06HK3: MG]ERU9*M/"*RTV"A_G/R.Z$]$J$5LJ&.B! #;+_?292 P7H[_6FV&V+202*" M<1WX<8+JV? ?251E$L=I:3Y5$(_UVX+')H#']?*7^.%Q$8+ +@Y[N$2BD;RK M#2!1Q;L'>M=1^*IT"B\%= D-3_I=W0#0B:;J@+ -/QMM]^FSPF!$WK9+Y+5 M*D$#[*P6;8GSEN0^J7-C,R)XQR6"AYY^XRRP' F>B58_EVGI!1&_0)';"*X M+:"*@IW=!8KHQ6K#;-:)Z4@K0< 3'(DOR4!WGM>"A& QXS%HK3!X\J&?"223V^Z-%5/FSDW0.G,S9_)? M)BW'(#"35;0''1VB7U)FA&ACHR1 NU]HC'L>B9Z:9QLEAY+8BR 6&9X^?LOH-^ M\K/1(S32@_8I%U=$;V%($+VL=F$4=QIRLZ/NC7V83B6QAA*&2ZH8$UT!'6 2 MA^\S%O 8SKF4./UNMJ])WYQ4SE62TS2^&![W!LT6*$(9A"=$,!S7Y3.7CJ%- M VI*1BV4UX)'&Q!&U+UWA[IGF1RF:'-E/X6J;B2H1K>F233,)AS*./2H2E4, MP[SZB#.% 0B1[\?$/Y-DAX>+)$)PS/$T@#&1-RI6;RSS28&5IEO0*Q_%,@&?B)\M# M]Y+*KSA[T;8UV1GK@1QF5@8JLN5=)R/'2_>V=C*6 2Q62$Q:*Z3&PIEIHJ;8 M=*^]Y"W6W# !),)D,OP;$W5L]D\A]W0RJ"&HQ%?'^)7=78*@/#03^QJUK5= MO K>Q>W>=R6NM$NG7*!9;+@T$0RN!6&2!"E[+$R_C;@,_TV&?=LAM%'G9;&U M:(V;$5\+X[[8!'T94_,SIC#DX]R)+)&=TXC?SSCE^B*.4]?I.!UF7ZL<%*X'.J6DLN4 MR]4Q8+\7T-0/X\FA9V(;R-0D#"[.Z1LQ%XH^I!8VVZ>4$1:@:T=:AK["<9EMPR;>UR2!=U[SFC>!W0@7D MWF,V>#Q'(:O=R%T"X3/WON< L'B%KO1MH1Q0'E32LXY>*<$Z-? M,Z+N1?2,N&Y82KD@]K_E, M2FUNN@(@GUW51$]ZV#523 KRFMG+R]H8+A> T[U;6MF_CS0\*C&=/IH.(,U3 MS"H/"+S W8QMO85R=<=_">45(;).Y1R_Q_&*$%GW2>YU)2?M-@2JV3[I!QW" M[J!%%#19-E9S)JL+%[WFP;(XM):W1W.O"WUZ_'59?/0?4$L#!!0 ( *!5 ML$IX$H-ABTR,#$W,#,S,5]D968N>&UL[5U;<]LX MEG[?JOT/6O?K.+:L)-U)379*OF5=)5LN2YF>FA<634(2)A2I)D#;ZE^_ &^Z MX481$*!.7E*.#8#GG _ 0[.Y>__>)M'G1>0(IC$7TZZ[\Y/.B .DA#&TR\G MW\:WI[^=_.-___N__OX_IZ?_NGP:=*Z3()N#&'?N29L)!&'G%>)9Y^;/TYL0 MXB3M_+,8J]-]]_'=^;OS#OEQG $4^LN_=>[]9:?[\6^=B_/NKYWS7S]_./_< M_=!YO.^C+R0SCQ>>SL]?7UW=OSVGT+DFG9Q?GY[VS MJN%)T?+S&X(;K5][5=ONV;_N!Z-@!N;^*8P1]N-@U8L.P^K7_?3ITUG^5](4 MP<\H[S]( A_G4I+2U>&VH/\[K9J=TE^==B].>]UW;RBLZ2)M0EQ_9GV #V?% M'T^HN/PT2),(/(%)I_SQV]/=;C<8X[,0SL_*-F=^%)$O41H^X^4"?#E!<+Z( M0/6[60HF7!:K[U/*/U":?Z&CG;6@AOP,8CIA3D,P\;,(:Z1M=VQ-E"9S'\9F M""V&;D5G/L3I',R?0:J3R(UQVU X(\2D0?8,3FO&-=+)&KT-M7&"^UJ73#E@ M3E-%D&SP^1+]>4JWS?->L5G\$.A.0'E$0P]#$(1YC\2[=G-)KY*9@E M44BVXYL_,HB7UV " T@V]^6WV,_(9@W(CK,M!?(=^"> X;L@F9_E[&OY3DM> MOX(8I'YT#; /(Z1"]5:/EM^_A3%1'-"/[H@*27/]AQH0(^K>DK(13H+OEWX. MSWQ!<,I55 /:Q .8I&X,WG#F1ZV)K,9IOYXP.?20>0L!ZL?T2W.(FT*M,$I; MF<)I3 Y>@1_CFY=\W"PE7WP"BR2EGWX$*4S")C.@T8!MJ<^>$?@C(Y\!^;?" M!G1RNFJCJ.2^^>P4CY#31PX@,(9TU@X(,1MDDF: ;+%A12@=T_1^G)^VDV"# MCHB>;Y.4J=1RA3;QT7.NU3)T.O7]!=%NW8]G(,*H^@V5[,?3\VYYH/VE_+57 MDT>8!W?D1U1])?*?091_V^,W]LX+(=J@>.P_K^:0B-J\H=?=AKN?;M),3A75 M:.4!H]&)?9(F&""7)@M),IWUQ:/DZJRQ-J>+_2L@<) C=;]@$&!@*^WGOC6#',E<)*8'.HDV$_;S/AR-/I/Q40'5M8[4%H'2?9'9 MWOMH5X5)Q+,\M($SB.*"N]*+FGIJAU)(ESZXY4->VT]7ZUJ(ZX"X&- M"(MX9U#HAR$L/OWHP_ NOO(7$/N1%!%A/^^WXT%'QH@.W;-K>**_\?HO/HRH M9B0'E9%/;5@(I"^ *WMY)^^3^X)7XJ*2^H7]!1($V3R+J*%MB&<@I?RE8$9W M\1=0'$SEBT5U#*][[CZ >W%5 =JS#N@3M=#&(+SQTQC&4_F]B-W!ZQHQ]YF! MBL]"A"V\^6PW]KI&['>*>#0SQ+)H=^>.D[\BH&&&J<<,]042 MX;#=UNN:L<\9@(%%NCMZA[&;/@ \G(S]-_%!F=?+Z]HTX31!1L*$.ZJD'_XG M0\4#[SCA'"3S:;;S?)WO <.<;O0$R": ( 8C<@2" 2C>7)] D$P+F(3'\(-0 MX'6-&),,S)T#"L0QU7F'4 ;"XOV^H/>??I2!_&@FTZ2BOE[7C+G*D&*5L5*A M]L%5U$J]M!]L:YV]KDT;B0;FR:0)6#(N*IA^M0Z3BBKXW4]3/\;%Y&NI9S?&\KHV33&Z->8.:Q7* MOUE'6;3I7R5Q&=TPG!0_8[@Q M_^%.FP.Z'O)X9EGYMTBTY7#(>WZ9IB#_$,?+8K>111=!ICQ9#RM;]&IX:)2) MC_O.SFIFRWV/+1R1 '4ZYVD6H64/A?UEJ=,+@2/3VRP.GWR(B/JJ/R]^4>7W ML.+TQIN%#/D**7?&Q: ^@HP"$/OD1*'JU;;>WJ(WF\+6*R/=H<>=DK!O,5J M( _BEOI)@%RS9FM-5('4"&KF*YQB(=C.)I'N.VX_^DFKRFG2I QV[@UU?1Y4EQ(:,SXVY$TFUL1=1Y?UG MA%,_P+R#![NU'8?%?SX-,JPX.QD39AR9B^[\M%,Y$Y'_FS'HW$_$"IZ#08M4)L3>@#]_28NCWX=OIX\G5J? "8/"69*E]G.CC_<'A.; M1;@.GT6Y/*]F(/BN(M"BH1U/M78275$N<2@T^N0M2BYVZ*P#1,7G7B.7?D03 M;8YF ."O:9(M8#RMZ:SM@%=^X6D[4$@*U'9H"RF$5B0O643+$@NI=+>0;D@# M$)S]7Y'AXTY9M,9D_>/_0;+_I,%L.0 O()+8']4&<""1D2JQ%W9E+S-^*?:Q6['GCNV516=O+_#*7H;\ M5ZR#MV+/'8,6ZZI:_ZZ/$,"(=51$@L<.74-;];PP>*=J+Q9WUOY=_ +***5: M8M<0T?L<63N"R2'N:#53D0Z V-!+F3;W5/F8X3*(FF?_6[6PFJY(O_1WN7-G M_0BY'4#_&4:YT=W('JPZOEV7 $L[<1/AZ%#GG'5;AGAR5VWU=[MYC_1)DK%T MUUETYL9R#5+XXF/X M;8*U+:BM:CJ)O=5$FF(%3EW)T]^88(*@Q!N**XWH*& MD]T_LA_=]Q_,;JHFT]-@/WE(-EBCCWGB:CP'GYN+*%F"*@$..V5./XK*5-S# M29D_;/0BP_"[$<$62.O"'^&(581B B8TY+'[-^'/;#.9$W M/;K2(^?-&]V'@#P!<:-QCK%02U,&G4&XU!\@9*N7DG !M&H#6'UD/-@I35D6 MDAN\O4M:5?711L+F74BH,6N:K\/+Y:I)&;[4?_734.5ZUGYPJS'\ 6&-#Q*K+R8[5VH0FE>=?%8=^>M<8?"WR&>/8&HR'PP@XMQMEDV',EVCC N-(I(2KES=[T>#F)'M*1IK ^0>^R*?)E\P9G:.6^#7\>@DM>Q7+4RY<2I?"K;%*1 V+N5 M*H]2VHXQ>4M"\S9 3--A["8K&Q?@/9AT9W+S6.:! "$Z)8(@TXN&@U" M2Y#5[ B6F;2OG;J;6I:;$F\&\R?F4I [=(^=+1WEG;DJ"E"PZ)-4:_,;>A;5$W*T$SV7&H2K- M!W*AOK"6Q;NMHE=G4$=59I&VI]\N;^Z(W,;(2@;PA5K,N5D#)-V\"VM)PMOK M=C%;#M5%WMN, M2/*2MS MB&VFD[X&Q S ''=8B1Z_7)=" M2ER>*NQISI.I,X\2]IQ!+4>U<)%1!%+*W4^(G8F*,8VU>\XOUV1C"\C84E>, MS8968V/V6&)L_'9X,N<>3%5"'-)D@&('U>UV5B/U6PN:QY)#CA6S),5CD,ZO MP;-20"VKO9F0E!_F[,.3J<.S1!X!RNYA**I"/427)VI%9&HNG%%@&J%QY!"B M"R/W#AM72?P"4@S);D")E9XYF.VMALD(%@0;'1X+SF"B+Z>$$:^*'T<)4WE0(AG*SMTY7P2W4+F3%Y07="B17M*).M-Q3C7HR5EA-I2]>'DH@N1J< MI1ZU^-,*WD8);@A2AZNIM0 ]RT;K34$*A+T;J724TG9$2347NWN::,]P2)L& MX>V9S!;\#L'NB'R_<$B;IF%%D6\3;#AJIW0QRAV.UAR0%&,BU4>P$U3E@EO& M'H(RB/D@06CU^>6U/_>G E=X@5=+$9B-90H Q,)7\[L=6PZ1TDVG6$><,I] M+49?M4*P$8,'7T]%'.8-]0#%(-QC=3$&L!B$96JM<;ATQWRW98M6-[Q;#-;2 MLJP8[!B,8]SZ6C\,(2Z= 3G'#G9[B\%9[9>(B"F#P8GY=_*Q5A5KAW%_F@)A MN+:DF\5HK?9(*/"F(W)1EY?^,U[5[Z,/;2*7I)W&%H.RM&Q4;(YT1#*:@&=M MC1<_4B-)'J#<549-,(;%6"X#8$H8=2=^-.=.76Y>+!GX/A MY#$BHL%P,E&_'6]U]"Z.T[BASITLX-$>A@/_%640WT+RH>DUV1744=SIZEW\ MI4P<3/YJ).U[?EYF",: DCQ_AG%N:JVIQQMI*-:SP:H%.K<>V[LX3B.*5@'4 MD\6^@>66@@ &\(7:V*D9"'U-R7073 %.#Z]WW 87 5LU7 8L+P\996PX&0": M20' )&2(GM/2ZQVQM87-3BWJ-H8630J1$G;SMH#%B.R&KN]8[3""/C MJ4;)OO5EN,BWVWB:TXIN,YREH'PVKQX-'PC#3TE>7G7\"J(7<$_$,1/M<2U& M]7K';<]IR7H]-0SDL%IE^+OTX^]?,S^ESQ:@? (>$*V\&FA[]U3IZ_6.TWK3 MB,$:(/MFFWR&$7:?J+$ADF>Y8K;W>L=MC.$R50-E()/5%5F\_G-2'E0KN[KX M"J#6T>L=IZ%%G;L:%_MVEY&?5_J@V9M6-KOA9/@:@Y3&NO8G&*1YBEO"M/AB MUW0HKW?;WCMN0TY[;&W(#KRMK&,ISD1RSZX!DD[WCM+@TY;%&JHU1 M106I,0AF<1(ET^5HB3C9TQ1Z>>^/TV"BR%H-A_U8B#7ZRI5/]P%ANBAV#^_] M<1I<%-BJX;)O>"F3(Q=SJW(>^/VQ CXZU&S[Y!1EC$9)6+ MN8\0$"[!1N-X[X_;Z-*8V1IP^PXVJQS_(C3K1M[[XS2RL#FI<7# FK+Y2MF/ M(C MLAZI/]VN=?+>'[E=1Q*G,LPUQYIU0&_#N3&37.FW2C".[C6WG>6TF=#EP[N5W M;0V0*U'VAI!R+Q9_."$G&R!/SKK1SFIN5O8*X+R.;U%M+OMJ^:5AS,\KP6QG M-?NJBBAY5!N,$2V_-GY-E&19MS.3)-60+->IUA' R2N"I'1Y42WIO,]@AA*2 M-D=%[6#=BE%W\LFN(O%$1^"U5E:27K83-GO/W^3)&46[7FI89GDKFYG)=VD! MDBVF#*J.AR1^ -,$0WK]^=VG/MT8W;R1>Q9$'%N!4C]3J20/AX4RFPYE$XA\ MA(:3DLYA^@2G,UQ26]ATZS^B\J](Y/.[UWAV,AZ:6(5[LZ\[31X"P;MI\D)D M0G=J.A]ZY<]T)O369D+QV[4M?35GU[V<&9@K]C243O& Z#9@]! EFX>3 =E< M8 3Q;[@=;'Q M;+&5EU;V*L%H;N'102! WCF.3?AQOR7D0?24G%$ 8I^L:UER>E9[%UX(..!P MH.1PX>^U-B_V="JM5^X%-B8[%#O# !2+[K28\SFFT#S4T%-M#O6S^J@#8'0 MFVK5RNK307.1;U+NCL4F=XR<)1$A!]W\D9&;CO @M=W8ZE/!'L=A%@/NU!18 MFR3].&P$C:RKW0I9;98+CQV);>1 =_#2V%#[H MKN-D47+0TEA-R[ MJ1_:P=S(C=^@OFK$FCMV@;;^R6:L!"82ZVPL@1W26*:3#W ML.B2RIB&# &+27=&@>T6&!:?ZIGM#7F)&CS!<]EPYP%CAT1:=S+7W?0H-8.+ M<7(38ZAP4FPXDBFO4.6#/A\<13#E_+F[_@Z(LB.W!?-PNW=ON(8I"%3N#9L- M[3@%MUEG; AWN7(&&3T.D6;*=1_<(W*MB+?]5&MZ7>X,5?=NZ11)!N#<4';@SMGEMF^OJQ6"K#O@Q"??G>>4VC9 I^6+1@^1[!,UW:Y?/!I M#0K)H4'6U5"==8/G!Q6.W"F#RZ*VH%6JK61=315>5SY8*"&A#N(V;\[L@68Q M=.3@819,]^[%9=&>FG:Y@F-VH!7H[2DZI67$T7=<=LR=%@NWV_7CT*4?T>(" MHQD 6#$Y3J-!:)%Z9SQV!I)L.(TY,YC@@SXJH ? 1:'Z.RTZ;^EUI+FX.(\G M%1_.[$WDDO =8'H,&H$@2V7Q-:SFM-K\D>(B8\N=<_F5CV8"7.B?:47X(\>A M8L.@&\%*CTT>$LR<[,QV%DO.:]E]6/SH>!>4B_EJ!H+O*G(N&EHL%*];T"N& M#.9IZ8?_REO-E,50AQRG,P MHC#/Z.C/!'CRG_\'4$L#!!0 ( *!5L$H05(+VUD ->6 P 5 ;7ES M>BTR,#$W,#,S,5]L86(N>&UL[7W[<^,VTN#O5W7_ RY[5=],E3R/3!Z;W.Y^ M);\F2CR6SW9VO[W458HF(8L;BE1(RK;RUQ\:X$LB 0)\-6;K?DA&EH &&N@7 M&HWNO_SGRR8@3S1._"C\ZQ?OW[S[@M#0C3P_?/SK%S_?7Y[\^8O__-M__V]_ M^1\G)_]U>GM%SB-WMZ%A2CZQ-BN?>N393]?DXH^3"\]/HYC\7< B[]]\\^;= MFW>$?;S?T<1S]C/RR=F3]]_,R)?OWG]+WGW[_=?OOG__-;GY1$Y.8(S #W][ M'N+@310_OOWRW;L/;_.&7XB6W[\D_D'K MYP]YV_=O_^O3U9V[IAOGQ ^3U G=LA> :>KW_KOOOGO+?V5-$__[A/>_BEPG MY:O4.B\B;0%_G>3-3N"KD_=?GGQX_^8E\;Z -8BC@-[2%>'#?Y_NM_2O7R3^ M9AO M/EWZYBNFN<0Q/%;Z/\VI(].2CV _QW ?_\-P/]3]O65\T"#+PBT_/EV M(47GNP-8HM/;OY$I9GA#8S_R+L)N4SWJ/>F<[U(G3GO,NM)_HGG?1ZD3=)IQ MI>=$<[VFW=:VZ#?5FC(92+NM:=ESP+FF]7D:+V2Y@B"IX?,5&_]@9O0EI:%' MO7QNT%,A+3E@+F6Y\(_< V !B-LH/L1SLT_^. 'M\>Z#D)E_@F]^S972/&1L MG_KI?A&NHGC#Q?7\(4ECQTUS0'SJ'/RO'Q;O_OS#5]\NWGWS_NM?]0&]_5N^ M @<3CFD2[6*7&F$O-N%P9L[#KU__].6['[_Y[J4:_%>JM-=1F:',6$NF\>HZ>W'O49JN^_@@] D5^=O'N? MZ?$_L:]^%>/>TDV? M?Y7VGX#R?OKQQQ^_7GSZ=/7I&\9F5U>+;[Y[)Y]0G> R&BO;$6B(05QF2WM$ M4V;+, 4IG3%ZCIU@P03LRT]TWR;.Y!VG%E\J%"34DS4DO"5A3=&%4^L^- JC MMDT8BV+N8P<.<'?[S4-4VQ\5:QQVQ!0WQR@<4TKV.Q$-K)(OC:O?*EB:EGXL M^I@SY>B!@KP,G$<=27+8 4."'$_YF!Z*WPDTL$)>-*ZR5$XT+?%8^W^VBV,8 MR4]<)_@G=6)V6#YGQP\342&%@2DU%(@=$TS6E(BV!!HS ]DCT-PJ<=*V6:V2 MI66GQB*RW B_9V!U9,Q!>PP1)$M3EC4U0IPR[9-XF)6#GNBBEAZFA(Z:BJGGAC MJR2/9#]:A5#S9DQ#/8)N9?33RC1U(#;(I2;4VF@J$U%H5-5AJ4UEE&RSQG75 M7/H!C<^85'R,8@-'S6$W/#?-\?0E3AK>C.3MK!!+BN5O\<\TK?W(_KQHLXG" MNS1R?[M;.VQ;E[L4[J?!"6#N*%9"PW<;MR K
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
7-Z+3(P,37-Z+3(P,3!*#87,7 =: $ %0 @ $Z MC ;7ES>BTR,#$W,#,S,5]D968N>&UL4$L! A0#% @ H%6P2A!4@O;6 M0 UY8# !4 ( !X*, &UYGD M !M>7-Z+3(P,3